nanotools 1042/PC3/LC3II说明书

nanotools  1042/PC3/LC3II说明书

 

 

 阳性对照细胞裂解物

复溶

 

应用

含LC3 II的细胞组分是用LC3 I缓冲液(订单号3041-050/LC3I-缓冲液)和LC3-试剂盒中的LC II缓冲液(订单号3042-025/LC3II-缓冲液)从半流式PC3细胞中制备。

3043/LC3-KIT)。

冻干提取的蛋白。1瓶相当于3.7 x 106个细胞。样品含有SDS和0.001%溴酚蓝。

 

加入200µl H2O复溶。*溶解后,加入200µl 2x SDS-PAGE样品缓冲液,混合并在90 ℃下孵育5 min。

等分并冷冻储存。避免反复冻融循环。

 

建议将阳性对照细胞裂解物用于免疫印迹应用。

使用20µl/泳道(迷你凝胶)对目标蛋白进行HRPO/ECL检测。20µl/泳道相当于约105个细胞。

请注意:

冻干细胞裂解物含有SDS,不推荐用于天然蛋白的应用,如免疫沉淀。

 

LC3I和LC3II的检测(Western Blot)

阳性对照PC3-LC3I(编号1041)

PC3-LC3II(编号1042)

含mabs

LC3B:LC3-2G6(编号0260)LC3B:LC3-5F10(编号0231)LC3ABC:LC3-5H3(编号0261)

 

– LC3 I

– LC3 II

 

 

 

真空聚碳酸脂干燥箱

真空聚碳酸脂干燥箱

  • 产品特性
  • 相关资料
  • Q&A
  • 参考文献

真空聚碳酸脂干燥箱真空聚碳酸脂干燥箱

 


真空聚碳酸脂干燥箱

真空聚碳酸脂干燥箱

真空聚碳酸脂干燥箱


PC-210/PC-250


PC-210K/PC-250K


PC-210KG/PC-250KG


由透明聚碳酸酯制成,可视性、气密性优异,是一款兼具耐冲击性和耐热性的真空多功能干燥器。PC-210K、PC-250K 和 PC-210KG、PC-250KG 喷嘴直径 φ9 mm,带旋塞。


备注:

  • 每种类型都配有特殊的陶瓷板。

  • 带真空计型号的真空计测量范围为 0~-0.1 MPa(最小刻度单位是 0.002 MPa)。



真空聚碳酸脂干燥箱



◆优点特色


● 本体和盖子都是完全透明的。保管品的状况和凝胶交换时机您都可以一目了然。
● 箱盖接口有 O ring 密封设计,无须涂抹凡士林。
● 本干燥箱使用透明树脂中有大强度的材质,不会轻易打烂或刮花,做减压真空实验时可完全放心。
● 磁制板耐热、耐蚀、不粘性优越。
● PC 材料,拉伸性,耐冲击性好,耐热性优越。
 

◆案例应用

干燥箱广泛应用于生物化学,化工制药、医疗卫生、农业科研、环境保护等研究应用领域,作粉末干燥、烘培以及各类玻璃容器的消毒和灭菌用。特别适合于对干燥热敏性、易分解、易氧化物质和复杂成分物品进行快速高效的干燥处理。

真空聚碳酸脂干燥箱

三博特干燥箱单页



Q1:

聚碳酸脂干燥箱(附活栓)有可能在真空泵的作用下保持真空状态吗?

A1:

本产品是用名为聚碳酸脂(即 PC )一类的树脂压制而成。聚碳酸脂是一种抗冲击性极强的树脂。当然,为了减少压力、保持真空状态,采用真空泵的设计。若要开展实验确认真空聚碳酸脂干燥箱内真空度,我们建议使用产品号为 4705PC-210G 的产品。

Q2:

聚碳酸脂干燥箱的耐热温度是多少?我想在容器内放置反应皿。

A2:

聚碳酸脂干燥箱的材质为 PC(聚碳酸脂)。一般的PC热变形温度为 130℃~140℃,使用附属的陶瓷板隔开反应皿等高温物,避免其与真空聚碳酸脂干燥箱本体接触便没有问题。

Q3:

想把聚碳酸脂干燥箱作为真空干燥箱使用,按照以往那样使用会不会有问题?

A3:

即使当作真空干燥箱使用也是完全没问题。聚碳酸脂干燥箱外形为圆形,和有角的类型相比在有效容积方面虽显拙劣,但由于是一体成型品,强度方面是完全没问题的。另外,与通常的真空干燥箱相比重量也是尤其轻,即使是女性也能方便携带。

产品列表
产品编号 产品名称 产品规格 产品等级 备注
WEB0062 PC-210K Φ200附活栓
WEB0063 PC-250K Φ230附活栓
WEB0064 PC-210 Φ213无活栓
WEB0065 PC-250 Φ243无活栓
WEB4705 PC-210KG Φ200附活栓真空计
WEB4706 PC-250KG Φ230附活栓真空计

PC-Biotin-NHS


PC-Biotin-NHS

简要描述:Ambergen是著名的分子和蛋白诊断原料提供商,其生产的高品质原料广泛应用于各大诊断试剂公司,客户分布于,现金畔实验为其中国*代理,想享受Ambergen的高品质产品请直接金畔实验
PC-Biotin-NHS
Catalog Number PCB-N-001: 1 mg size
Catalog Number PCB-N-005: 5 mg size

详细介绍

产品咨询

Ambergen是著名的分子和蛋白诊断原料提供商,其生产的高品质原料广泛应用于各大诊断试剂公司,客户分布于,现金畔实验为其中国*代理,想享受Ambergen的高品质产品请直接金畔实验
 

PC-Biotin-NHS

  • Catalog Number PCB-N-001: 1 mg size
  • Catalog Number PCB-N-005: 5 mg size
  • Catalog Number PCB-N-100: 100 mg size

上海金畔生物科技有限公司

实验试剂一站式采购服务商

1:强大的进口辐射能力,血清、抗体、耗材、大部分限制进口品等。

2:产品种类齐全,经营超过700多个品牌,基本涵盖所有生物实验试剂耗材。

3:提供加急服务,货品一般1-2周到货。

4:富有竞争力的价格优势,绝大部分价格有优势。

5:多年积累良好的信誉,大部分客户提供货到付款服务。客户包括清华、北大、交大、复旦、中山等100多所高校,ROCHE,阿斯利康、国药、fisher等药企。

6:我们还是Santa,Advanced Biotechnologies Inc,Athens Research & Technology,bangs,BBInternational,crystalchem,dianova,FD Neurotechnologies,Inc. FormuMax Scientific,Inc, Genebridege, Glycotope Biotechnology GmbH; iduron,Innovative Research of America, Ludger, neuroprobe,omicronbio, Polysciences,prospecbi, QA-BIO,quickzyme,RESEARCH DIETS,INC,sterlitech;sysy,TriLink BioTechnologies,Inc;worthington-biochem,zyagen等几十家国外公司代理。

7:我们还是invitrogen,qiagen,abcam,sigma;neb,roche,merck, rnd,BD, GE,pierce,BioLegend等*批发,欢迎合作。

Trevigen 2275-PC-100说明书

Trevigen 2275-PC-100说明书 

Human/Mouse/Rat GAPDH Antibody

Catalog # 2275-PC-100
Catalog #
Availability
Size / Price
Qty
2275-PC-100
  In Stock
100 uL

主要产品详情

物种反应性: 人、小鼠、大鼠
免疫原: 对应于人 GAPDH/G3PDH 序列的一部分的合成肽
应用: 免疫沉淀,简单蛋白质印迹,蛋白质印迹
标签: 未结合的
来源: 多克隆兔IgG
特异性:

在蛋白质印迹中检测人类、小鼠和大鼠 GAPDH/G3PDH。

货号 品名 规格 价格 品牌
2275-PC-020 Human/Mouse/Rat GAPDH Antibody (T0893) (20 uL )  20 uL 1,014.00  Trevigen
3400-010-02 Cultrex Mouse Laminin I, Pathclear (1 MG) 1 MG 1,711.00  Trevigen
3421-001-03 Cultrex Stem Cell Qualified Human Vitronectin, PathClear (200 ug) 200 ug 3,700.00  Trevigen
3432-005-01P Cultrex PathClear Basement Membrane Extract with Phenol Red (5 mL) 5 mL 2,175.00  Trevigen
3432-010-01 Cultrex PathClear Basement Membrane Extract (2 x 5 mL) (10 mL) 10 mL 3,633.00  Trevigen
3432-010-01P Cultrex PathClear BME with Phenol Red (2 x 5 mL) (10 mL) 10 mL 3,633.00  Trevigen
3433-005-01P Cultrex PathClear Reduced Growth Factor BME with Phenol Red (5 mL) 5 mL 2,599.00  Trevigen
3433-010-01 Cultrex PathClear Reduced Growth Factor BME (2 x 5 mL) (10 mL) 10 mL 4,429.00  Trevigen
3433-010-01P Cultrex PathClear RGF BME with Phenol Red (2 x 5 mL) (10 mL) 10 mL 4,429.00  Trevigen
3433-010-R1 Cultrex Reduced Growth Factor Basement Membrane, Type R1 (10 mL) 10 mL 4,429.00  Trevigen
3434-010-02 Cultrex Stem Cell Qualified, Reduced Growth Factor BME (10 mL) 10 mL 5,079.00  Trevigen
3438-200-01 Cultrex Poly-L-Lysine (2 x 100 mL) (200 mL) 200 mL 2,042.00  Trevigen
3439-200-01 Cultrex Poly-D-Lysine (2 x 100 mL) (200 mL) 200 mL 2,042.00  Trevigen
3442-050-01 Cultrex Bovine Collagen I (50 mg) 50 mg 2,307.00  Trevigen
3443-100-01 Cultrex Rat Collagen I, Lower Viscosity (100 mg) 100 mg 2,175.00  Trevigen
3445-010-01 Cultrex PathClear 3-D Culture Matrix RGF BME (2 x 5 mL) (10 mL) 10 mL 5,172.00  Trevigen
3447-020-01 Cultrex 3D Culture Matrix Rat Collagen I (100 mg) 100 mg 2,241.00  Trevigen
3448-020-01 Cultrex™ 3-D Culture 10X Cell Harvesting Buffer (100 mL) 100 mL 1,180.00  Trevigen
3448-020-02 Cultrex™ 3-D Culture 10X Cell Wash Buffer (100 mL) 100 mL 1,180.00  Trevigen
3448-020-03 Cultrex™ 3-D Culture Sample Buffer (10 mL) 10 mL 583.00  Trevigen
3448-020-04 Cultrex™ 3-D Culture 10X Loading Buffer (1 mL) 1 mL 583.00  Trevigen
3448-020-CH 3-D Culture Cell Harvest Buffers (100 mL) 100 mL 1,246.00  Trevigen
3448-020-CL 3-D Culture Cell Loading Buffers (10 mL) 10 mL 583.00  Trevigen
3448-020-K 3D Culture Cell Harvesting Kit (20 Tests) 20 Tests 1,909.00  Trevigen
3450-048-05 DIVAA Cell Sperse (15 mL) 15 mL 1,074.00  Trevigen
3450-048-B10 DIVAA FGF-2 (1.8 ?g)/VEGF(600 ng) (60 uL) 60 uL 2,042.00  Trevigen
3450-048-B9 DIVAA FGF-2 (300 ng)/VEGF(100 ng) (10 uL) 10 uL 544.00  Trevigen
3450-048-DA DIVAA Angioreactor with BME (3450-048-01 & 3450-048-02) (48 Tests) 48 Tests 6,219.00  Trevigen
3450-048-FL 200X FITC Lectin & Diluent (48 Tests) 48 Tests 517.00  Trevigen
3450-048-IK Directed In Vivo Angiogenesis Assay Inhibition Kit (1 Kit) 1 Kit 8,473.00  Trevigen
3450-048-K Directed In Vivo Angiogenesis Assay (1 Kit) 1 Kit 8,075.00  Trevigen
3450-048-SK Directed In Vivo Angiogenesis Assay Starter Kit (1 Kit) 1 Kit 9,401.00  Trevigen
3455-096-04 25X Cell Wash Buffer (3 mL) 3 mL 782.00  Trevigen
3470-096-K Cultrex In Vitro Angiogenesis Assay (Tube Formation) 96 well (1 Kit) 1 Kit 3,965.00  Trevigen
3500-096-01 Cultrex Spheroid Formation Extracellular Matrix, 10XCultrex (600 uL) 600 uL 3,169.00  Trevigen
3500-096-03 Cultrex Spheroid Invasion Extracellular Matrix (6 mL) 6 mL 3,169.00  Trevigen
3500-096-IP 10x Spheroid Invasion Matrix and Plate (96 Tests) 96 Tests 3,434.00  Trevigen
3500-096-K Cultrex 3D BME Cell Invasion Assay, 96 well (1 Kit) 1 Kit 3,965.00  Trevigen
3500-096-SP 10X Spheroid Formation Matrix and Plate (96 Tests) 96 Tests 3,434.00  Trevigen
3510-096-K Cultrex 3D Spheroid Fluorometric Assay, 96 well (1 Kit) 1 Kit 3,965.00  Trevigen
3511-096-K Cultrex 3D Spheroid Colorimetric Assay, 96 well (1 Kit) 1 Kit 3,965.00  Trevigen
3532-005-02P Cultrex PathClear BME, Type 2 (w/ Phenol Red) (5 mL) 5 mL 2,321.00  Trevigen
3532-010-02 Cultrex PathClear BME, Type 2 (2 x 5 mL) (10 mL) 10 mL 3,700.00  Trevigen
3532-010-02P Cultrex PathClear BME, Type 2 (w/ Phenol Red) (2 x 5 mL) (10 mL) 10 mL 3,700.00  Trevigen
3533-005-02P Cultrex PathClear Reduced Growth Factor BME (w/ Phenol Red) (5 mL) 5 mL 3,249.00  Trevigen
3533-010-02P Cultrex PathClear Reduced GF BME (w/ Phenol Red) (2 x 5 mL) (10 mL) 10 mL 5,168.00  Trevigen
3632-005-02P Cultrex PathClear BME, Type 3 (w/ Phenol Red) (5 mL) 5 mL 2,166.00  Trevigen
3632-010-02 Cultrex PathClear BME, Type 3 (2 x 5 mL) (10 mL) 10 mL 3,644.00  Trevigen
3632-010-02P Cultrex PathClear BME, Type 3 (w/ Phenol Red) (2 x 5 mL) (10 mL) 10 mL 3,644.00  Trevigen
3700-100-01 Cultrex™ Organoid Harvesting Solution (100 mL) 100 mL 796.00  Trevigen
3950-075-02 FLARE Slides 25 Slides (T0278) (25 EA) 25 EA 2,231.00  Trevigen
3950-300-02 FLARE Slides 100 Slides (100 EA) 100 EA 5,124.00  Trevigen
4250-004-03 CometSlide 2 Slides (T0135) (2 Tests) 2 Tests 608.00  Trevigen
4250-010-01 CometAssay Lysis Solution (T0131) (100 mL) 100 mL 1,068.00  Trevigen
4250-050-02 CometAssay LM Agarose (T0132) (15 mL) 15 mL 744.00  Trevigen
4250-050-03 CometSlide 25 Slides (25 EA) 25 EA 1,555.00  Trevigen
4250-050-04 200 mM EDTA, pH 10 (T0133) (12.5 mL) 12.5 mL 744.00  Trevigen
4250-050-ES CometAssay Electrophoresis System II (1 Kit) 1 Kit 30,406.00  Trevigen
4250-050-ESK CometAssay Electrophoresis Starter Kit (1 Kit) 1 Kit 32,434.00  Trevigen
4250-200-03 CometSlide 100 Slides (100 Tests) 100 Tests 3,718.00  Trevigen
4250-500-02 CometAssay LMAgarose (100 mL) 100 mL 4,259.00  Trevigen
4251-050-K CometAssay® Silver Kit (50 Tests) 50 Tests 5,070.00  Trevigen
4252-02K-01 CometSlide High Throughput, 100 Slides (100 Tests) 100 Tests 15,210.00  Trevigen
4252-040-01 CometSlide High Throughput, 2 Slides (2 Tests) 2 Tests 744.00  Trevigen
4252-040-ESK CometAssay 20 Well ES Starter Kit (1 Kit) 1 Kit 32,434.00  Trevigen
4252-040-K CometAssay High Throughput Kit (40 Tests) 40 Tests 3,772.00  Trevigen
4252-200-01 CometSlide High Throughput, 10 Slides (10 Tests) 10 Tests 3,177.00  Trevigen
4252-500-01 CometSlide High Throughput, 25 Slides (25 Tests) 25 Tests 5,259.00  Trevigen
4253-096-03 96-well CometSlide (1 Tests) 1 Tests 744.00  Trevigen
4253-096-ESK CometAssay 96-well Electrophoresis Starter Kit (1 Kit) 1 Kit 32,434.00  Trevigen
4253-096-K CometAssay® 96-well Kit (96 Tests) 96 Tests 3,772.00  Trevigen
4254-200-K CometAssay Silver Staining Components Kit (200 Tests) 200 Tests 2,690.00  Trevigen
4260-000-CS CometAssay Software (1 EA) 1 EA 44,602.00  Trevigen
4260-096-CS 96-well CometChip System (96 Tests) 96 Tests 18,238.00  Trevigen
4260-096-ESK CometChip ES Starter Kit (1 Kit) 1 Kit 45,954.00  Trevigen
4260-096-K CometChip Kit (96 Tests) 96 Tests 5,070.00  Trevigen
4335-MC-100 Anti-PAR Monoclonal Antibody (100 uL) 100 uL 4,320.00  Trevigen
4336-100-01 Poly(ADP-ribose) Polymer/pADPr (100 uL) 100 uL 2,516.00  Trevigen
4336-100-02 Biotin(Terminal)-PAR (T1165) (100 uL) 100 uL 3,469.00  Trevigen
4354-MC-050 8-oxo-dG Antibody (50 uL) 50 uL 6,166.00  Trevigen
4380-096-K HT 8-oxo-dG ELISA II Kit (1 Kit) 1 Kit 12,606.00  Trevigen
4380-192-K HT 8-oxo-dG ELISA II Kit, 2 Plates (1 KIT) 1 KIT 17,219.00  Trevigen
4418-096-K HT Gamma H2AX Elisa Kit (96 Tests) 96 Tests 16,380.00  Trevigen
4418-APC-020 Anti-phos histone H2AX (20 uL) 20 uL 1,225.00  Trevigen
4418-APC-100 Anti-Phospho Histone H2AX Affinity Purified Polyclonal Ab (100 uL) 100 uL 5,017.00  Trevigen
4500-10-P PARP Treated Protein Control for Western Blot (T0439) (10 uL) 10 uL 1,148.00  Trevigen
4667-50-03 200 mM 3-Aminobenzamide (60 uL) 60 uL 1,166.00  Trevigen
4668-100-01 Recombinant Human PARP Enzyme (HSA) (1000 U) 1000 U 3,525.00  Trevigen
4671-096-04 10X Strep-Diluent (2 mL) 2 mL 577.00  Trevigen
4675-096-01 PeroxyGlow A (6 mL) 6 mL 577.00  Trevigen
4675-096-02 PeroxyGlow B (6 mL) 6 mL 577.00  Trevigen
4676-096-K Universal Chemiluminescent PARP Assay – Histone Coated Wells (96 Tests) 96 Tests 6,539.00  Trevigen
4677-096-K PARP Universal Colorimetric Assay Kit (1 Kit) 1 Kit 6,539.00  Trevigen
4684-096-06 10 mM Etoposide (T0909) (100 uL) 100 uL 933.00  Trevigen
4684-096-K HT Colorimetric  PARP Apoptosis Assay Kit (96 Tests) 96 Tests 7,129.00  Trevigen
4685-096-K HT Chemiluminescent PARP Apoptosis Assay Kit (96 Tests) 96 Tests 7,129.00  Trevigen
4800-30-01 Proteinase K (50 uL) 50 uL 504.00  Trevigen
4800-30-06 Streptavidin-HRP (30 uL) 30 uL 838.00  Trevigen
4800-30-07 Diaminobenzidine (DAB) (3.75 ml) 3.75 ml 446.00  Trevigen
4800-30-09 DAB Enhancer (1 mL) 1 mL 516.00  Trevigen
4800-30-14 Streptavidin-Fluorescein (30 uL) 30 uL 994.00  Trevigen
4800-30-17 Nuclear Fast Red (T0136) (50 mL) 50 mL 594.00  Trevigen
4800-30-18 Methyl Green 1% (T0199) (50 mL) 50 mL 594.00  Trevigen
4800-30-19 Red Counterstain C (50 mL) 50 mL 632.00  Trevigen
4800-30-N TACS Nuclease and Buffer (15 uL) 15 uL 915.00  Trevigen
4810-30-02 10X TdT Labeling Buffer (T0176) (100 mL) 100 mL 796.00  Trevigen
4810-30-03 10X TdT Stop Buffer  (T0177), 100 mL (100 mL) 100 mL 504.00  Trevigen
4810-30-04 TdT dNTP Mix (30 uL) 30 uL 1,465.00  Trevigen
4810-30-05 Terminal Deoxynucleotidyl Transferase (TdT) Enzyme (30 uL) 30 uL 1,750.00  Trevigen
4810-30-CK TACS 2 TdT Core Reagent Kit (30 Tests) 30 Tests 4,230.00  Trevigen
4810-30-K TdT In Situ Apoptosis Detection Kit – DAB (30 Tests) 30 Tests 5,291.00  Trevigen
4810-30-R TdT In Situ Apoptosis Detection Kit – Replenisher (30 Tests) 30 Tests 3,965.00  Trevigen
4810-90-09 Cobalt Cation (3 Vial) 3 Vial 573.00  Trevigen
4810-90-10 Magnesium Cation (3 Vial) 3 Vial 573.00  Trevigen
4810-90-14 Manganese Cation (3 Vial) 3 Vial 573.00  Trevigen
4811-30-K TdT In Situ Apoptosis Detection Kit – TACS Blue Label (30 Tests) 30 Tests 5,291.00  Trevigen
4812-30-K TdT In Situ Apoptosis Detection Kit – Fluorescein (30 Tests) 30 Tests 5,291.00  Trevigen
4815-30-K TumorTACS In Situ Apoptosis Detection Kit (30 Tests) 30 Tests 5,291.00  Trevigen
4817-60-02 10X TdT Labeling Buffer (20 mL) 20 mL 446.00  Trevigen
4817-60-03 10X TdT Stop Buffer  (T0177), 20 mL (20 mL) 20 mL 369.00  Trevigen
4817-60-04 PI/RNase (1 mL) 1 mL 650.00  Trevigen
4817-60-K FlowTACS Flow Cytometry Apoptosis Detection Kit (60 Tests) 60 Tests 5,158.00  Trevigen
4820-30-13 Blue Counterstain (50 mL) 50 mL 624.00  Trevigen
4822-96-08 TACS-Sapphire (10 mL) 10 mL 1,021.00  Trevigen
4822-96-K TiterTACS In Situ Detection Kit – Colorimetric (96 Tests) 96 Tests 5,291.00  Trevigen
4823-30-K NeuroTACS In Situ Apoptosis Detection Kit (30 Tests) 30 Tests 5,158.00  Trevigen
4826-30-K VasoTACS in Situ Apoptosis Detection Kit (30 Tests) 30 Tests 5,158.00  Trevigen
4827-30-K CardioTACS In Situ Apoptosis Detection Kit (30 Tests) 30 Tests 5,158.00  Trevigen
4828-30-12 Strep-Diluent (7.5 mL) 7.5 mL 662.00  Trevigen
4828-30-BK TACS-XL In Situ Apoptosis Detection Kit – TACS Blue (30 Tests) 30 Tests 5,158.00  Trevigen
4828-30-DK TACS-XL In Situ Apoptosis Detection Kit – DAB (30 Tests) 30 Tests 5,158.00  Trevigen
4828-30-K TACS-XL In Situ Apoptosis Detection Kit – Basic (30 Tests) 30 Tests 4,363.00  Trevigen
4829-30-K DermaTACs In Situ Apoptosis Detection Kit (30 Tests) 30 Tests 5,158.00  Trevigen
4830-01-K TACS Annexin V-FITC Apoptosis Detection Kit (125 Tests) 125 Tests 3,906.00  Trevigen
4830-250-K TACS Annexin V-FITC Apoptosis Detection Kit (250 Tests) 250 Tests 5,007.00  Trevigen
4866-20 Fluorescent Mounting Medium (T0466) (20 mL) 20 mL 1,549.00  Trevigen
4870-500 10X PBS (T0090) (500 mL) 500 mL 605.00  Trevigen
4870-500-6 10X PBS Buffer, pH 7.4 (3 L) 3 L 2,656.00  Trevigen
4890-025-K MTT Cell Proliferation/Viability Assay (2500 Tests) 2500 Tests 3,567.00  Trevigen
4890-050-K MTT Cell Proliferation/Viability Assay (5000 Tests) 5000 Tests 5,291.00  Trevigen
4890-25-01 MTT Reagent (25 mL) 25 mL 3,209.00  Trevigen
4890-25-02 Detergent Reagent (250 mL) 250 mL 729.00  Trevigen
4891-025-K TACS XTT Cell Proliferation Assay (2500 Tests) 2500 Tests 4,893.00  Trevigen
4892-010-01 Calcein AM (50 ug) 50 ug 1,817.00  Trevigen
4892-010-K Calcein AM Cell Viability Assay (1000 Tests) 1000 Tests 2,771.00  Trevigen
7501-500-K HT Superoxide Dismutase Assay Kit (1 Kit) 1 Kit 7,351.00  Trevigen
6300-100-02 10X Reaction Buffer (60 mL) 60 mL 1,021.00  Trevigen
6300-100-03 Stabilizer Solution (5 mL) 5 mL 583.00  Trevigen

 

胶原蛋白酸性溶液 I-PC、I-AC Atelocollagen/Native Collagen Acidic Solutions

胶原蛋白酸性溶液 I-PC、I-AC
Atelocollagen/Native Collagen Acidic Solutions

  • 产品特性
  • 相关资料
  • Q&A
  • 参考文献

胶原蛋白酸性溶液 I-PC、I-AC胶原蛋白酸性溶液 I-PC、I-AC                              Atelocollagen/Native Collagen Acidic Solutions

Atelocollagen/Native Collagen Acidic Solutions

胶原蛋白酸性溶液 I-PC、I-AC                              Atelocollagen/Native Collagen Acidic Solutions



◆概要


本产品为牛皮来源的高纯度胶原蛋白酸性溶液,适用于制备 3D 培养和共培养用支架(支架材料)的胶原蛋白凝胶,以及包被培养皿或培养板等器材。有 I-PC(去端肽胶原蛋白)与 I-AC(天然胶原蛋白)两种类型,去端肽胶原蛋白通过蛋白酶切断天然胶原蛋白分子两端存在的肽。

胶原蛋白酸性溶液 I-PC、I-AC                              Atelocollagen/Native Collagen Acidic Solutions

◆应用


胶原蛋白酸性溶液 I-PC、I-AC                              Atelocollagen/Native Collagen Acidic Solutions

胶原蛋白酸性溶液 I-PC、I-AC                              Atelocollagen/Native Collagen Acidic Solutions

胶原蛋白酸性溶液 I-PC、I-AC                              Atelocollagen/Native Collagen Acidic Solutions

包被胶原蛋白


胶原蛋白凝胶中的 3D 培养


在胶原蛋白凝胶上方培养


胶原蛋白酸性溶液 I-PC、I-AC                              Atelocollagen/Native Collagen Acidic Solutions

胶原蛋白凝胶共培养

◆特点


● I-PC(去端肽胶原蛋白)和 I-AC(天然胶原蛋白)中和时,在生理条件下会凝胶化(纤维化)。

● 可选择3mg/mL 与5mg/mL 两种浓度,分别适用于制备包被、3D 培养和共培养用支架(支架材料)的胶原蛋白凝胶。

● 区别于可溶性底物膜制备品,不含细胞来源的生理活性物质、核酸和 MMP 等,可准确评估实验结果。



◆胶原蛋白种类

胶原蛋白酸性溶液 I-PC:牛皮来源去端肽胶原蛋白

胶原蛋白酸性溶液 I-AC:牛皮来源天然胶原蛋白



35 mm 胶原海绵培养皿

◆原理

胶原海绵细胞培养是以胶原蛋白为基础新开发出来的,可用于细胞 3D 培养。多孔胶原海绵是由牛跟腱提取的不溶性I型胶原蛋白制备而成。细胞可渗透入海绵,朝不同方向增殖。

◆优点特色

       所有产品均已灭菌 

◆案例应用

细胞在海绵上培养


产品编号

品名

包装

储存

KOU-CS-35

Collagen sponge for35mm culture dish Bovine tendon   Sterile

5pcs/box

RT

 


Atelocollagen, Permeable membrane for50mmculture dish

◆原理

从牛跟腱中提取的Ⅰ型胶原蛋白制备的可渗透性胶原蛋白膜可用于单层或双层细胞培养。此胶原蛋白膜特别适用于研究在膜两侧培养的不同细胞间的分子相互作用,相互关系。膜的可渗透性允许氨基酸,蛋白质等小分子自由通过胶原蛋白膜,这对于细胞间的营养吸收,物质交换有重要作用。

◆优点特色


 两种不同细胞可在膜两侧生长,因此特别适合研究细胞或小分子相互间的作用。

 可渗透性膜非常适合细胞培养,也适合人工皮肤,人工胰腺等其它人工器官的培养。

产品编号

品名

规格

储存

KOU-MEN-01

Atelocollagen, Permeable membrane for50mmculture   dish

(33mm)Bovine   dermis   Sterile

5pcs/box

-20℃

 


 

Atelocollagen, Honeycomb sponge

◆原理

“蜂窝状”海绵的结构比较特殊,它的孔径大约 200-400μm,密集地向一个方向排列,因此细胞可以顺着小孔渗透增殖。这样的结构,有利于海绵内部的细胞吸收营养物质,排出生物代谢物质。细胞在空腔内增殖,并形成统一的细胞团。

优势:从牛跟腱中提取胶原蛋白制备“蜂窝状”海绵,可以用胶原酶降解此海绵。


 

胶原蛋白酸性溶液 I-PC、I-AC                              Atelocollagen/Native Collagen Acidic Solutions

胶原蛋白酸性溶液 I-PC、I-AC                              Atelocollagen/Native Collagen Acidic Solutions

Honeycomb sponge 的电镜图

 

产品编号

品名

规格

储存

KOU-CSH-10

Atelocollagen Honeycomb sponge Bovine dermis

Size: about 3X3X2 mm/sponge   total surface area:2000cm2/g  weight per volume:   12-13mg/ml sterile

100mg/btl

室温

胶原蛋白酸性溶液 I-PC、I-AC                              Atelocollagen/Native Collagen Acidic Solutions

AteloCell 细胞培养胶原.pdf

参考文献

◆I-PC3D培养

1.

Component Analysis and Antiangiogenic Activity of Thailand Stingless Bee Propolis. Ishizu, E., Honda, S., Ohta, T., Vongsak, B., &Kumazawa, S. (2019).Makara Journal Of Technology, 23(2), 77-82.


2.

Development of an in vitro cholestatic drug-induced liver injury evaluation system using HepG2-hNTCP-C4 cells in sandwich configuration.Sakai Y, Okumura H, Iwao T, Watashi K, Ito K, Matsunaga T.Toxicol In Vitro. 2019 Aug 5:104619. doi: 10.1016/j.tiv.2019.104619. [Epub ahead of print]

PMID: 31394163


3.

Isolation of Bipotential Liver Progenitor Cells from Neonatal Mouse Liver.

TanimizuN.Methods Mol Biol. 2019;1905:9-17. PMID: 30536086


4.

FilGAP regulates distinct stages of epithelial tubulogenesis.Zuinen T, Tsutsumi K, OhtaY.BiochemBiophys Res Commun. 2019 Jun 30;514(3):742-749. PMID: 3107826

0

5.

Rod-Shaped Neural Units for Aligned 3D Neural Network Connection.Kato-Negishi M, Onoe H, Ito A, Takeuchi S.AdvHealthc Mater. 2017 Aug;6(15). PMID: 28429415


6.

Sustained inflammation after pericyte depletion induces irreversible blood-retina barrier breakdown.Ogura S, Kurata K, Hattori Y, Takase H, Ishiguro-Oonuma T, Hwang Y, Ahn S, Park I, Ikeda W, Kusuhara S, Fukushima Y, Nara H, Sakai H, Fujiwara T, Matsushita J, Ema M, Hirashima M, Minami T, Shibuya M, Takakura N, Kim P, Miyata T, Ogura Y, Uemura A.JCI Insight. 2017 Feb 9;2(3):e90905. PMID: 28194443


7.

Interstitial fluid flow-induced growth potential and hyaluronan synthesis of fibroblasts in a fibroblast populated stretched collagen gel culture.Saito N, Adachi H, Tanaka H, Nakata S, Kawada N, Oofusa K, Yoshizato K.BiochimBiophys Acta. 2017 Jun 28;1861(9):2261-2273. PMID: 28668298


8.

Progressive induction of hepatocyte progenitor cells in chronically injured liver.Tanimizu N, Ichinohe N, Yamamoto M, Akiyama H, Nishikawa Y, Mitaka T.Sci Rep. 2017 Jan 4;7:39990. PMID: 28051157


9.

Progranulin and granulin-like protein as novel VEGF-independent angiogenic factors derived from human mesothelioma cells.Eguchi R, Nakano T, Wakabayashi I.Oncogene. 2017 Feb 2;36(5):714-722. PMID: 27345409


10.

Wound healing delays in α-Klotho-deficient mice that have skin appearance similar to that in aged humans – Study of delayed wound healing mechanism.Yamauchi M, Hirohashi Y, Torigoe T, Matsumoto Y, Yamashita K, Kayama M, Sato N, Yotsuyanagi T.BiochemBiophys Res Commun. 2016 May 13;473(4):845-52. PMID: 27037022


11.

Co-expression of S100A14 and S100A16 correlates with a poor prognosis in human breast cancer and promotes cancer cell invasion.Tanaka M, Ichikawa-Tomikawa N, Shishito N, Nishiura K, Miura T, Hozumi A, Chiba H, Yoshida S, Ohtake T, Sugino T.BMC Cancer. 2015 Feb 13;15:53. PMID: 25884418


12.

Use of biomimetic microtissue spheroids and specific growth factor supplementation to improve tenocyte differentiation and adaptation to a collagen-based scaffold in vitro.Theiss F, Mirsaidi A, Mhanna R, Kümmerle J, Glanz S, Bahrenberg G, Tiaden AN, Richards PJ.Biomaterials. 2015 Nov;69:99-109. PMID: 26283157


13.

Recombinant human soluble thrombomodulin attenuates FK506-induced endothelial dysfunction through prevention of Akt inactivation.Eguchi R, Fujimori Y, Okada M, Tamaki H, Wakabayashi I, Ogawa H.Exp Cell Res. 2014 Apr 15;323(1):112-7. PMID: 24582967


14.

A human cancer xenograft model utilizing normal pancreatic duct epithelial cells conditionally transformed with defined oncogenes.Inagawa Y, Yamada K, Yugawa T, Ohno S, Hiraoka N, Esaki M, Shibata T, Aoki K, Saya H, Kiyono T.Carcinogenesis. 2014 Aug;35(8):1840-6. PMID: 24858378.


15.

Differential sensitivity of epithelial cells to extracellular matrix in polarity establishment.

Yonemura S.PLoS One. 2014 Nov 13;9(11):e112922. PMID: 25393292


16.

FK506 induces endothelial dysfunction through attenuation of Akt and ERK1/2 independently of calcineurin inhibition and the caspase pathway.Eguchi R, Kubo S, Ohta T, Kunimasa K, Okada M, Tamaki H, Kaji K, Wakabayashi I, Fujimori Y, Ogawa H.Cell Signal. 2013 Sep;25(9):1731-8. PMID: 23707520.


17.

Dynamics of Centrosome Translocation and Microtubule Organization in Neocortical Neurons during Distinct Modes of Polarization.Sakakibara A, Sato T, Ando R, Noguchi N, Masaoka M, Miyata T.Cereb Cortex. 2014 May;24(5):1301-1. PMID: 2330763

2

18.

Nymphaeol-A Isolated from Okinawan Propolis Suppresses Angiogenesis and Induces Caspase-Dependent Apoptosis via Inactivation of Survival Signals.Tsuchiya I, Hosoya T, Ushida M, Kunimasa K, Ohta T, Kumazawa S.Evid Based Complement Alternat Med. 2013;2013:826245. PMID: 23710238


19.

Construction of multi-functional extracellular matrix proteins that inhibits migration and tube formation of endothelial cells.Nakamura M, Mie M, Nakamura M, Kobatake E.Biotechnol Lett. 2012 Aug;34(8):1571-7. PMID: 22048848


20.

A selective inhibitor of the Rho kinase pathway, Y-27632, and its influence on wound healing in the corneal stroma.Yamamoto M, Quantock AJ, Young RD, Okumura N, Ueno M, Sakamoto Y, Kinoshita S, Koizumi N.Mol Vis. 2012;18:1727-39. PMID:2281562

6

21.

Features of wound healing shown by fibroblasts obtained from the superficial and deep dermis.Kaminishi-Tanikawa A, Kurita M, Okazaki M, Kawaguchi R, Ihara A, Niikura M, Takushima A, Harii K.J Plast Surg Hand Surg. 2011 Sep;45(4-5):219-25. PMID: 22150144


22.

Brazilian Propolis Suppresses Angiogenesis by Inducing Apoptosis in Tube-forming Endothelial Cells through Inactivation of Survival Signal ERK1/2.Kunimasa K, Ahn MR, Kobayashi T, Eguchi R, Kumazawa S, Fujimori Y, Nakano T, Nakayama T, Kaji K, Ohta T.Evid Based Complement Alternat Med. 2011;2011:870753.


23.

Dermal carbonyl modification is related to the yellowish color change of photo-aged Japanese facial skin.Ogura Y, Kuwahara T, Akiyama M, Tajima S, Hattori K, Okamoto K, Okawa S, Yamada Y, Tagami H, Takahashi M, Hirao T.J Dermatol Sci. 2011 Oct;64(1):45-52. PMID: 21798719


24.

Calpain is involved in cisplatin-induced endothelial injury in an in vitro three-dimensional blood vessel model.Eguchi R, Fujimori Y, Ohta T, Kunimasa K, Nakano T.Int J Oncol. 2010 Nov;37(5):1289-96. PMID: 20878076


25.

Effect of monosaccharides composing glycosaminoglycans on type 2 collagen accumulation in a three-dimensional culture of chondrocytes.Kagita E, Ikeda M, Wakitani S, Takagi M.J BiosciBioeng. 2010 Jan;109(1):51-4. PMID: 20129082


26.

Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.Kunimasa K, Ikekita M, Sato M, Ohta T, Yamori Y, Ikeda M, Kuranuki S, Oikawa T.Cancer Sci. 2010 Nov;101(11):2462-9. PMID: 20670297


27.

Antiangiogenic effects of indole-3-carbinol and 3,3'-diindolylmethane are associated with their differential regulation of ERK1/2 and Akt in tube-forming HUVEC.Kunimasa K, Kobayashi T, Kaji K, Ohta T.

J Nutr. 2010 Jan;140(1):1-6. PMID: 19889811


28.

Correlation between antiangiogenic activity and antioxidant activity of various components from propolis.Ahn MR, Kunimasa K, Kumazawa S, Nakayama T, Kaji K, Uto Y, Hori H, Nagasawa H, Ohta T.Mol Nutr Food Res. 2009 May;53(5):643-51. PMID: 19065585


29.

Possible involvement of caspase-6 and -7 but not caspase-3 in the regulation of hypoxia-induced apoptosis in tube-forming endothelial cells.Eguchi R, Toné S, Suzuki A, Fujimori Y, Nakano T, Kaji K, Ohta T.Exp Cell Res. 2009 Jan 15;315(2):327-35. PMID: 19022247


30.

Interaction between PAR-3 and the aPKC-PAR-6 complex is indispensable for apical domain development of epithelial cells.Horikoshi Y, Suzuki A, Yamanaka T, Sasaki K, Mizuno K, Sawada H, Yonemura S, Ohno S.J Cell Sci. 2009 May 15;122(Pt 10):1595-606. PMID: 19401335


31.

Intracellular polarity protein PAR-1 regulates extracellular laminin assembly by regulating the dystroglycan complex.Masuda-Hirata M, Suzuki A, Amano Y, Yamashita K, Ide M, Yamanaka T, Sakai M, Imamura M, Ohno S.Genes Cells. 2009 Jul;14(7):835-50. PMID: 19549170


32.

Proteomic analysis of hypoxia-induced tube breakdown of an in vitro capillary model composed of HUVECs: potential role of p38-regulated reduction of HSP27.Eguchi R, Naitou H, Kunimasa K, Ayuzawa R, Fujimori Y, Ohashi N, Kaji K, Ohta T.Proteomics. 2008 Jul;8(14):2897-906. PMID: 18655027


33.

Differentiation of adipose-derived stromal vascular fraction culture cells into chondrocytes using the method of cell sorting with a mesenchymal stem cell marker.Ishimura D, Yamamoto N, Tajima K, Ohno A, Yamamoto Y, Washimi O, Yamada H.Tohoku J Exp Med. 2008 Oct;216(2):149-56.


34.

Low-intensity pulsed ultrasound activates the phosphatidylinositol 3 kinase/Akt pathway and stimulates the growth of chondrocytes in three-dimensional cultures: a basic science study.Takeuchi R, Ryo A, Komitsu N, Mikuni-Takagaki Y, Fukui A, Takagi Y, Shiraishi T, Morishita S, Yamazaki Y, Kumagai K, Aoki I, Saito T.Arthritis Res Ther. 2008;10(4):R77. PMID: 18616830


35.

Suppression of tumor-induced angiogenesis by Brazilian propolis: major component artepillin C inhibits in vitro tube formation and endothelial cell proliferation.Ahn MR, Kunimasa K, Ohta T, Kumazawa S, Kamihira M, Kaji K, Uto Y, Hori H, Nagasawa H, Nakayama T.Cancer Lett. 2007 Jul 18;252(2):235-43. PMID: 17343983


36.

Hypoxia induces apoptosis of HUVECs in an in vitro capillary model by activating proapoptotic signal p38 through suppression of ERK1/2.Eguchi R, Suzuki A, Miyakaze S, Kaji K, Ohta T.Cell Signal. 2007 Jun;19(6):1121-31. PMID: 17303382


37.

Hypoxia-induced apoptosis and tube breakdown are regulated by p38 MAPK but not by caspase cascade in an in vitro capillary model composed of human endothelial cells.Ohta T, Eguchi R, Suzuki A, Miyakaze S, Ayuzawa R, Kaji K.J Cell Physiol. 2007 Jun;211(3):673-81. PMID: 17373651


38.

Atelocollagen for culture of human nucleus pulposus cells forming nucleus pulposus-like tissue in vitro: influence on the proliferation and proteoglycan production of HNPSV-1 cells.Sakai D, Mochida J, Iwashina T, Watanabe T, Suyama K, Ando K, Hotta T.Biomaterials. 2006 Jan;27(3):346-53. PMID: 16102816


39.

Effects of low-level hard laser irradiation on mineralization in three-dimensional cultured rat bone marrow cells.Gomi Kazuhiro, Yashima Akihiro, Shirakawa Satoshi, Kanazashi Mikimoto, Sekine Akiko, Kobayashi Kazuyuki, Nagano Takatoshi, Matsui Koutarou, Yamaguchi Hiroyasu, Arai Takashi.J Oral Laser Applications. 2005;5:145-150.


40.

Differentiation of Human Bone Marrow Mesenchymal Stem Cells to Chondrocytes for Construction of Three-dimensional Cartilage Tissue.Matsuda C, Takagi M, Hattori T, Wakitani S, Yoshida T.Cytotechnology. 2005 Jan;47(1-3):11-7. PMID: 19003040


41.

Effect of chondroitin sulfate and hyaluronic acid on gene expression in a three-dimensional culture of chondrocytes.Nishimoto S, Takagi M, Wakitani S, Nihira T, Yoshida T.J BiosciBioeng. 2005 Jul;100(1):123-6. PMID: 16233863


42.

Activation of matrix metalloproteinase-2 causes peritoneal injury during peritoneal dialysis in rats.Hirahara I, Ogawa Y, Kusano E, Asano Y.Nephrol Dial Transplant. 2004 Jul;19(7):1732-41. PMID: 15128883


43.

Concept for organ engineering: a reconstruction method of rat liver for in vitro culture.Takezawa T, Inoue M, Aoki S, Sekiguchi M, Wada K, Anazawa H, Hanai N.Tissue Eng. 2000 Dec;6(6):641-50. PMID: 11103085


44.

Vitronectin or fibronectin is required for corneal fibroblast-seeded collagen gel contraction.Taliana L, Evans MD, Dimitrijevich SD, Steele JG.Invest Ophthalmol Vis Sci. 2000 Jan;41(1):103-9. PMID: 10634608


45.

Maintenance of embedded pig pancreatic pseudo-islets in a collagen gel matrix: study of the effect of hydrocortisone, a collagenase inhibitor, and nicotinamide on collagenolysis and the morphogenesis of pancreatic islet-cells in collagen gel matrix.Ohgawara H, Mochizuki N, Taira T, Nishijima S, Iwasaki N, Yui R, Hirata Y, Hayakawa T.In Vitro Cell Dev Biol. 1990 Apr;26(4):348-52. PMID: 2160924

◆I-PC共培养

1.

In vivo reprogramming of wound-resident cells generates skin epithelial tissue.Kurita M, Araoka T, Hishida T, O'Keefe DD, Takahashi Y, Sakamoto A, Sakurai M, Suzuki K, Wu J, Yamamoto M, Hernandez-Benitez R, Ocampo A, Reddy P, Shokhirev MN, Magistretti P, NúñezDelicado E, Eto H, Harii K, Izpisua Belmonte JC.Nature. 2018 Sep;561(7722):243-247. PMID: 30185909


2.

Influence of shear stress on phenotype and MMP production of smooth muscle cells in a co-culture model, Journal of Biorheology.Xiaobo Han, Naoya Sakamoto, Noriko Tomita, Hui Meng, Masaaki Sato, Makoto Ohta.J Biorheol (2017) 31(2):50-56.


3.

Fetal Therapy Model of Myelomeningocele with Three-Dimensional Skin Using Amniotic Fluid Cell-Derived Induced Pluripotent Stem Cells.Kajiwara K, Tanemoto T, Wada S, Karibe J, Ihara N, Ikemoto Y, Kawasaki T, Oishi Y, Samura O, Okamura K, Takada S, Akutsu H, Sago H, Okamoto A, Umezawa A.Stem Cell Reports. 2017 Jun 6;8(6):1701-1713. PMID: 28591652


4.

Regeneration of Vocal Fold Mucosa Using Tissue-Engineered Structures with Oral Mucosal Cells.Fukahori M, Chitose S, Sato K, Sueyoshi S, Kurita T, Umeno H, Monden Y, Yamakawa R.PLoS One. 2016 Jan 5;11(1):e0146151. PMID: 26730600


5.

Hepatocyte growth factor activator inhibitor type 1 maintains the assembly of keratin into desmosomes in keratinocytes by regulating protease-activated receptor 2-dependent p38 signaling.Kawaguchi M, Kanemaru A, Sawaguchi A, Yamamoto K, Baba T, Lin CY, Johnson MD, Fukushima T, Kataoka H.Am J Pathol. 2015 Jun;185(6):1610-23. PMID: 25842366


6.

Oncogenic Ras/ERK signaling activates CDCP1 to promote tumor invasion and metastasis.Uekita T, Fujii S, Miyazawa Y, Iwakawa R, Narisawa-Saito M, Nakashima K, Tsuta K, Tsuda H, Kiyono T, Yokota J, Sakai R.Mol Cancer Res. 2014 Oct;12(10):1449-59. PMID: 24939643


7.

Characterization of a liver organoid tissue composed of hepatocytes and fibroblasts in dense collagen fibrils.Tamai M, Adachi E, Tagawa YI.TissueEng Part A. 2013 Nov;19(21-22):2527-35. PMID: 23815236


8.

Enhancement of in vitro human tubulogenesis by endothelial cell-derived factors: implications for in vivo tubular regeneration after injury.Miya M, Maeshima A, Mishima K, Sakurai N, Ikeuchi H, Kuroiwa T, Hiromura K, Yokoo H, Nojima Y.Am J Physiol Renal Physiol. 2011 Aug;301(2):F387-95. PMID:21561997


9.

Development of an endothelial-smooth muscle cell coculture model using phenotype-controlled smooth muscle cells.Sakamoto N, Kiuchi T, Sato M.Ann Biomed Eng. 2011 Nov;39(11):2750-8. PMID: 21811870


10.

An in vitro multistep carcinogenesis model for human cervical cancer.Narisawa-Saito M, Yoshimatsu Y, Ohno S, Yugawa T, Egawa N, Fujita M, Hirohashi S, Kiyono T.Cancer Res. 2008 Jul 15;68(14):5699-705. PMID: 18632622


11.

Effect of fluid shear stress on migration of vascular smooth muscle cells in cocultured model.Sakamoto N, Ohashi T, Sato M.Ann Biomed Eng. 2006 Mar;34(3):408-15. PMID: 16482415


12.

Nitric Oxide Production and Smooth Muscle Cell Phenotype of Endothelial Cell-Smooth Muscle Cell Cocultured Model.Naoya SAKAMOTO, Masaki OI, Toshiro OHASHI and Masaaki SATO.Journal of Biomechanical Science and Engineering, Vol. 1, No. 1 (2006), pp.224-233.


13.

Effect of Shear Stress on Permeability of Vascular Endothelial Monolayer Cocultured with Smooth Muscle Cells.N Sakamoto, T Ohashi, M Sato.JSME international journal. Series C, Mechanical systems, machine elements and manufacturing. 47(4), 992-999, 2004-12-15.

I-PC培养器材包被

1.

TGF-β promotes fetal gene expression and cell migration velocity in a wound repair model of untransformed intestinal epithelial cells.Anzai S, Kawamoto A, Nagata S, Takahashi J, Kawai M, Kuno R, Kobayashi S, Watanabe S, Suzuki K, Shimizu H, Hiraguri Y, Takeoka S, Sugihara HY, Yui S, Oshima S, Watanabe M, Okamoto R.BiochemBiophys Res Commun. 2020 Jan 31. [Epub ahead of print] PMID: 32014254


2.

Mitochondrial Remodeling in Endothelial Cells under Cyclic Stretch is Independent of Drp1 Activation.Megumi Baba, Aya Shinmura, Shigeru Tada, Taku Amo and Akira Tsukamoto.Molecular & Cellular Biomechanics, Vol.16 No.1 2019 ,pp.1-12.


3.

Direct conversion of fibroblasts into urothelial cells that may be recruited to regenerating mucosa of injured urinary bladder.Inoue Y, Kishida T, Kotani SI, Akiyoshi M, Taga H, Seki M, Ukimura O, Mazda O.Sci Rep. 2019 Sep 25;9(1):13850. PMID: 31554870


4.

Optimal stimulation toward the dermal papilla lineage can be promoted by combined use of osteogenic and adipogenic inducers.Kazi T, Niibe I, Nishikawa A, Matsuzaki T.FEBS Open Bio. 2019 Nov 15. doi: 10.1002/2211-5463.12763. [Epub ahead of print]PMID: 31730301


5.

Assays for Modulators of Ryanodine Receptor (RyR)/Ca2+ Release Channel Activity for Drug Discovery for Skeletal Muscle and Heart Diseases.Murayama T, Kurebayashi N.CurrProtocPharmacol. 2019 Dec;87(1):e71. PMID: 31834676


6.

Cyclic Stretch Force Induces Periodontal Ligament Cells to Secrete Exosomes That Suppress IL-1β Production Through the Inhibition of the NF-κB Signaling Pathway in Macrophages.Wang Z, Maruyama K, Sakisaka Y, Suzuki S, Tada H, Suto M, Saito M, Yamada S, Nemoto E.Front Immunol. 2019 Jun 20;10:1310. PMID: 31281309


7.

Low-energy shock waves evoke intracellular Ca2+ increases independently of sonoporation.Takahashi T, Nakagawa K, Tada S, Tsukamoto A.Sci Rep. 2019 Mar 1;9(1):3218. PMID: 30824781


8.

Possible role of complement factor H in podocytes in clearing glomerular subendothelial immune complex deposits.Zoshima T, Hara S, Yamagishi M, Pastan I, Matsusaka T, Kawano M, Nagata M.Sci Rep. 2019 May 27;9(1):7857. PMID: 31133737


9.

Planar compression of extracellular substrates induces S phase arrest via ATM-independent CHK2 activation.Hayakawa K, Hirata H, Samsonov M, Sokabe M.BiochemBiophys Res Commun. 2018 Dec 2;506(4):983-989. PMID: 30404732


10.

Cyclic Stretch Negatively Regulates IL-1β Secretion Through the Inhibition of NLRP3 Inflammasome Activation by Attenuating the AMP Kinase Pathway.Maruyama K, Sakisaka Y, Suto M, Tada H, Nakamura T, Yamada S, Nemoto E.Front Physiol. 2018 Jun 28;9:802. PMID: 30002631


11.

"All-in-one" in vitro selection of collagen-binding vascular endothelial growth factor.Park SH, Uzawa T, Hattori F, Ogino S, Morimoto N, Tsuneda S, Ito Y.Biomaterials. 2018 Apr;161:270-278. PMID: 29425847


12.

Alkyne-Functionalized Cationic Polysiloxane Polymers Conjugated with Targeting Molecules by Click Reactions for DNA Delivery.Kihara, Yoshihiko; Maeda, Riho; Imaizumi, Azusa; Ichikawa, Tsukasa; Nemoto, Nobukatsu; Ishihara, Tsutomu; Hirano, Nobutaka; Haruki, Mitsuru.Journal of Nanoscience and Nanotechnology, Volume 17, Number 7, July 2017, pp. 5081-5089(9).


13.

Identification of laminin α5 short arm peptides active for endothelial cell attachment and tube formation.Kikkawa Y, Sugawara Y, Harashima N, Fujii S, Ikari K, Kumai J, Katagiri F, Hozumi K, Nomizu M.J Pept Sci. 2017 Jul;23(7-8):666-673. PMID: 28220599


14.

Nicotine enhances the malignant potential of human pancreatic cancer cells via activation of atypical protein kinase C.Hanaki T, Horikoshi Y, Nakaso K, Nakasone M, Kitagawa Y, Amisaki M, Arai Y, Tokuyasu N, Sakamoto T, Honjo S, Saito H, Ikeguchi M, Yamashita K, Ohno S, Matsura T.BiochimBiophys Acta. 2016 Nov;1860(11 Pt A):2404-15. PMID: 27424921


15.

Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model.Kitakaze K, Mizutani Y, Sugiyama E, Tasaki C, Tsuji D, Maita N, Hirokawa T, Asanuma D, Kamiya M, Sato K, Setou M, Urano Y, Togawa T, Otaka A, Sakuraba H, Itoh K.J Clin Invest. 2016 May 2;126(5):1691-703. PMID: 27018595


16.

Combined replacement effects of human modified β-hexosaminidase B and GM2 activator protein on GM2 gangliosidoses fibroblasts.Keisuke Kitakaze, Chikako Tasaki, Youichi Tajima, Takatsugu Hirokawa, Daisuke Tsuji, Hitoshi Sakuraba, Kohji Itoh.Biochemistry and Biophysics Reports, Volume 7, September 2016, Pages 157-163.


17.

Engineered bone marrow-derived cell sheets restore structure and function of radiation-injured rat urinary bladders.Imamura T, Ogawa T, Minagawa T, Yokoyama H, Nakazawa M, Nishizawa O, Ishizuka O.Tissue Eng Part A. 2015 May;21(9-10):1600-10. PMID: 25669695


18.

Calcineurin B homologous protein 3 negatively regulates cardiomyocyte hypertrophy via inhibition of glycogen synthase kinase 3 phosphorylation.Kobayashi S, Nakamura TY, Wakabayashi S.J Mol Cell Cardiol. 2015 Jul;84:133-42. PMID: 25935310


19.

Bovine and porcine fibroblasts can be immortalized with intact karyotype by the expression of mutant cyclin dependent kinase 4, cyclin D, and telomerase.Donai K, Kiyono T, Eitsuka T, Guo Y, Kuroda K, Sone H, Isogai E, Fukuda T.J Biotechnol. 2014 Apr 20;176:50-7. PMID: 24589663


20.

Analysis of beat fluctuations and oxygen consumption in cardiomyocytes by scanning electrochemical microscopy.Hirano Y, Kodama M, Shibuya M, Maki Y, Komatsu Y.Anal Biochem. 2014 Feb 15;447:39-42. PMID: 24252541


21.

Establishment of cell lines derived from the genus Macaca through controlled expression of cell cycle regulators.Kuroda K, Kiyono T, Eitsuka T, Isogai H, Takahashi K, Donai K, Isogai E, Fukuda T.J Cell Biochem. 2015 Feb;116(2):205-11. PMID: 25187009


22.

Cyclic tensile force up-regulates BMP-2 expression through MAP kinase and COX-2/PGE2 signaling pathways in human periodontal ligament cells.Suzuki R, Nemoto E, Shimauchi H.Exp Cell Res. 2014 Apr 15;323(1):232-41. PMID: 24561081


23.

Probing the microenvironmental conditions for induction of superficial zone protein expression.Mhanna R, Oztürk E, Schlink P, Zenobi-Wong M.Osteoarthritis Cartilage. 2013 Dec;21(12):1924-32 PMID: 23978656


24.

Induction of albumin expression in HepG2 cells using immobilized simplified recombinant fibronectin protein.Nishida Y, Taniguchi A.In Vitro Cell Dev Biol Anim. 2013 Jun;49(6):400-7. ID: 23649815.


25.

Survival of primary human hepatocytes and death of induced pluripotent stem cells in media lacking glucose and arginine.Tomizawa M, Shinozaki F, Sugiyama T, Yamamoto S, Sueishi M, Yoshida T.PLoS One. 2013 Aug 14;8(8):e71897. PMID: 23967260


26.

The AP-1 complex regulates intracellular localization of insulin receptor substrate 1, which is required for insulin-like growth factor I-dependent cell proliferation.Yoneyama Y, Matsuo M, Take K, Kabuta T, Chida K, Hakuno F, Takahashi S.Mol Cell Biol. 2013 May;33(10):1991-2003. PMID: 23478262


27.

NIH3T3 cells overexpressing CD98 heavy chain resist early G1 arrest and apoptosis induced by serum starvation.Hara K, Ueda S, Ohno Y, Tanaka T, Yagi H, Okazaki S, Kawahara R, Masayuki T, Enomoto T, Hashimoto Y, Masuko K, Masuko T.Cancer Sci. 2012 Aug;103(8):1460-6. PMID:22497681


28.

N-propionyl-4-S-cysteaminylphenol induces apoptosis in B16F1 cells and mediates tumor-specific T-cell immune responses in a mouse melanoma model.Ishii-Osai Y, Yamashita T, Tamura Y, Sato N, Ito A, Honda H, Wakamatsu K, Ito S, Nakayama E, Okura M, Jimbow K.J Dermatol Sci. 2012 Jul;67(1):51-60. PMID:22622238


29.

Activation of macrophage-stimulating protein by human airway trypsin-like protease.Orikawa H, Kawaguchi M, Baba T, Yorita K, Sakoda S, Kataoka H.FEBS Lett. 2012 Feb 3;586(3):217-21. PMID:22245154


30.

Effects of Hypoxia-Inducible Factor-1α Chemical Stabilizer, CoCl(2) and Hypoxia on Gene Expression of CYP3As in Human Fetal Liver Cells.Suzuki E, Matsunaga T, Aonuma A, Sasaki T, Nagata K, Ohmori S.Drug MetabPharmacokinet. 2012;27(4):398-404. PMID: 22277676


31.

Lower expression of HNF4α and PGC1α might impair rifampicin-mediated CYP3A4 induction under conditions where PXR overexpressed in human fetal liver cells.Takezawa T, Matsunaga T, Aikawa K, Nakamura K, Ohmori S.Drug MetabPharmacokinet. 2012;27(4):430-8. PMID:22333269


32.

Cyclic stretch induces upregulation of endothelin-1 with keratinocytes in vitro: possible role in mechanical stress-induced hyperpigmentation.Kurita M, Okazaki M, Fujino T, Takushima A, Harii K.BiochemBiophys Res Commun. 2011 May 27;409(1):103-7. PMID: 21557930


33.

The TRPV4 channel is a novel regulator of intracellular Ca2+ in human esophageal epithelial cells.Ueda T, Shikano M, Kamiya T, Joh T, Ugawa S.Am J PhysiolGastrointest Liver Physiol. 2011 Jul;301(1):G138-47. PMID:21493730


34.

Expansion and characterization of adipose tissue-derived stromal cells cultured with low serum medium.Hattori H, Nogami Y, Tanaka T, Amano Y, Fukuda K, Kishimoto S, Kanatani Y, Nakamura S, Takase B, Ishihara M.J Biomed Mater Res B Appl Biomater. 2008 Oct;87(1):229-36. PMID: 18496860


35.

Nuclear deformation and expression change of cartilaginous genes during in vitro expansion of chondrocytes.Hoshiba T, Yamada T, Lu H, Kawazoe N, Tateishi T, Chen G.BiochemBiophys Res Commun. 2008 Oct 3;374(4):688-92. PMID: 18675249


36.

Visible light regulates neurite outgrowth of nerve cells.Higuchi A, Watanabe T, Noguchi Y, Chang Y, Chen WY, Matsuoka Y.Cytotechnology. 2007 Jul;54(3):181-8. PMID: 18832797


37.

Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney.Sawai K, Mukoyama M, Mori K, Kasahara M, Koshikawa M, Yokoi H, Yoshioka T, Ogawa Y, Sugawara A, Nishiyama H, Yamada S, Kuwahara T, Saleem MA, Shiota K, Ogawa O, Miyazato M, Kangawa K, Nakao K.Am J Physiol Renal Physiol. 2007 Oct;293(4):F1363-72. PMID: 17699553


38.

Altered gene expression related to glomerulogenesis and podocyte structure in early diabetic nephropathy of db/db mice and its restoration by pioglitazone.Makino H, Miyamoto Y, Sawai K, Mori K, Mukoyama M, Nakao K, Yoshimasa Y, Suga S.Diabetes. 2006 Oct;55(10):2747-56. PMID: 17003339


39.

Regulation of neurite outgrowth by intermittent irradiation of visible light.Higuchi A, Watanabe T, Matsubara Y, Matsuoka Y, Hayashi S.J Phys Chem B. 2005 Jun 2;109(21):11033-6. PMID: 16852344


40.

Platelet-rich plasma provides nucleus for mineralization in cultures of partially differentiated periodontal ligament cells.Kawase T, Okuda K, Saito Y, Amizuka N, Suzuki H, Yoshie H.In Vitro Cell Dev Biol Anim. 2005 May-Jun;41(5-6):171-6. PMID: 16153151


41.

Visible light is able to regulate neurite outgrowth.Higuchi A, Kitamura H, Shishimine K, Konishi S, Yoon BO, Hara M.J Biomater Sci Polym Ed. 2003;14(12):1377-88. PMID: 14870941


42.

A simple electroporation method for the introduction of plasmids into cells cultured on coverslips for histochemical examination.TAKATA Kuniaki ; TAKAHASHI Yukiko ; MATSUZAKI Toshiyuki ; TAJIKA Yuki ; SUZUKI Takeshi ; AOKI Takeo ; HAGIWARA Haruo.Act Histochem Cytochem,2003; 36 (4):317-23.


43.

Synergistic effect of BMP-2 and ascorbate on the phenotypic expression of osteoblastic MC3T3-E1 cells.Torii Y, Hitomi K, Tsukagoshi N.Mol Cell Biochem. 1996 Dec 6;165(1):25-9. PMID: 8974078

I-PC支架制备/包被

1.

Effect of Cyclic Stretch on Tissue Maturation in Myoblast-Laden Hydrogel Fibers.Bansai S, Morikura T, Onoe H, Miyata S.Micromachines (Basel). 2019 Jun 15;10(6). pii: E399. PMID: 31208059


2.

Bone Marrow Cells Inhibit BMP-2-Induced Osteoblast Activity in the Marrow Environment.Nguyen HT, Ono M, Oida Y, Hara ES, Komori T, Akiyama K, Nguyen HTT, Aung KT, Pham HT, Tosa I, Takarada T, Matsuo K, Mizoguchi T, Oohashi T, Kuboki T.J Bone Miner Res. 2019 Feb;34(2):327-332. PMID: 30352125


3.

Establishment of perpendicular protrusion of type I collagen on TiO2 nanotube surface as a priming site of peri-implant connective fibers.Nojiri T, Chen CY, Kim DM, Da Silva J, Lee C, Maeno M, McClelland AA, Tse B, Ishikawa-Nagai S, Hatakeyama W, Kondo H, Nagai M.J Nanobiotechnology. 2019 Mar 1;17(1):34. PMID: 30823919


4.

Microdimpled surface atelocollagen maintains primary human hepatocytes in culture and may promote their functionality compared with collagen coat culture.Sato T, Semura K, Fujimoto I.Int J Mol Med. 2019 Sep;44(3):960-972. PMID: 31257473


5.

Three-dimensional bone formation including vascular networks derived from dental pulp stem cells in vitro.Watanabe M, Ohyama A, Ishikawa H, Tanaka A.Hum Cell. 2019 Apr;32(2):114-124. PMID: 30523537


6.

Anisotropic Multi-channel Collagen Gel (MCCG) Guides the Growth Direction of the Neurite-like Processes of PC12 Cells.Koh I, Furusawa K, Haga H.Sci Rep. 2018 Sep 17;8(1):13901. PMID: 30224813


7.

Effects of Three-Dimensional Culture of Mouse Calvaria-Derived Osteoblastic Cells in a Collagen Gel with a Multichannel Structure on the Morphogenesis Behaviors of Engineered Bone TissuesSaki Yahata, Kazuya Furusawa, Kei Nagao, Masahiro Nakajima, and Toshio Fukuda.ACS Biomater. Sci. Eng., 2017, 3 (12), pp 3414–3424.


8.

Bone and Gingival Connective Tissue Responses towards Nanosecond-Pulsed Laser-Treated Titanium ImplantsYugo Fukayo, Tsuyoshi Amemiya, KazutoshiNakaoka, Masayoshi Mizutani, Jun Komotori, Yoshiki Hamada, Tohru HayakawaJournal of Hard Tissue Biology Vol. 25 (2016) No. 2 p. 181-194.


9.

Systemically replicated organic and inorganic bony microenvironment for new bone formation generated by a 3D printing technology. Wan-Gun La, Jinah Jang, Byoung Soo Kim, Min Suk Lee, Dong-Woo Cho and Hee Seok YangRSC Adv., 2016,6, 11546-11553


10.

Application of Multichannel Collagen Gels in Construction of Epithelial Lumen-like Engineered Tissues.Furusawa K, Mizutani T, Machino H, Yahata S, Fukui A, Sasaki N.ACS Biomater. Sci. Eng., 2015, 1 (7), pp 539–548.


11.

Expansion of mouse hematopoietic progenitor cells in three-dimensional cocultures on frozen-thawed stromal cell layers formed within porous scaffolds.Miyoshi H, Morita M, Ohshima N, Sato C.Exp Hematol. 2015 Feb;43(2):115-24. PMID: 25461256


12.

Tissue Response of Surface-Modified Three-Dimensional Titanium Fiber Structure.Amemiya T, Fukayo Y, Nakaoka K, Hamada Y.J Hard Tissue Biol. 23(2), 137-148, 2014-04


13.

The use of gene activated matrix to mediate effective SMAD2 gene silencing against hypertrophic scar.Yin L, Zhao X, Ji S, He C, Wang G, Tang C, Gu S, Yin C.Biomaterials. 2014 Mar;35(8):2488-98. PMID: 24388384


14.

Multiscale analysis of changes in an anisotropic collagen gel structure by culturing osteoblasts.Hanazaki Y, Masumoto J, Sato S, Furusawa K, Fukui A, Sasaki N.ACS Appl Mater Interfaces. 2013 Jul 10;5(13):5937-46. PMID: 23806015


15.

Three-dimensional culture of mouse bone marrow cells on stroma formed within a porous scaffold: influence of scaffold shape and cryopreservation of the stromal layer on expansion of haematopoietic progenitor cells.Miyoshi H, Ohshima N, Sato C.J Tissue Eng Regen Med. 2013 Jan;7(1):32-8. PMID: 22081538


16.

Cartilage tissue engineering with controllable shape using a poly(lactic-co-glycolic acid)/collagen hybrid scaffold.Wenda Dai, Zhenjun Yao, Jian Dong, Naoki Kawazoe, Chi Zhang, Guoping Chen. J BioactCompat Poly. May 2013 vol. 28 no. 3 247-257.


17.

Studies on the formation mechanism and the structure of the anisotropic collagen gel prepared by dialysis-induced anisotropic gelation.Furusawa K, Sato S, Masumoto J, Hanazaki Y, Maki Y, Dobashi T, Yamamoto T, Fukui A, Sasaki N.Biomacromolecules. 2012 Jan 9;13(1):29-39. PMID: 22107030


18.

Development of biodegradable scaffolds based on magnetically guided assembly of magnetic sugar particles.Hu C, Uchida T, Tercero C, Ikeda S, Ooe K, Fukuda T, Arai F, Negoro M, Kwon G.J Biotechnol. 2012 May 31;159(1-2):90-8. PMID:22361001


19.

Application of collagen hydrogel/sponge scaffold facilitates periodontal wound healing in class II furcation defects in beagle dogs.Kosen Y, Miyaji H, Kato A, Sugaya T, Kawanami M.J Periodontal Res. 2012 Oct;47(5):626-34. PMID:22443229


20.

Spatial immobilization of bone morphogenetic protein-4 in a collagen-PLGA hybrid scaffold for enhanced osteoinductivity.Lu H, Kawazoe N, Kitajima T, Myoken Y, Tomita M, Umezawa A, Chen G, Ito Y.Biomaterials. 2012 Sep;33(26):6140-6. PMID:22698726


21.

Micropatterned angiogenesis induced by poly(d,l-lactic-co-glycolic acid) mesh-structured scaffolds.Hwan H Oh, Hongxu Lu, Naoki Kawazoe, Guoping Chen. J BioactCompat Pol. March 2012 vol. 27 no. 2 97-106.


22.

Three-dimensional culture of mouse bone marrow cells within a porous polymer scaffold: effects of oxygen concentration and stromal layer on expansion of haematopoietic progenitor cells.Miyoshi H, Murao M, Ohshima N, Tun T.J Tissue Eng Regen Med. 2011 Feb;5(2):112-8. PMID:20653040


23.

Ectopic Bone Induction by BMP-loaded Collagen Scaffold and Bone Marrow Stromal Cell Sheet.Kana INOUE, Hirofumi MIYAJI, Tsutomu SUGAYA and Masamitsu KAWANAMI. J Oral Tissue Eng. Vol. 8 (2010) , No. 1 pp.19-29.


24.

A cell leakproof PLGA-collagen hybrid scaffold for cartilage tissue engineering.Kawazoe N, Inoue C, Tateishi T, Chen G.Biotechnol Prog. 2010 May-Jun;26(3):819-26. PMID: 20039440


25.

Efficacy of Tooth Extraction Wound Protection Made of Atelocollagen Sponge (TRE-641): A Pilot Study in DogsMakoto Hirota), Nobuyuki Mizuki), Shinjiro Aoki), Susumu Omura), Kei Watanuki), Tomomichi Ozawa), Toshinori Iwai), Yoshiro Matsui) and Iwai Tohnai. Journal of Hard Tissue Biology Vol. 18 (2009) , No. 2 pp.89-94.


26.

Three-dimensional Cultures of Rat Pancreatic RIN-5F Cells in Porous PLGA-collagen Hybrid Scaffolds.Naoki Kawazoe, Xiaoting Lin, Tetsuya Tateishi, and Guoping Chen.J BioactCompat Pol. January 2009 24: 25-42.


27.

Stimulating effects of fibroblast growth factors on hepatic function of fetal liver cells synergistically with oncostatin M in three-dimensional culture.Minagawa K, Koyama T, Miyoshi H.J BiosciBioeng. 2009 Mar;107(3):307-11. PMID: 19269598


28.

Recombinant human bone morphogenetic protein-2/atelocollagen composite as a new material for ossicular reconstruction.Takeuchi A, Tsujigiwa H, Murakami J, Kawasaki A, Takeda Y, Fukushima K, Rodriguez AP, Nagatsuka H, Yamada M, Nishizaki K.J Biomed Mater Res A. 2009 Apr;89(1):36-45. PMID: 18404714


29.

Multiwalled carbon nanotube coating on titanium.Terada M, Abe S, Akasaka T, Uo M, Kitagawa Y, Watari F.Biomed Mater Eng. 2009;19(1):45-52. PMID: 19458445


30.

Development of biodegradable scaffolds based on patient-specific arterial configuration.Uchida T, Ikeda S, Oura H, Tada M, Nakano T, Fukuda T, Matsuda T, Negoro M, Arai F.J Biotechnol. 2008 Jan 20;133(2):213-8. PMID: 17868940


31.

Evaluation of diaphragmatic hernia repair using PLGA mesh-collagen sponge hybrid scaffold: an experimental study in a rat model.Urita Y, Komuro H, Chen G, Shinya M, Saihara R, Kaneko M.Pediatr Surg Int. 2008 Sep;24(9):1041-5. PMID: 18668247


32.

Establishment of Nanofiber Preparation Technique by Electrospinning.Y Yamashita, F Ko, H Miyake, A HigashiyamaSen'IGakkaishi. 2008 Vol. 64 No. 1 P 24-28.


33.

In situ tissue regeneration using a novel tissue-engineered, small-caliber vascular graft without cell seeding.Yokota T, Ichikawa H, Matsumiya G, Kuratani T, Sakaguchi T, Iwai S, Shirakawa Y, Torikai K, Saito A, Uchimura E, Kawaguchi N, Matsuura N, Sawa Y.J Thorac Cardiovasc Surg. 2008 Oct;136(4):900-7. PMID: 18954628


34.

Effects of oncostatin M on secretion of vascular endothelial growth factor and reconstruction of liver-like structure by fetal liver cells in monolayer and three-dimensional cultures.Ehashi T, Koyama T, Ookawa K, Ohshima N, Miyoshi H.Biomed Mater Res A. 2007 Jul;82(1):73-9. PMID: 17269136


35.

Acceleration of bone formation with BMP2 in frame-reinforced carbonate apatite-collagen sponge scaffolds.Hirata I, Nomura Y, Ito M, Shimazu A, Okazaki M.J Artif Organs. 2007;10(4):212-7. PMID: 18071850


36.

Ultrastructural study on the specific binding of genetically engineered epidermal growth factor to type I collagen fibrils.Kato K, Sato H, Iwata H.Bioconjug Chem. 2007 Nov-Dec;18(6):2137-43. PMID: 17894450


37.

Osteochondral tissue engineering using a PLGA–collagen hybrid mesh.Guoping Chen, Junzo Tanaka, Tetsuya Tateishi.Materials Science and Engineering: C, Volume 26, Issue 1, January 2006, Pages 124-129.


38.

Polymer Scaffolds for Tissue Engineering.G. P. Chen, M. Tanaka, T. Tateishi.Advances in Science and Technology, Vol. 49, pp. 136-141, Oct. 2006.


39.

Preparation of a biphasic scaffold for osteochondral tissue engineering.Guoping Chen, Takashi Sato, Junzo Tanaka, Tetsuya Tateishi.Materials Science and Engineering: C, Volume 26, Issue 1, January 2006, Pages 118-123.


40.

Three-dimensional culture of porcine fetal liver cells for a bioartificial liver.Ehashi T, Ohshima N, Miyoshi H.J Biomed Mater Res A. 2006 Apr;77(1):90-6. PMID: 16355413


41.

Osteoblast Behavior at the Surface of CO3Ap-Collagen Sponges.M. Okazaki, Y. Tieliewuhan, I. Hirata.Key Engineering Materials, Vols. 309-311, pp. 989-992, May. 2006.


42.

Albumin and urea production by hepatocytes cultured on polyurethane foaming membranes coated with extracellular matrix.Akon Higuchi, Masuhiro Satoh, Kenichi Kobayashi, Chong Su Cho, Toshihiro Akaike, Tae Moon Tak, Satsuki Egashira, Yuki Matsuoka, Shizue Hayashi Natori.Journal of Membrane Science, Volume 280, Issues 1–2, 1 September 2006, Pages 983-989.


43.

Detailed consideration of physicochemical properties of CO3apatites as biomaterials in relation to carbonate content using ICP, X-ray diffraction, FT-IR, SEM, and HR-TEM.Yokota R, Hayashi H, Hirata I, Miake Y, Yanagisawa T, Okazaki M.Dent Mater J. 2006 Sep;25(3):597-603. PMID: 17076333


44.

Culturing of skin fibroblasts in a thin PLGA-collagen hybrid mesh.Chen G, Sato T, Ohgushi H, Ushida T, Tateishi T, Tanaka J.Biomaterials. 2005 May;26(15):2559-66. PMID: 15585258


45.

Albumin and urea production by hepatocytes cultured on extracellular matrix proteins-conjugated poly(vinyl alcohol) membranes.Higuchi A, Kurihara M, Kobayashi K, Cho CS, Akaike T, Hara M.J Biomater Sci Polym Ed. 2005;16(7):847-60. PMID: 16128292


46.

Temperature-dependent cell detachment on Pluronic gels.Higuchi A, Yamamoto T, Sugiyama K, Hayashi S, Tak TM, Nakagawa T.Biomacromolecules. 2005 Mar-Apr;6(2):691-6. PMID: 15762631


47.

SEM observation of collagen fibrils secreted from the body surface of osteoblasts on a CO3apatite-collagen sponge.Hirata I, Nomura Y, Tabata H, Miake Y, Yanagisawa T, Okazaki M.Dent Mater J. 2005 Sep;24(3):460-4. PMID: 16279740


48.

Effects of biomaterials on cell adhesion of human periodontal ligament fibroblasts and fibronectin adsorption.Y. Iwamatsu-Kobayashi, D. Nishihara, M. Hirata, K. Kindaichi, M. Komatsu.International Congress Series, Volume 1284, September 2005, Pages 334-335.


49.

Cell adhesion of bone marrow cells, chondrocytes, ligament cells and synovial cells on a PLGA–collagen hybrid mesh.Guoping Chen, Dechang Liu, Norio Maruyama, Hajime Ohgushi, Junzo Tanaka, Tetsuya Tateishi.Materials Science and Engineering: C. Volume 24, Issues 6–8, 1 December 2004, Pages 867–873.


50.

Application of PLGA-collagen hybrid mesh for three-dimensional culture of canine anterior cruciate ligament cells.Guoping Chen, Takashi Sato, MasatakaSakane, Hajime Ohgushi, Takashi Ushida, Junzo Tanaka, Tetsuya Tateishi.Materials Science and Engineering: C. Volume 24, Issues 6–8, 1 December 2004, Pages 861–866.


51.

Regeneration of cartilage tissue by combination of canine chondrocyte and a hybrid mesh scaffold.Guoping Chen, Takashi Sato, Takashi Ushida, Rei Hirochika, NaoyukiOchiai, Tetsuya Tateishi.Materials Science and Engineering: C. Volume 24, Issue 3, 1 April 2004, Pages 373–378.


52.

Characterization of CO3Ap-collagen sponges using X-ray high-resolution microtomography.Itoh M, Shimazu A, Hirata I, Yoshida Y, Shintani H, Okazaki M.Biomaterials. 2004 Jun;25(13):2577-83. PMID: 14751743


53.

Osteoblast proliferation behavior and bone formation on and in CO3apatite-collagen sponges with a porous hydroxyapatite frame.Tieliewuhan Y, Hirata I, Sasaki A, Minagi H, Okazaki M.Dent Mater J. 2004 Sep;23(3):258-64. PMID: 15510851


54.

Custom-shaping system for bone regeneration by seeding marrow stromal cells onto a web-like biodegradable hybrid sheet.Tsuchiya K, Mori T, Chen G, Ushida T, Tateishi T, Matsuno T, Sakamoto M, Umezawa A.Cell Tissue Res. 2004 May;316(2):141-53. PMID: 14999559


55.

Bone augmentation using rhGDF-5-collagen composite.Kuniyasu H, Hirose Y, Ochi M, Yajima A, Sakaguchi K, Murata M, Pohl J.Clin Oral Implants Res. 2003 Aug;14(4):490-9. PMID: 12869012

I-PC凝胶上方培养、其他

1.

In Vitro and In Vivo Comparison of Different Types of Rabbit Mesenchymal Stem Cells for Cartilage Repair.Khalilifar MA, BaghabanEslaminejad MR, Ghasemzadeh M, Hosseini S, Baharvand H.Cell J. 2019 Jul;21(2):150-160. PMID: 30825288

.

2.

Temperature dependence of synchronized beating of cultured neonatal rat heart-cell networks with increasing age measured by multi-electrode arrays.Uchida T, Kitora R, Gohara K (2018). Trends Med 18, Volume 18(4): 1-10.


3.

Spontaneous acquisition of infinite proliferative capacity by a rabbit corneal endothelial cell line with maintenance of phenotypic and physiological characteristics.Kageyama T, Hayashi R, Hara S, Yoshikawa K, Ishikawa Y, Yamato M, Nishida K.J Tissue Eng Regen Med. 2017 Apr;11(4):1057-1064. PMID: 25758102


4.

Electrochemical Sensing of Casein Based on the Interaction between Its Phosphate Groups and a Ruthenium(III) Complex.Inaba I1, Kuramitz H, Sugawara K.Anal Sci. 2016;32(8):853-9. PMID: 27506711


5.

Biochemical Mechanism of Titanium Fixation into Living Bone: Acid Soluble Phosphoproteins in Bone Binds with Titanium and Induced Endochondral Ossification in vivo.Yoshinori KUBOKI, Kimitoshi YAGAMI, Michiko TERADA-NAKAISHI, Toshitake FURUSAWA, Yasuko NAKAOKI, Masaaki KURASAKI.J. Oral Tissue Engin. 2017;15(2):109-118.


6.

Time of flight-secondary ion mass spectrometry analysis of protein adsorption on a polyvinylidene difluoride surface modified by ion irradiation.Okuji S, Kitazawa H, Takeda Y.Colloids Surf B Biointerfaces. 2016 Dec 1;148:249-254. PMID: 27616065


7.

Surface Modification of PMMA to Improve Adhesion to Corneal Substitutes in a Synthetic Core-Skirt Keratoprosthesis.Riau AK1,2, Mondal D2, Yam GH2, Setiawan M2, Liedberg B1,3, Venkatraman SS1, Mehta JS1,2,4,5.ACS Appl Mater Interfaces. 2015 Oct 7;7(39):21690-702. PMID: 26389670


8.

Synergistic effect of ascorbic acid and collagen addition on the increase in type 2 collagen accumulation in cartilage-like MSC sheet.Sato Y, Mera H, Takahashi D, Majima T, Iwasaki N, Wakitani S, Takagi M.Cytotechnology. 2017 Jun;69(3):405-416. PMID: 26572654


9.

Comparison of different cationized proteins as biomaterials for nanoparticle-based ocular gene delivery.Zorzi GK, Párraga JE, Seijo B, Sanchez A.Colloids Surf B Biointerfaces. 2015 Aug 12;135:533-541. PMID: 26298086


10.

Protective Effects of Soluble Collagen during Ultraviolet-A Crosslinking on Enzyme-Mediated Corneal Ectatic Models.Wang X, Huang Y, Jastaneiah S, Majumdar S, Kang JU, Yiu SC, Stark W, Elisseeff JH.PLoS One. 2015 Sep 1;10(9):e0136999. PMID: 26325407


11.

Construction of an electrode modified with gallium(III) for voltammetric detection of ovalbumin.Sugawara K, Okusawa M, Takano Y, Kadoya T.Anal Sci. 2014;30(6):649-55. PMID: 24919669


12.

The promotion of angiogenesis by growth factors integrated with ECM proteins through coiled-coil structures.Assal Y, Mie M, Kobatake E.Biomaterials. 2013 Apr;34(13):3315-23. PMID: 23388150


13.

Hollow Fiber Module Applied for Effective Proliferation and Harvest of Cultured Chondrocytes.Y. Mori, M. Watanabe, S. Nakagawa, Y. Asawa, S. Nishizawa, K. Okubo, H. Saijo, S. Nagata, Y. Fujihara, T. Takato and K. Hoshi,Materials Sciences and Applications, Vol. 4 No. 8A, 2013, pp. 62-67.


14.

Effects of hyaluronan oligosaccharides on apoptosis ofhuman gingival fibroblasts.Tanne, Y. ,Tanimoto, K. , Okuma, S. , Kunimatsu, R. , Hirose, N. , Mitsuyoshi, T. and Tanne, K.Open Journal of Stomatology (2013), 3, 19-24.


15.

The optimization of porous polymeric scaffolds for chondrocyte/atelocollagen based tissue-engineered cartilage.Tanaka Y, Yamaoka H, Nishizawa S, Nagata S, Ogasawara T, Asawa Y, Fujihara Y, Takato T, Hoshi K.Biomaterials. 2010 Jun;31(16):4506-16. PMID: 20206380


16.

The application of atelocollagen gel in combination with porous scaffolds for cartilage tissue engineering and its suitable conditions.Yamaoka H, Tanaka Y, Nishizawa S, Asawa Y, Takato T, Hoshi K.J Biomed Mater Res A. 2010 Apr;93(1):123-32. PMID: 19536835


17.

Gastric submucosa as the safer and repeatable site for hepatocyte transplantation.Kakihara N, Takeshita K, Naka S, Ishibashi H.Transplant Proc. 2009 Jan-Feb;41(1):425-8. PMID: 19249571


18.

Experimental evaluation of a new antithrombogenic stent using ion beam surface modification.Sugita Y, Suzuki Y, Someya K, Ogawa A, Furuhata H, Miyoshi S, Motomura T, Miyamoto H, Igo S, Nosé Y.Artif Organs. 2009 Jun;33(6):456-63. PMID: 19473141


19.

Construction of multi-functional extracellular matrix proteins that promote tube formation of endothelial cells.Nakamura M, Mie M, Mihara H, Nakamura M, Kobatake E.Biomaterials. 2008 Jul;29(20):2977-86. PMID: 18423582


20.

Effect of interleukins response to ECM-induced acquisition of drug resistance in MCF-7 cells.Ohbayashi M, Yasuda M, Kawakami I, Kohyama N, Kobayashi Y, Yamamoto T.Exp Oncol. 2008 Dec;30(4):276-82. PMID: 19112424


21.

Feasibility of using a human nucleus pulposus cell line as a cell source in cell transplantation therapy for intervertebral disc degeneration.Iwashina T, Mochida J, Sakai D, Yamamoto Y, Miyazaki T, Ando K, Hotta T.Spine (Phila Pa 1976). 2006 May 15;31(11):1177-86. PMID: 16688029


22.

Effect of DNA structure on the formation of collagen-DNA complex.Kaya M, Toyama Y, Kubota K, Nodasaka Y, Ochiai M, Nomizu M, Nishi N.Int J Biol Macromol. 2005 Mar;35(1-2):39-46. PMID: 15769514


23.

Differentiation of mesenchymal stem cells transplanted to a rabbit degenerative disc model: potential and limitations for stem cell therapy in disc regeneration.Sakai D, Mochida J, Iwashina T, Watanabe T, Nakai T, Ando K, Hotta T.Spine (Phila Pa 1976). 2005 Nov 1;30(21):2379-87. PMID: 16261113


24.

Novel bone graft model using bead-cell sheets composed of tricalcium phosphate beads and bone marrow cells.ShunsukeMiyauchi, Katsuko S. Furukawa, Yoshikazu Umezu, Yasuyuki Ozeki, Takashi Ushida, Tetsuya Tateishi.Materials Science and Engineering: C. Volume 24, Issues 6–8, 1 December 2004, Pages 875–879.


25.

Effect of poly DL-lactic-co-glycolic acid mesh on a three-dimensional culture of chondrocytes.Takagi M, Fukui Y, Wakitani S, Yoshida T.J BiosciBioeng. 2004;98(6):477-81. PMID: 16233739


26.

Effects of basic fibroblast growth factor on the repair of large osteochondral defects of articular cartilage in rabbits: dose-response effects and long-term outcomes.Tanaka H, Mizokami H, Shiigi E, Murata H, Ogasa H, Mine T, Kawai S.Tissue Eng. 2004 Mar-Apr;10(3-4):633-41. PMID: 15165479


27.

Bioartificial liver support system using porcine hepatocytes entrapped in a three-dimensional hollow fiber module with collagen gel: An evaluation in the swine acute liver failure model.Naka S, Takeshita K, Yamamoto T, Tani T, Kodama M.Artif Organs. 1999 Sep;23(9):822-8. PMID: 10491029


28.

Effects of collagen matrix on proliferation and differentiation of vascular smooth muscle cells in vitro.Sakata N, Kawamura K, Takebayashi S.Exp Mol Pathol. 1990 Apr;52(2):179-91. PMID: 2332035


29.

In vitro maturation of collagen fibrils modulates spreading, DNA synthesis, and collagenolysis of epidermal cells and fibroblasts.Nishikawa A, Taira T, Yoshizato K.Exp Cell Res. 1987 Jul;171(1):164-77. PMID: 3040448

I-AC三维培养(3D培养)

1.

Two-photon microscopic observation of cell-production dynamics in the developing mammalian neocortex in utero.Kawasoe R, Shinoda T, Hattori Y, Nakagawa M, Pham TQ, Tanaka Y, Sagou K, Saito K, Katsuki S, Kotani T, Sano A, Fujimori T, Miyata T.Dev Growth Differ. 2020 Feb;62(2):118-128. PMID: 31943159


2.

Rapid Photoinduced Single Cell Detachment from Gold Nanoparticle-Embedded Collagen Gels with Low Denaturation Temperature.Kojima C, Nishio M, Nakajima Y, Kawano T, Takatsuka K, Matsumoto A.Polymers (Basel). 2020 Jan 15;12(1). PMID: 31952267


3.

Hydrostatic pressure promotes endothelial tube formation through aquaporin 1 and Ras-ERK signaling.Yoshino D, Funamoto K, Sato K, Kenry, Sato M, Lim CT.Commun Biol. 2020 Apr 2;3(1):152. PMID: 32242084


4.

Torula yeast (Candida utilis)‐derived glucosylceramide contributes to dermal elasticity in vitro.Fukunaga, S, Wada, S, Yamashita, M, et al.J Food Biochem. 2019;e12847.


5.

Nω -(Carboxymethyl)arginine Is One of the Dominant Advanced Glycation End Products in Glycated Collagens and Mouse Tissues.Kinoshita S, Mera K, Ichikawa H, Shimasaki S, Nagai M, Taga Y, Iijima K, Hattori S, Fujiwara Y, Shirakawa JI, Nagai R.Oxid Med Cell Longev. 2019 Sep 10;2019:9073451. PMID: 31583049


6.

Effect of Mechanical Compression on Invasion Process of Malignant Melanoma Using In Vitro Three-Dimensional Cell Culture Device.Morikura T, Miyata S.Micromachines (Basel). 2019 Sep 30;10(10). PMID: 31575066


7.

Effect of cell culture density on dental pulp-derived mesenchymal stem cells with reference to osteogenic differentiation.Noda S, Kawashima N, Yamamoto M, Hashimoto K, Nara K, Sekiya I, Okiji T.Sci Rep. 2019 Apr 1;9(1):5430. PMID: 30931957


8.

Utility of the Teslar Facial Massager for Skin Elasticity and the Mechanism of its Effects. Kazuhisa Maeda, Sakura Koizumi, Taiga Sano, Ayano Yoshimura, HarukaKiriyama and Seina Mimura.Cosmetics 2018, 5(3), 49.


9.

Downregulation of ERG and FLI1 expression in endothelial cells triggers endothelial-to-mesenchymal transition.Nagai N, Ohguchi H, Nakaki R, Matsumura Y, Kanki Y, Sakai J, Aburatani H, Minami T.PLoS Genet. 2018 Nov 30;14(11):e1007826. PMID: 30500808


10.

Role of extrinsic mechanical force in the development of the RA-I tactile mechanoreceptor.Pham TQ, Kawaue T, Hoshi T, Tanaka Y, Miyata T, Sano A.Sci Rep. 2018 Jul 23;8(1):11085. PMID: 30038295


11.

Elasticity-based boosting of neuroepithelial nucleokinesis via indirect energy transfer from mother to daughter.Shinoda T, Nagasaka A, Inoue Y, Higuchi R, Minami Y, Kato K, Suzuki M, Kondo T, Kawaue T, Saito K, Ueno N, Fukazawa Y, Nagayama M, Miura T, Adachi T, Miyata T.PLoS Biol. 2018 Apr 20;16(4):e2004426. PMID: 29677184


12.

Differentiating cells mechanically limit the interkinetic nuclear migration of progenitor cells to secure apical cytogenesis.Watanabe Y, Kawaue T, Miyata T.Development. 2018 Jul 17;145(14). PMID: 29945866


13.

Both triazolyl ester of ketorolac (15K) and YM155 inhibit the embryonic angiogenesis in ovo (fertilized eggs) via their common PAK1-survivin/VEGF signaling pathway.Ahn MR, Bae JY, Jeong DH, Takahashi H, Uto Y, Maruta H.Drug DiscovTher. 2017;11(6):300-306. PMID: 29332887


14.

Dysregulated Collagen Homeostasis by Matrix Stiffening and TGF-β1 in Fibroblasts from Idiopathic Pulmonary Fibrosis Patients: Role of FAK/Akt.Giménez A, Duch P, Puig M, Gabasa M, Xaubet A, Alcaraz J.

Int J Mol Sci. 2017 Nov 16;18(11). PMID: 29144435


15.

Defined three-dimensional microenvironments boost induction of pluripotency.Caiazzo M, Okawa Y, Ranga A, Piersigilli A, Tabata Y, Lutolf MP.Nat Mater. 2016 Mar;15(3):344-52. PMID: 26752655


16.

ECM microenvironment unlocks brown adipogenic potential of adult human bone marrow-derived MSCs.Lee MH, Goralczyk AG, Kriszt R, Ang XM, Badowski C, Li Y, Summers SA, Toh SA, Yassin MS, Shabbir A, Sheppard A, Raghunath M.Sci Rep. 2016 Feb 17;6:21173. PMID: 26883894


17.

Dynamics of Tissue-Induced Alignment of Fibrous Extracellular Matrix.Piotrowski-Daspit AS, Nerger BA, Wolf AE, Sundaresan S, Nelson CM.Biophys J. 2017 Aug 8;113(3):702-713. PMID: 28793224


18.

Increased AGE-RAGE ratio in idiopathic pulmonary fibrosis.Machahua C, Montes-Worboys A, Llatjos R, Escobar I, Dorca J, Molina-Molina M, Vicens-Zygmunt V.Respir Res. 2016 Nov 5;17(1):144.PMID: 27816054


19.

Differences in the Mechanical Properties of the Developing Cerebral Cortical Proliferative Zone between Mice and Ferrets at both the Tissue and Single-Cell Levels.Nagasaka A, Shinoda T, Kawaue T, Suzuki M, Nagayama K, Matsumoto T, Ueno N, Kawaguchi A and Miyata T.(2016) Front. Cell Dev. Biol. 4:139.


20.

Interstitial fluid pressure regulates collective invasion in engineered human breast tumors via Snail, vimentin, and E-cadherin.Piotrowski-Daspit AS, Tien J, Nelson CM.Integr Biol (Camb). 2016 Mar 14;8(3):319-31. PMID: 26853861


21.

Mammary Branching Morphogenesis Requires Reciprocal Signaling by Heparanase and MMP-14.Gomes AM, Bhat R, Correia AL, Mott JD, Ilan N, Vlodavsky I, Pavão MS, Bissell M.J Cell Biochem. 2015 Aug;116(8):1668-79. PMID: 25735873


22.

Fibroblast viability and phenotypic changes within glycated stiffened three-dimensional collagen matrices.Vicens-Zygmunt V, Estany S, Colom A, Montes-Worboys A, Machahua C, Sanabria AJ, Llatjos R, Escobar I, Manresa F, Dorca J, Navajas D, Alcaraz J, Molina-Molina M.Respir Res. 2015 Jul 1;16:82. PMID: 26126411


23.

Three-dimensional traction force microscopy of engineered epithelial tissues.Piotrowski AS, Varner VD, Gjorevski N, Nelson CM.Methods Mol Biol. 2015;1189:191-206. PMID: 25245695


24.

Response of Human Skin Fibroblasts to Mechanical Stretch in Wound Healing Process Analyzed Using a Three-Dimensional Culture Model. Kaori Shikano, Keisuke Chiba, Shogo Miyata.Advanced Biomedical Engineering. Vol. 4 (2015) p. 170-178.


25.

Oxygen diffusion and consumption in extracellular matrix gels: Implications for designing three-dimensional cultures.Colom A, Galgoczy R, Almendros I, Xaubet A, Farré R, Alcaraz J.J Biomed Mater Res A. 2014 Aug;102(8):2776-84. PMID: 24027235


26.

A spectrophotometer-based diffusivity assay reveals that diffusion hindrance of small molecules in extracellular matrix gels used in 3D cultures is dominated by viscous effects.Galgoczy R, Pastor I, Colom A, Giménez A, Mas F, Alcaraz J.Colloids Surf B Biointerfaces. 2014 Aug 1;120:200-7. PMID: 24916283


27.

A novel three-dimensional cell culture method to analyze epidermal cell differentiation in vitro.Okugawa Y, Hirai Y.Methods Mol Biol. 2014;1195:183-90. PMID: 24281867


28.

Tissue-culture light sheet fluorescence microscopy (TC-LSFM) allows long-term imaging of three-dimensional cell cultures under controlled conditions.Pampaloni F, Berge U, Marmaras A, Horvath P, Kroschewski R, Stelzer EH. Integr Biol (Camb). 2014 Oct;6(10):988-98. PMID: 25183478


29.

Age-related disruption of autophagy in dermal fibroblasts modulates extracellular matrix components.Tashiro K, Shishido M, Fujimoto K, Hirota Y, Yo K, Gomi T, Tanaka Y.BiochemBiophys Res Commun. 2014 Jan 3;443(1):167-72. PMID: 24287182


30.

The hemopexin domain of MMP3 is responsible for mammary epithelial invasion and morphogenesis through extracellular interaction with HSP90β.Correia AL, Mori H, Chen EI, Schmitt FC, Bissell MJ.Genes Dev. 2013 Apr 1;27(7):805-17. PMID: 23592797


31.

Transmembrane/cytoplasmic, rather than catalytic, domains of Mmp14 signal to MAPK activation and mammary branching morphogenesis via binding to integrin β1.Mori H, Lo AT, Inman JL, Alcaraz J, Ghajar CM, Mott JD, Nelson CM, Chen CS, Zhang H, Bascom JL, Seiki M, Bissell MJ.Development. 2013 Jan;140(2):343-52. PMID: 23250208


32.

Extracellular epimorphin modulates epidermal differentiation signals mediated by epidermal growth factor receptor.Okugawa Y, Hirai Y.J Dermatol Sci. 2013 Mar;69(3):236-42. PMID: 23219092


33.

PI3K regulates branch initiation and extension of cultured mammary epithelia via Akt and Rac1 respectively.Zhu W, Nelson CM.Dev Biol. 2013 Jul 15;379(2):235-45. PMID: 23665174


34.

Knockdown of electron transfer flavoprotein β subunit reduced TGF-β-induced α-SMA mRNA expression but not COL1A1 in fibroblast-populated three-dimensional collagen gel cultures.Hirokawa S, Shimanuki T, Kitajima H, Nishimori Y, Shimosaka M.J Dermatol Sci. 2012 Dec;68(3):179-86. PMID: 23068445


35.

Modulation of invasive phenotype by interstitial pressure-driven convection in aggregates of human breast cancer cells.Tien J, Truslow JG, Nelson CM.PLoS One. 2012;7(9):e45191. PMID: 23028839


36.

Collective epithelial cell invasion overcomes mechanical barriers of collagenous extracellular matrix by a narrow tube-like geometry and MMP14-dependent local softening.Alcaraz J, Mori H, Ghajar CM, Brownfield D, Galgoczy R, Bissell MJ.Integr Biol (Camb). 2011 Dec;3(12):1153-66. PMID:21993836


37.

The metastasis-promoting protein S100A4 regulates mammary branching morphogenesis.Andersen K, Mori H, Fata J, Bascom J, Oyjord T, Mælandsmo GM, Bissell M.Dev Biol. 2011 Apr 15;352(2):181-90. PMID: 21195708


38.

Role of tumour necrosis factor-α (TNFα) in the functional properties of hyalocytes.Hata Y, Nakao S, Kohno R, Oba K, Kita T, Miura M, Sassa Y, Schering A, Ishibashi T.Br J Ophthalmol. 2011 Feb;95(2):261-5. PMID: 21030411 .


39.

Identification of ETFB as a candidate protein that participates in the mechanoregulation of fibroblast cell number in collagen gel culture.Hirokawa S, Shimanuki T, Kitajima H, Nishimori Y, Shimosaka M.J Dermatol Sci. 2011 Nov;64(2):119-26. PMID: 21903359


40.

Novel migrating mouse neural crest cell assay system utilizing P0-Cre/EGFP fluorescent time-lapse imaging.Kawakami M, Umeda M, Nakagata N, Takeo T, Yamamura K.BMC Dev Biol. 2011 Nov 9;11:68. PMID: 22070366


41.

Snail1, Snail2, and E47 promote mammary epithelial branching morphogenesis.Lee K, Gjorevski N, Boghaert E, Radisky DC, Nelson CM.EMBO J. 2011 May 24;30(13):2662-74. PMID: 21610693


42.

Mammary branch initiation and extension are inhibited by separate pathways downstream of TGFβ in culture.Pavlovich AL, Boghaert E, Nelson CM.Exp Cell Res. 2011 Aug 1;317(13):1872-84. PMID: 21459084


43.

Endogenous patterns of mechanical stress are required for branching morphogenesis.Gjorevski N, Nelson CM.Integr Biol (Camb). 2010 Sep;2(9):424-34. PMID: 20717570


44.

Epimorphin-derived peptide antagonists remedy epidermal parakeratosis triggered by unsaturated fatty acid.Okugawa Y, Bascom JJ, Hirai Y.J Dermatol Sci. 2010 Sep;59(3):176-83. PMID: 20688483


45.

Madin-Darby canine kidney cells are increased in aerobic glycolysis when cultured on flat and stiff collagen-coated surfaces rather than in physiological 3-D cultures.Pampaloni F, Stelzer EH, Leicht S, Marcello M.Proteomics. 2010 Oct;10(19):3394-413. PMID: 20718008


46.

Adipose stroma induces branching morphogenesis of engineered epithelial tubules.Pavlovich AL, Manivannan S, Nelson CM.Tissue Eng Part A. 2010 Dec;16(12):3719-26. PMID: 20649458


47.

Neurotrophic effect of gonadotropin-releasing hormone on neurite extension and neuronal migration of embryonic gonadotropin-releasing hormone neurons in chick olfactory nerve bundle culture.Kanaho Y, Enomoto M, Endo D, Maehiro S, Park MK, Murakami S.J Neurosci Res. 2009 Aug 1;87(10):2237-44. PMID: 19301422


48.

Potent inhibition of cicatricial contraction in proliferative vitreoretinal diseases by statins.Kawahara S, Hata Y, Kita T, Arita R, Miura M, Nakao S, Mochizuki Y, Enaida H, Kagimoto T, Goto Y, Hafezi-Moghadam A, Ishibashi T.Diabetes. 2008 Oct;57(10):2784-93. PMID: 18599521. Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17504-9. PMID: 18952846


49.

Hic-5, an adaptor protein expressed in vascular smooth muscle cells, modulates the arterial response to injury in vivo.Kim-Kaneyama JR, Wachi N, Sata M, Enomoto S, Fukabori K, Koh K, Shibanuma M, Nose K.

BiochemBiophys Res Commun. 2008 Nov 28;376(4):682-7. PMID: 18812162


50.

Role of TGF-beta in proliferative vitreoretinal diseases and ROCK as a therapeutic target.Kita T, Hata Y, Arita R, Kawahara S, Miura M, Nakao S, Mochizuki Y, Enaida H, Goto Y, Shimokawa H, Hafezi-Moghadam A, Ishibashi T.Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17504-9. PMID: 18952846


51.

Overexpression of extracellular epimorphin leads to impaired epidermal differentiation in HaCaT keratinocytes.Okugawa Y, Hirai Y.J Invest Dermatol. 2008 Aug;128(8):1884-93. PMID: 18273050


52.

Non-classical export of epimorphin and its adhesion to alphav-integrin in regulation of epithelial morphogenesis.Hirai Y, Nelson CM, Yamazaki K, Takebe K, Przybylo J, Madden B, Radisky DC.J Cell Sci. 2007 Jun 15;120(Pt 12):2032-43. PMID: 17535848


53.

Functional characteristics of connective tissue growth factor on vitreoretinal cells.Kita T, Hata Y, Miura M, Kawahara S, Nakao S, Ishibashi T.Diabetes. 2007 May;56(5):1421-8. PMID: 17303801


54.

Critical role of the Rho-kinase pathway in TGF-beta2-dependent collagen gel contraction by retinal pigment epithelial cells.Miura M, Hata Y, Hirayama K, Kita T, Noda Y, Fujisawa K, Shimokawa H, Ishibashi T.Exp Eye Res. 2006 May;82(5):849-59. PMID: 16310190


55.

Lgl mediates apical domain disassembly by suppressing the PAR-3-aPKC-PAR-6 complex to orient apical membrane polarity.Yamanaka T, Horikoshi Y, Izumi N, Suzuki A, Mizuno K, Ohno S.J Cell Sci. 2006 May 15;119(Pt 10):2107-18. PMID: 16638806


56.

The effect of hyaluronic acid with different molecular weights on collagen crosslink synthesis in cultured chondrocytes embedded in collagen gels.Abe M, Takahashi M, Nagano A.J Biomed Mater Res A. 2005 Nov 1;75(2):494-9. PMID: 16092114


57.

Repulsive guidance of axons of spinal sensory neurons in Xenopus laevis embryos: roles of Contactin and notochord-derived chondroitin sulfate proteoglycans.Fujita N, Nagata S.Dev Growth Differ. 2005 Sep;47(7):445-56. PMID: 16179071


58.

Leukemia inhibitory factor induces multi-lineage differentiation of adult stem-like cells in kidney via kidney-specific cadherin 16.Hishikawa K, Marumo T, Miura S, Nakanishi A, Matsuzaki Y, Shibata K, KohikeH, Komori T, Hayashi M, Nakaki T, Nakauchi H, Okano H, Fujita T.BiochemBiophys Res Commun. 2005 Mar 4;328(1):288-91. PMID: 15670782


59.

Extraocular dorsal signal affects the developmental fate of the optic vesicle and patterns the optic neuroepithelium.Kagiyama Y, Gotouda N, Sakagami K, Yasuda K, Mochii M, Araki M.Dev Growth Differ. 2005 Oct;47(8):523-36. PMID: 16287484


60.

Uni-axial stretching regulates intracellular localization of Hic-5 expressed in smooth-muscle cells in vivo.Kim-Kaneyama JR, Suzuki W, Ichikawa K, Ohki T, Kohno Y, Sata M, Nose K, Shibanuma M.J Cell Sci. 2005 Mar 1;118(Pt 5):937-49. PMID: 15713747


61.

Subculture of chondrocytes on a collagen type I-coated substrate with suppressed cellular dedifferentiation.Kino-Oka M, Yashiki S, Ota Y, Mushiaki Y, Sugawara K, Yamamoto T, Takezawa T, Taya M.Tissue Eng. 2005 Mar-Apr;11(3-4):597-608. PMID: 15869436


62.

Repair of articular cartilage defect by autologous transplantation of basic fibroblast growth factor gene-transduced chondrocytes with adeno-associated virus vector.Yokoo N, Saito T, Uesugi M, Kobayashi N, Xin KQ, Okuda K, Mizukami H, Ozawa K, Koshino T.Arthritis Rheum. 2005 Jan;52(1):164-70. PMID: 15641065


63.

Activin A augments vascular endothelial growth factor activity in promoting branching tubulogenesis in hepatic sinusoidal endothelial cells.Endo D, Kogure K, Hasegawa Y, Maku-uchi M, Kojima I.J Hepatol. 2004 Mar;40(3):399-404. PMID: 15123352


64.

The involvement of the rho-kinase pathway and its regulation in cytokine-induced collagen gel contraction by hyalocytes.Hirayama K, Hata Y, Noda Y, Miura M, Yamanaka I, Shimokawa H, Ishibashi T.Invest Ophthalmol Vis Sci. 2004 Nov;45(11):3896-903. PMID: 15505034


65.

P311 accelerates nerve regeneration of the axotomized facial nerve.Fujitani M, Yamagishi S, Che YH, Hata K, Kubo T, Ino H, Tohyama M, Yamashita T.J Neurochem. 2004 Nov;91(3):737-44. PMID: 15485502


66.

Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis.Minami T, Horiuchi K, Miura M, Abid MR, Takabe W, Noguchi N, Kohro T, Ge X, Aburatani H, Hamakubo T, Kodama T, Aird WC.J Biol Chem. 2004 Nov 26;279(48):50537-54. PMID: 15448146


67.

Odontoblasts induced from mesenchymal cells of murine dental papillae in three-dimensional cell culture.Kikuchi H, Suzuki K, Sakai N, Yamada S.Cell Tissue Res. 2004 Aug;317(2):173-85. PMID: 15221440


68.

Vascular endothelial growth factor- and thrombin-induced termination factor, Down syndrome critical region-1, attenuates endothelial cell proliferation and angiogenesis.Minami T, Horiuchi K, Miura M, Abid MR, Takabe W, Noguchi N, Kohro T, Ge X, Aburatani H, Hamakubo T, Kodama T, Aird WC.J Biol Chem. 2004 Nov 26;279(48):50537-54. PMID: 15448146


69.

Interaction between hex and GATA transcription factors in vascular endothelial cells inhibits flk-1/KDR-mediated vascular endothelial growth factor signaling.Minami T, Murakami T, Horiuchi K, Miura M, Noguchi T, Miyazaki J, Hamakubo T, Aird WC, Kodama T.J Biol Chem. 2004 May 14;279(20):20626-35. PMID: 15016828


70.

Crosslinking of collagen gels by transglutaminase.Orban JM, Wilson LB, Kofroth JA, El-Kurdi MS, Maul TM, Vorp DA.J Biomed Mater Res A. 2004 Mar 15;68(4):756-62. PMID: 14986330


71.

Heterologous desensitization of T cell functions by CCR5 and CXCR4 ligands: inhibition of cellular signaling, adhesion and chemotaxis.Hecht I, Cahalon L, Hershkoviz R, Lahat A, Franitza S, Lider O.Int Immunol. 2003 Jan;15(1):29-38. PMID: 12502723


72.

Collapsin response mediator protein-2 accelerates axon regeneration of nerve-injured motor neurons of rat.Suzuki Y, Nakagomi S, Namikawa K, Kiryu-Seo S, Inagaki N, Kaibuchi K, Aizawa H, Kikuchi K, Kiyama H.J Neurochem. 2003 Aug;86(4):1042-50. PMID: 12887701


73.

Effects of growth factors on cell proliferation and matrix synthesis of low-density, primary bovine chondrocytes cultured in collagen I gels.Chaipinyo K, Oakes BW, van Damme MP.J Orthop Res. 2002 Sep;20(5):1070-8. PMID: 12382975


74.

Growth, antrum formation, and estradiol production of bovine preantral follicles cultured in a serum-free medium.Itoh T, Kacchi M, Abe H, Sendai Y, Hoshi H.Biol Reprod. 2002 Oct;67(4):1099-105. PMID: 12297524


75.

Tea catechins inhibit angiogenesis in vitro, measured by human endothelial cell growth, migration and tube formation, through inhibition of VEGF receptor binding.Kondo T, Ohta T, Igura K, Hara Y, Kaji K.Cancer Lett. 2002 Jun 28;180(2):139-44. PMID: 12175544


76.

beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium.Weaver VM, Lelièvre S, Lakins JN, Chrenek MA, Jones JC, Giancotti F, Werb Z, Bissell MJ.Cancer Cell. 2002 Sep;2(3):205-16. PMID: 12242153


77.

Resveratrol and quercetin inhibit angiogenesis in vitro.Igura K, Ohta T, Kuroda Y, Kaji K.Cancer Lett. 2001 Sep 28;171(1):11-6. PMID: 11485823


78.

The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells.Simian M, Hirai Y, Navre M, Werb Z, Lochter A, Bissell MJ.Development. 2001 Aug;128(16):3117-31. PMID: 11688561


79.

Concept for organ engineering: a reconstruction method of rat liver for in vitro culture.Takezawa T, Inoue M, Aoki S, Sekiguchi M, Wada K, Anazawa H, Hanai N.Tissue Eng. 2000 Dec;6(6):641-50. PMID: 11103085


80.

The small GTP-binding protein TC10 promotes nerve elongation in neuronal cells, and its expression is induced during nerve regeneration in rats.Tanabe K, Tachibana T, Yamashita T, Che YH, Yoneda Y, Ochi T, Tohyama M, Yoshikawa H, Kiyama H.J Neurosci. 2000 Jun 1;20(11):4138-44. PMID: 10818149


81.

Epimorphin functions as a key morphoregulator for mammary epithelial cells.Hirai Y, Lochter A, Galosy S, Koshida S, Niwa S, Bissell MJ.J Cell Biol. 1998 Jan 12;140(1):159-69. PMID: 9425164


82.

Tissue phenotype depends on reciprocal interactions between the extracellular matrix and the structural organization of the nucleus.Lelièvre SA, Weaver VM, Nickerson JA, Larabell CA, Bhaumik A, Petersen OW, Bissell MJ.Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14711-6. PMID: 9843954


83.

Effects of basic fibroblast growth factor on proliferation and phenotype expression of chondrocytes embedded in collagen gel.Matsusaki M, Ochi M, Uchio Y, Shu N, Kurioka H, Kawasaki K, Adachi N.Gen Pharmacol. 1998 Nov;31(5):759-64. PMID: 9809475


84.

Accelerated Nerve Regeneration in Mice by upregulated expression of interleukin (IL) 6 and IL-6 receptor after trauma.Hirota H, Kiyama H, Kishimoto T, Taga T.J Exp Med. 1996 Jun 1;183(6):2627-34. PMID: 8676083


85.

Immortalised mouse submandibular epithelial cell lines retain polarised structural and functional properties.Laoide BM, Courty Y, Gastinne I, Thibaut C, Kellermann O, Rougeon F.J Cell Sci. 1996 Dec;109 ( Pt 12):2789-800. PMID: 9013327


86.

Inhibitory effect of isoliquiritin, a compound in licorice root, on angiogenesis in vivo and tube formation in vitro.Kobayashi S, Miyamoto T, Kimura I, Kimura M.Biol Pharm Bull. 1995 Oct;18(10):1382-6. PMID: 8593441

I-AC共培养、机械刺激培养                                       

1.

Cancer cell migration on elongate protrusions of fibroblasts in collagen matrix.Miyazaki K, Oyanagi J, Hoshino D, Togo S, Kumagai H, Miyagi Y.Sci Rep. 2019 Jan 22;9(1):292. PMID: 30670761


2.

IGF-1R deficiency in human keratinocytes disrupts epidermal homeostasis and stem cell maintenance.Muraguchi T, Nanba D, Nishimura EK, Tashiro T.J Dermatol Sci. 2019 May;94(2):298-305. PMID: 31122679


3.

Transfection of T-Box Transcription Factor BRACHYURY and SOX2 Synergistically Promote Self-Renewal and Invasive Phenotype in Oral Cancer Cells.Akimoto N, Nakamura K, Hijioka H, Kume K, Matsumura Y, Sugiura T.Int J Mol Sci. 2018 Nov 16;19(11). PMID: 30453543


4.

Type IV collagen aggregates promote keratinocyte proliferation and formation of epidermal layer in human skin equivalents.Matsuura-Hachiya Y, Arai KY, Muraguchi T, Sasaki T, Nishiyama T. Exp Dermatol. 2018 May;27(5):443-448. PMID: 28266764


5.

Perfusable and stretchable 3D culture system for skin-equivalent.Mori N, Morimoto Y, Takeuchi S.Biofabrication. 2018 Nov 15;11(1):011001. PMID: 30431022


6.

Fluid shear stress suppresses ICAM-1-mediated transendothelial migration of leukocytes in coculture model.Sakamoto N, Ueki Y, Oi M, Kiuchi T, Sato M.BiochemBiophys Res Commun. 2018 Jul 20;502(3):403-408. PMID: 29852173


7.

Skin integrated with perfusable vascular channels on a chip.Mori N, Morimoto Y, Takeuchi S.Biomaterials. 2016 Nov 27;116:48-56. PMID: 27914266


8.

Hyaluronic acid secretion by synoviocytes alters under cyclic compressive load in contracted collagen gels.Uehara K, Hara M, Matsuo T, Namiki G, Watanabe M, Nomura Y.Cytotechnology. 2015 Jan;67(1):19-26. PMID: 24287612


9.

Stimulatory effect of fibroblast-derived prostaglandin E2 on keratinocyte stratification in the skin equivalent.Arai KY, Fujioka A, Okamura R, Nishiyama T.Wound Repair Regen. 2014 Nov;22(6):701-11. PMID: 25224163


10.

Repeated folding stress-induced morphological changes in the dermal equivalent.Arai KY, Sugimoto M, Ito K, Ogura Y, Akutsu N, Amano S, Adachi E, Nishiyama T.Skin Res Technol. 2014 Nov;20(4):399-408. PMID: 24506301


11.

Construction of collagen gel scaffolds for mechanical stress analysis.Hara M, Nakashima M, Fujii T, Uehara K, Yokono C, Hashizume R, Nomura Y.BiosciBiotechnolBiochem. 2014 Mar;78(3):458-61. PMID: 25036833


12.

Autocrine galectin-1 promotes collective cell migration of squamous cell carcinoma cells through up-regulation of distinct integrins.Rizqiawan A, Tobiume K, Okui G, Yamamoto K, Shigeishi H, Ono S, Shimasue H, Takechi M, Higashikawa K, Kamata N.BiochemBiophys Res Commun. 2013 Nov 29;441(4):904-10. PMID: 24211210


13.

Identification of a novel subpopulation of tumor-initiating cells from gemcitabine-resistant pancreatic ductal adenocarcinoma patients.Shimizu K, Chiba S, Hori Y.PLoS One. 2013 Nov 21;8(11):e81283. PMID: 24278411


14.

IL-1beta stimulates activin betaA mRNA expression in human skin fibroblasts through the MAPK pathways, the nuclear factor-kappaB pathway, and prostaglandin E2.Arai KY, Ono M, Kudo C, Fujioka A, Okamura R, Nomura Y, Nishiyama T.Endocrinology. 2011 Oct;152(10):3779-90. PMID: 21828177


15.

Netrin 1 provides a chemoattractive cue for the ventral migration of GnRH neurons in the chick forebrain.Murakami S, Ohki-Hamazaki H, Watanabe K, Ikenaka K, Ono K.J Comp Neurol. 2010 Jun 1;518(11):2019-34. PMID: 20394056


16.

DeltaNp63alpha-dependent expression of Id-3 distinctively suppresses the invasiveness of human squamous cell carcinoma.Higashikawa K, Yoneda S, Tobiume K, Saitoh M, Taki M, Mitani Y, Shigeishi H, Ono S, Kamata N.Int J Cancer. 2009 Jun 15;124(12):2837-44. PMID: 19267405


17.

Critical role for GATA3 in mediating Tie2 expression and function in large vessel endothelial cells.Song H, Suehiro J, Kanki Y, Kawai Y, Inoue K, Daida H, Yano K, Ohhashi T, Oettgen P, Aird WC, Kodama T, Minami T.J Biol Chem. 2009 Oct 16;284(42):29109-24. PMID: 1967497


18.

Antibody neutralization of TGF-beta enhances the deterioration of collagen fascicles in a tissue-cultured tendon matrix with ex vivo fibroblast infiltration.Azuma C, Tohyama H, Nakamura H, Kanaya F, Yasuda K.J Biomech. 2007;40(10):2184-90. PMID: 17462658


19.

Snail-induced down-regulation of DeltaNp63alpha acquires invasive phenotype of human squamous cell carcinoma.Higashikawa K, Yoneda S, Tobiume K, Taki M, Shigeishi H, Kamata N.Cancer Res. 2007 Oct 1;67(19):9207-13. PMID: 17909026


20.

Ex vivo infiltration of fibroblasts into the tendon deteriorates the mechanical properties of tendon fascicles but not those of tendon bundles.Ikema Y, Tohyama H, Yamamoto E, Kanaya F, Yasuda K.Clin Biomech (Bristol, Avon). 2007 Jan;22(1):120-6. PMID: 17084002


21.

TGF-beta and glutathione promote tissue repair in cigarette smoke induced injury.Noguchi C, Umino T, Miyazaki Y, Jinta T, Usui Y, Yoshizawa Y.J Med Dent Sci. 2007 Mar;54(1):109-16. PMID: 19845143


22.

Middle ear mucosa regeneration by grafting of artificial mucosa.Yaguchi Y, Wada K, Uchimizu H, Tanaka Y, Kojima H, Moriyama H.Acta Otolaryngol. 2007 Oct;127(10):1038-44. PMID: 17851908


23.

Immunohistochemical distribution of heat shock protein 47 (HSP47) in scirrhous carcinoma of the stomach.Hirai K, Kikuchi S, Kurita A, Ohashi S, Adachi E, Matsuoka Y, Nagata K, Watanabe M.Anticancer Res. 2006 Jan-Feb;26(1A):71-8. PMID: 16475681


24.

In vitro reconstruction of a three-dimensional middle ear mucosal organ and its in vivo transplantation.Wada K, Tanaka Y, Kojima H, Inamatsu M, Yoshizato K, Moriyama H.Acta Otolaryngol. 2006 Aug;126(8):801-10. PMID: 16846921


25.

Growth kinetics and integrin expression of fibroblasts infiltrating devitalised patellar tendons are different from those of intrinsic fibroblasts.Ikema Y, Tohyama H, Nakamura H, Kanaya F, Yasuda K.J Bone Joint Surg Br. 2005 Dec;87(12):1689-93. PMID: 16326888


26.

Creation of a cholesteatoma model using three-dimensional cultured skin equivalents.Tanaka Y, Yaguchi Y, Wada K, Kojima H, Moriyama H.Laryngoscope. 2005 Aug;115(8):1421-7. PMID: 16094116


27.

Characterization of hair follicles induced in implanted, cultured rat keratinocyte sheets.Miyashita H, Hakamata Y, Kobayashi E, Kobayashi K.Exp Dermatol. 2004 Aug;13(8):491-8. PMID: 15265013


28.

Influence of external uniaxial cyclic strain on oriented fibroblast-seeded collagen gels.Berry CC, Shelton JC, Bader DL, Lee DA.Tissue Eng. 2003 Aug;9(4):613-24. PMID: 13678440


29.

In vitro and in vivo characterization of a novel semaphorin 3A inhibitor, SM-216289 or xanthofulvin.Kikuchi K, Kishino A, Konishi O, Kumagai K, Hosotani N, Saji I, Nakayama C, Kimura T.J Biol Chem. 2003 Oct 31;278(44):42985-91. PMID: 12933805


30.

Colonization of in vitro-formed cervical human papillomavirus- associated (pre)neoplastic lesions with dendritic cells: role of granulocyte/macrophage colony-stimulating factor.Hubert P, van den Brüle F, Giannini SL, Franzen-Detrooz E, Boniver J, Delvenne P.Am J Pathol. 1999 Mar;154(3):775-84. PMID: 10079255


31.

Effects of microgravity on c-fos gene expression in osteoblast-like MC3T3-E1 cells.Sato A, Hamazaki T, Oomura T, Osada H, Kakeya M, Watanabe M, Nakamura T, Nakamura Y, Koshikawa N, Yoshizaki I, Aizawa S, Yoda S, Ogiso A, Takaoki M, Kohno Y, Tanaka H.Adv Space Res. 1999;24(6):807-13. PMID: 11542626


32.

Assembly of basement membrane in vitro by cooperation between alveolar epithelial cells and pulmonary fibroblasts.Furuyama A, Kimata K, Mochitate K.Cell Struct Funct. 1997 Dec;22(6):603-14. PMID: 9591052


33.

A reconstituted skin:Dermal-epidermal interactions in collagenolysis and cell morphology.YoshizatoK,NishikawaA,Taira T. Biomed Res, 7(4):219-31. 1986.

I-AC培养器材包被

1.

Three-Dimensional Cell Sheet Construction Method with a Polyester Micromesh Sheet.Hori T, Kurosawa O, Ishihara K, Mizuta T, Iwata H.Tissue Eng Part C Methods. 2020 Mar;26(3):170-179. PMID: 32186996


2.

The reduced susceptibility of mouse keratinocytes to retinoic acid may be involved in the keratinization of oral and esophageal mucosal epithelium.Miyazono S, Otani T, Ogata K, Kitagawa N, Iida H, Inai Y, Matsuura T, Inai T.Histochem Cell Biol. 2020 Jan 31. [Epub ahead of print] PMID: 32006103


3.

Biomechanical analysis of the mechanical environment of the cell nucleus in serum starvation-induced vascular smooth muscle cell differentiation.Kazuaki NAGAYAMA.Journal of Biomechanical Science and Engineering, Vol.14, No.4 (2019)


4.

Differential transactivation of the upstream aggrecan enhancer regulated by PAX1/9 depends on SOX9-driven transactivation.Takimoto A, Kokubu C, Watanabe H, Sakuma T, Yamamoto T, Kondoh G, Hiraki Y, Shukunami C.Sci Rep. 2019 Mar 14;9(1):4605. PMID: 30872687


5.

Endovascular trophoblast expresses CD59 to evade complement-dependent cytotoxicity.Ueda M, Sato Y, Horie A, Tani H, Miyazaki Y, Okunomiya A, Matsumoto H, Hamanishi J, Kondoh E, Mandai M.Mol Cell Endocrinol. 2019 Apr 11. pii: S0303-7207(19)30106-6. PMID: 30981734


6.

CCL2 secreted from cancer-associated mesothelial cells promotes peritoneal metastasis of ovarian cancer cells through the P38-MAPK pathway.Yasui H1,2, Kajiyama H3, Tamauchi S1, Suzuki S1, Peng Y1, Yoshikawa N1, Sugiyama M1, Nakamura K1, Kikkawa F1.Clin Exp Metastasis. 2020 Feb;37(1):145-158. PMID: 31541326


7.

Reciprocal expression of Slug and Snail in human oral cancer cells.Nakamura R, Ishii H, Endo K, Hotta A, Fujii E, Miyazawa K, Saitoh M.PLoS One. 2018 Jul 3;13(7):e0199442. PMID: 29969465


8.

MicroRNA 148a-3p promotes Thrombospondin-4 expression and enhances angiogenesis during tendinopathy development by inhibiting Krüppel-like factor 6.Ge H, Shrestha A, Liu C, Wu P, Cheng B.BiochemBiophys Res Commun. 2018 Jul 12;502(2):276-282. PMID: 29807011 PMID: 29807011


9.

Internalization of CD239 highly expressed in breast cancer cells: a potential antigen for antibody-drug conjugates.Kikkawa Y, Enomoto-Okawa Y, Fujiyama A, Fukuhara T, Harashima N, Sugawara Y, Negishi Y, Katagiri F, Hozumi K, Nomizu M, Ito Y.Sci Rep. 2018 Apr 26;8(1):6612. PMID: 29700410.


10.

Enhanced survival and insulin secretion of insulinoma cell aggregates by incorporating gelatin hydrogel microspheres.Kanako Inoo, Hiroto Bando, Yasuhiko Tabata.Regenerative Therapy, Volume 8, June 2018, Pages 29-37.


11.

Scleraxis is a transcriptional activator that regulates the expression of Tenomodulin, a marker of mature tenocytes and ligamentocytes.Shukunami C, Takimoto A, Nishizaki Y, Yoshimoto Y, Tanaka S, Miura S, Watanabe H, Sakuma T, Yamamoto T, Kondoh G, Hiraki Y.Sci Rep. 2018 Feb 16;8(1):3155. PMID: 29453333


12.

Actomyosin contractility provokes contact inhibition in E-cadherin-ligated keratinocytes.Hirata H, Samsonov M, Sokabe M.Sci Rep. 2017 Apr 13;7:46326. PMID: 28406163


13.

Optical visualisation of thermogenesis in stimulated single-cell brown adipocytes.Kriszt R, Arai S, Itoh H, Lee MH, Goralczyk AG, Ang XM, Cypess AM, White AP, Shamsi F, Xue R, Lee JY, Lee SC, Hou Y, Kitaguchi T, Sudhaharan T, Ishiwata S, Lane EB, Chang YT, Tseng YH, Suzuki M, Raghunath M.Sci Rep. 2017 May 3;7(1):1383. PMID: 28469146


14.

The novel G-quadruplex-containing long non-coding RNA GSEC antagonizes DHX36 and modulates colon cancer cell migration.Matsumura K, Kawasaki Y, Miyamoto M, Kamoshida Y, Nakamura J, Negishi L, Suda S, Akiyama T.Oncogene. 2017 Mar 2;36(9):1191-1199. PMID: 27797375


15.

Bio-active molecules modified surfaces enhanced mesenchymal stem cell adhesion and proliferation.Mobasseri R, Tian L, Soleimani M, Ramakrishna S, Naderi-Manesh H.BiochemBiophys Res Commun. 2017 Jan 29;483(1):312-317. PMID: 28025144


16.

Methanol and Butanol Extracts of Paeonia lutea Leaves Repress Metastasis of Squamous Cell Carcinoma.Mukudai Y, Zhang M, Shiogama S, Kondo S, Ito C, Motohashi H, Kato K, Fujii M, Shintani S, Shigemori H, Yazawa K, Shirota T.Evid Based Complement Alternat Med. 2016;2016:6087213. PMID: 2729346

2

17.

Chronic inflammation imposes aberrant cell fate in regenerating epithelia through mechanotransduction.Nowell CS, Odermatt PD, Azzolin L, Hohnel S, Wagner EF, Fantner GE, Lutolf MP, Barrandon Y, Piccolo S, Radtke F.Nat Cell Biol. 2016 Feb;18(2):168-80. PMID: 26689676


18.

Ammonia-induced energy disorders interfere with bilirubin metabolism in hepatocytes.Wang Q, Wang Y, Yu Z, Li D, Jia B, Li J, Guan K, Zhou Y, Chen Y, Kan Q.Arch BiochemBiophys. 2014 Aug;555-556:16-22. PMID: 24878366


19.

Isolation of mesenchymal stem cells from human dermis.Soma T, Kishimoto J, Fisher D.Methods Mol Biol. 2013;989:265-74. PMID: 23483401


20.

Dexamethasone-mediated transcriptional regulation of rat carboxylesterase 2 gene.Hori T, Jin L, Fujii A, Furihata T, Nagahara Y, Chiba K, Hosokawa M.Xenobiotica. 2012 Jul;42(7):614-23. PMID:22235919


21.

Fibroblast Growth Factor Receptor 2 IIIc as a Therapeutic Target for Colorectal Cancer Cells.Matsuda Y, Hagio M, Seya T, Ishiwata T.Mol Cancer Ther. 2012 Sep;11(9):2010-20. PMID:22778155


22.

Effect of preservation conditions of collagen substrate on its fibril formation and rabbit chondrocyte morphology.Nadzir MM, Kino-oka M, Sugawara K, Taya M.J BiosciBioeng. 2012 Sep;114(3):360-3. PMID: 22677065


23.

Grainyhead-like 2 regulates epithelial morphogenesis by establishing functional tight junctions through the organization of a molecular network among claudin3, claudin4, and Rab25.Senga K, Mostov KE, Mitaka T, Miyajima A, Tanimizu N.Mol Biol Cell. 2012 Aug;23(15):2845-55. PMID:22696678


24.

α1- and α5-containing Laminins Regulate the Development of Bile Ducts via β1 Integrin Signals.Tanimizu N, Kikkawa Y, Mitaka T, Miyajima A.J Biol Chem. 2012 Aug 17;287(34):28586-97. PMID:22761447


25.

Modulation of cytochrome P450 gene expression in primary hepatocytes on various artificial extracellular matrices.Adachi T, Goto M, Cho CS, Akaike T.BiochemBiophys Res Commun. 2011 Oct 7;413(4):577-81. PMID: 21930114


26.

Overexpressed fibroblast growth factor receptor 2 in the invasive front of colorectal cancer: a potential therapeutic target in colorectal cancer.Matsuda Y, Ishiwata T, Yamahatsu K, Kawahara K, Hagio M, Peng WX, Yamamoto T, Nakazawa N, Seya T, Ohaki Y, Naito Z.Cancer Lett. 2011 Oct 28;309(2):209-19. PMID: 21745712


27.

Bile salt export pump inhibitors are associated with bile acid-dependent drug-induced toxicity in sandwich-cultured hepatocytes.Ogimura E, Sekine S, Horie T.BiochemBiophys Res Commun. 2011 Dec 16;416(3-4):313-7. PMID: 22108051


28.

Combined stimulation with cyclic stretching and hypoxia increases production of matrix metalloproteinase-9 and cytokines by macrophages.Oya K, Sakamoto N, Ohashi T, Sato M.BiochemBiophys Res Commun. 2011 Sep 9;412(4):678-82. PMID: 21867689


29.

Cell behavior on protein matrices containing laminin α1 peptide AG73.Yamada Y, Katagiri F, Hozumi K, Kikkawa Y, Nomizu M.Biomaterials. 2011 Jul;32(19):4327-35. PMID: 21420730


30.

Enhanced expression of lumican inhibited the attachment and growth of human embryonic kidney 293 cells.Ishiwata T, Yamamoto T, Kawahara K, Kawamoto Y, Matsuda Y, Ishiwata S, Naito Z.Exp Mol Pathol. 2010 Jun;88(3):363-70. PMID: 20138170


31.

Are integrin alpha(2)beta(1), glycoprotein Ib and vWf levels correlated with their contributions to platelet adhesion on collagen under high-shear flow?Jung SM, Sonoda M, Tsuji K, Jimi A, Nomura S, Kanaji T, Moroi M.Platelets. 2010;21(2):101-11. PMID: 20063990


32.

The adenomatous polyposis coli-associated guanine nucleotide exchange factor Asef is involved in angiogenesis.Kawasaki Y, Jigami T, Furukawa S, Sagara M, Echizen K, Shibata Y, Sato R, Akiyama T.J Biol Chem. 2010 Jan 8;285(2):1199-207. PMID: 19897489


33.

Atmospheric scanning electron microscope observes cells and tissues in open medium through silicon nitride film.Nishiyama H, Suga M, Ogura T, Maruyama Y, Koizumi M, Mio K, Kitamura S, Sato C.J Struct Biol. 2010 Nov;172(2):191-202. PMID: 20723603


34.

Involvement of PI3K/Akt/TOR pathway in stretch-induced hypertrophy of myotubes.Sasai N, Agata N, Inoue-Miyazu M, Kawakami K, Kobayashi K, Sokabe M, Hayakawa K.Muscle Nerve. 2010 Jan;41(1):100-6. PMID: 19768770


35.

Expression of Notch signalling-related genes in normal and differentiating rat dental pulp cells.Sun H, Kawashima N, Xu J, Takahashi S, Suda H.Aust Endod J. 2010 Aug;36(2):54-8. PMID: 20666749


36.

Natalizumab has no direct biological effect on JC virus infectivity in permissive human neural cell lines.Suzuki T, Yamanouchi S, Sunden Y, Orba Y, Kimura T, Sawa H.J Med Virol. 2010 Jul;82(7):1229-35. PMID: 20513089


37.

Construction of multifunctional proteins for tissue engineering: epidermal growth factor with collagen binding and cell adhesive activities.HannachiImen E, Nakamura M, Mie M, Kobatake E.J Biotechnol. 2009 Jan 1;139(1):19-25. PMID: 18984018


38.

Adenomatous polyposis coli and Asef function downstream of hepatocyte growth factor and phosphatidylinositol 3-kinase.Kawasaki Y, Tsuji S, Sagara M, Echizen K, Shibata Y, Akiyama T.J Biol Chem. 2009 Aug 14;284(33):22436-43. PMID: 19525225


39.

A collagen-coated surface enables quantitative evaluation of morphological behaviors of rabbit chondrocytes relating to cell differentiation in an early culture phase.Ali BaradarKhoshfetrata, Masahiro Kino-okaa, KatsuraSugawarab and Masahito TayaBiochemical Engineering Journal Volume 45, Issue 1, 1 June 2009, Pages 60-68


40.

ATP Release from Cultured Endothelial Cells and Intercellular Calcium Signaling during Shear Stress Exposure.Kudo Susumu, Hosoe Kaoru, Hosobuchi Makoto, Kawasaki Naoto, Tanishita KazuoJournal of Biomechanical Science and Engineering 4(2), 274-285, 2009.


41.

Human mammary progenitor cell fate decisions are products of interactions with combinatorial microenvironments.LaBarge MA, Nelson CM, Villadsen R, Fridriksdottir A, Ruth JR, Stampfer MR, Petersen OW, Bissell MJ.Integr Biol (Camb). 2009 Jan;1(1):70-9. PMID: 20023793


42.

Contribution of the LIM domain and nebulin-repeats to the interaction of Lasp-2 with actin filaments and focal adhesions.Nakagawa H, Suzuki H, Machida S, Suzuki J, Ohashi K, Jin M, Miyamoto S, Terasaki AG.PLoS One. 2009 Oct 23;4(10):e7530. PMID: 19851499


43.

Asef2 and Neurabin2 cooperatively regulate actin cytoskeletal organization and are involved in HGF-induced cell migration.Sagara M, Kawasaki Y, Iemura SI, Natsume T, Takai Y, Akiyama T.Oncogene. 2009 Mar 12;28(10):1357-65. PMID: 19151759


44.

Detection of mRNA in single living cells using AFM nanoprobes.Uehara H, Ikai A, Osada T.Methods Mol Biol. 2009;544:599-608. PMID: 19488726


45.

Expansion and characterization of adipose tissue-derived stromal cells cultured with low serum medium.Hattori H, Nogami Y, Tanaka T, Amano Y, Fukuda K, Kishimoto S, Kanatani Y, Nakamura S, Takase B, Ishihara M.J Biomed Mater Res B Appl Biomater. 2008 Oct;87(1):229-36. PMID: 18496860


46.

Different regulation of hepatocyte behaviors between natural extracellular matrices and synthetic extracellular matrices by hepatocyte growth factor.Hoshiba T, Wakejima M, Cho CS, Shiota G, Akaike T.J Biomed Mater Res A. 2008 Apr;85(1):228-35. PMID: 17688272


47.

Ectopic transplantation of hepatocyte sheets fabricated with temperature-responsive culture dishes.Kano K, Yamato M, Okano T.Hepatol Res. 2008;38(11):1140-7. PMID: 18513332


48.

Effect of dehydroaltenusin-C12 derivative, a selective DNA polymerase alpha inhibitor, on DNA replication in cultured cells.Kuriyama I, Mizuno T, Fukudome K, Kuramochi K, Tsubaki K, Usui T, Imamoto N, Sakaguchi K, Sugawara F, Yoshida H, Mizushina Y.Molecules. 2008 Dec 1;13(12):2948-61. PMID: 19043348


49.

Primary hepatocyte survival on non-integrin-recognizable matrices without the activation of Akt signaling.Hoshiba T, Nagahara H, Cho CS, Tagawa Y, Akaike T.Biomaterials. 2007 Feb;28(6):1093-104. PMID: 17081603


50.

Epidermal growth factor signaling for matrix-dependent cell proliferation and differentiation in primary cultured hepatocytes.Kim SH, Akaike T.Tissue Eng. 2007 Mar;13(3):601-9. PMID: 17518606


51.

Comparison of basal gene expression and induction of CYP3As in HepG2 and human fetal liver cells.Maruyama M, Matsunaga T, Harada E, Ohmori S.Biol Pharm Bull. 2007 Nov;30(11):2091-7. PMID: 17978482


52.

A mechanism to safeguard platelet adhesion under high shear flow: von Willebrand factor-glycoprotein Ib and integrin alphabeta-collagen interactions make complementary, collagen-type-specific contributions to adhesion.Moroi M, Jung SM.J ThrombHaemost. 2007 Apr;5(4):797-803. PMID: 17408410


53.

Combinatorial protein display for the cell-based screening of biomaterials that direct neural stem cell differentiation.Nakajima M, Ishimuro T, Kato K, Ko IK, Hirata I, Arima Y, Iwata H.Biomaterials. 2007 Feb;28(6):1048-60. PMID: 17081602


54.

Identification and characterization of GSRP-56, a novel Golgi-localized spectrin repeat-containing protein.Kobayashi Y, Katanosaka Y, Iwata Y, Matsuoka M, Shigekawa M, Wakabayashi S.Exp Cell Res. 2006 Oct 1;312(16):3152-64. PMID: 16875688


55.

Murine metanephric mesenchyme possesses characteristics of vascular endothelial cells in vitro.Usui J, Yamada R, Kanemoto K, Koyama A, Nagata M.Nephron Exp Nephrol. 2006;102(3-4):e93-8. PMID: 16282704


56.

Association of expression of receptor for advanced glycation end products and invasive activity of oral squamous cell carcinoma.Bhawal UK, Ozaki Y, Nishimura M, Sugiyama M, Sasahira T, Nomura Y, Sato F, Fujimoto K, Sasaki N, Ikeda MA, Tsuji K, Kuniyasu H, Kato Y.Oncology. 2005;69(3):246-55. PMID: 16127291


57.

Fibrous component of the blastocoelic extracellular matrix shapes epithelia in concert with mesenchyme cells in starfish embryos.Kaneko H, Okai M, Murabe N, Shimizu T, Ikegami S, Dan-Sohkawa M.Dev Dyn. 2005 Apr;232(4):915-27. PMID: 15739228


58.

Differential growth properties of normal and malignant esophageal epithelial cells: a possible cross talk between transforming growth factor-beta1 and epidermal growth factor signaling.Katayama M, Shoji M, Satomi S.Tohoku J Exp Med. 2005 May;206(1):61-71. PMID: 15802876


59.

Process design of chondrocyte cultures with monolayer growth for cell expansion and subsequent three-dimensional growth for production of cultured cartilage.Kino-oka M, Maeda Y, Ota Y, Yashiki S, Sugawara K, Yamamoto T, Taya M.J BiosciBioeng. 2005 Jul;100(1):67-76. PMID: 16233853


60.

Role of p38 mitogen-activated protein kinase activation in podocyte injury and proteinuria in experimental nephrotic syndrome.Koshikawa M, Mukoyama M, Mori K, Suganami T, Sawai K, Yoshioka T, Nagae T, Yokoi H, Kawachi H, Shimizu F, Sugawara A, Nakao K.J Am Soc Nephrol. 2005 Sep;16(9):2690-701. PMID: 15987752


61.

Effect of fluid force on vascular cell function.Kudo S, Yamaguchi R, Ikeda M, Tanishita K.J PhysiolAnthropol Appl Human Sci. 2005 Jul;24(4):459-61. PMID: 16079597


62.

Significance of HDAC6 regulation via estrogen signaling for cell motility and prognosis in estrogen receptor-positive breast cancer.Saji S, Kawakami M, Hayashi S, Yoshida N, Hirose M, Horiguchi S, Itoh A, Funata N, Schreiber SL, Yoshida M, Toi M.Oncogene. 2005 Jun 30;24(28):4531-9. PMID: 15806142


63.

Platelet-derived soluble factors induce human extravillous trophoblast migration and differentiation: platelets are a possible regulator of trophoblast infiltration into maternal spiral arteries.Sato Y, Fujiwara H, Zeng BX, Higuchi T, Yoshioka S, Fujii S.Blood. 2005 Jul 15;106(2):428-35. PMID: 15797992


64.

Regulation of biological activity and matrix assembly of laminin-5 by COOH-terminal, LG4-5 domain of alpha3 chain.Tsubota Y, Yasuda C, Kariya Y, Ogawa T, Hirosaki T, Mizushima H, Miyazaki K.J Biol Chem. 2005 Apr 15;280(15):14370-7. PMID: 15695818


65.

Genotype 2a hepatitis C virus subgenomic replicon can replicate in HepG2 and IMY-N9 cells.Date T, Kato T, Miyamoto M, Zhao Z, Yasui K, Mizokami M, Wakita T.J Biol Chem. 2004 May 21;279(21):22371-6. PMID: 14990575


66.

Astrocytes express type VIII collagen during the repair process of brain cold injury.Hirano S, Yonezawa T, Hasegawa H, Hattori S, Greenhill NS, Davis PF, Sage EH, Ninomiya Y.BiochemBiophys Res Commun. 2004 Apr 30;317(2):437-43. PMID: 15063777


67.

Expression of lysosomal protective protein/cathepsin A in a stably transformed human neuroblastoma cell line during bi-directional differentiation into neuronal and Schwannian cells.Itoh K, Satoh Y, Kadota Y, Oheda Y, Kuwahara J, Shimmoto M, Sakuraba H.Neurochem Int. 2004 May;44(6):447-57. PMID: 14687610


68.

Preparation of lactose-silk fibroin conjugates and their application as a scaffold for hepatocyte attachment.Gotoh Y, Niimi S, Hayakawa T, Miyashita T.Biomaterials. 2004 Mar;25(6):1131-40. PMID: 14615179


69.

Antithrombogenicity of cultured endothelial cells exposed to blood under stagnant flow conditions.Makoto Kaibara, TasukuYotoriyama, Ryutaro Himeno.Journal of Japanese Society of Biorheology. Vol. 18 (2004) No. 1 p. 52-59.


70.

The basement membrane protein laminin-5 acts as a soluble cell motility factor.Kariya Y, Miyazaki K.Exp Cell Res. 2004 Jul 15;297(2):508-20. PMID: 15212952


71.

N-WASP and WAVE2 acting downstream of phosphatidylinositol 3-kinase are required for myogenic cell migration induced by hepatocyte growth factor.Kawamura K, Takano K, Suetsugu S, Kurisu S, Yamazaki D, Miki H, Takenawa T, Endo T.J Biol Chem. 2004 Dec 24;279(52):54862-71. PMID: 15496413


72.

Hepatocyte behavior on synthetic glycopolymer matrix: inhibitory effect of receptor-ligand binding on hepatocyte spreading.Kim SH, Hoshiba T, Akaike T.Biomaterials. 2004 May;25(10):1813-23. PMID: 14738845


73.

Microbial serine carboxypeptidase inhibitors–comparative analysis of actions on homologous enzymes derived from man, yeast and wheat.Satoh Y, Kadota Y, Oheda Y, Kuwahara J, Aikawa S, Matsuzawa F, Doi H, Aoyagi T, Sakuraba H, Itoh K.J Antibiot (Tokyo). 2004 May;57(5):316-25. PMID: 15303492


74.

Human amniotic epithelial cells possess hepatocyte-like characteristics and functions.Takashima S, Ise H, Zhao P, Akaike T, Nikaido T.Cell Struct Funct. 2004 Jun;29(3):73-84. PMID: 15528839


75.

Expression of calcineurin B homologous protein 2 protects serum deprivation-induced cell death by serum-independent activation of Na+/H+ exchanger.Pang T, Wakabayashi S, Shigekawa M.J Biol Chem. 2002 Nov 15;277(46):43771-7. PMID: 12226101


76.

Acquisition of susceptibility to hepatitis C virus replication in HepG2 cells by fusion with primary human hepatocytes: establishment of a quantitative assay for hepatitis C virus infectivity in a cell culture system.Ito T, Yasui K, Mukaigawa J, Katsume A, Kohara M, Mitamura K.Hepatology. 2001 Sep;34(3):566-72. PMID: 11526543


77.

Molecular cloning of a novel polypeptide, DP5, induced during programmed neuronal death.Imaizumi K, Tsuda M, Imai Y, Wanaka A, Takagi T, Tohyama M.J Biol Chem. 1997 Jul 25;272(30):18842-8. PMID: 9228060


78.

Possible involvement of a novel protease in neurite outgrowth of PC12 cells.Saito Y, Tsubuki S, Ito H, Kawashima S.Neurosci Res Suppl. 1990;13:S97-101. PMID: 2088345

I-AC支架制备/包被

1.

Cell fibers promote proliferation of co-cultured cells on a dish.Shima A, Itou A, Takeuchi S.Sci Rep. 2020 Jan 14;10(1):288. PMID: 31937888


2.

Microfiber-shaped building-block tissues with endothelial networks for constructing macroscopic tissue assembly.Kurashina Y, Sato R, Onoe H.APL Bioeng. 2019 Nov 13;3(4):046101. PMID: 31737859


3.

A novel micro-grooved collagen substrate for inducing vascular smooth muscle differentiation through cell tissue arrangement and nucleus remodeling.Nagayama K, Uchida K, Sato A.J Mech Behav Biomed Mater. 2019 Feb;90:295-305. PMID: 30396043


4.

Microfluidic vascular-bed devices for vascularized 3D tissue engineering: tissue engineering on a chip.Takehara H, Sakaguchi K, Sekine H, Okano T, Shimizu T.Biomed Microdevices. 2019 Dec 20;22(1):9. PMID: 31863202


5.

Temporal Observation of Adipocyte Microfiber Using Anchoring Device.Yokomizo A, Morimoto Y, Nishimura K, Takeuchi S.Micromachines (Basel). 2019 May 29;10(6). PMID: 31146491


6.

VEGF delivery by smart polymeric PNIPAM nanoparticles affects both osteogenic and angiogenic capacities of human bone marrow stem cells.Adibfar A, Amoabediny G, BaghabanEslaminejad M, Mohamadi J, Bagheri F, ZandiehDoulabi B.Mater Sci Eng C Mater Biol Appl. 2018 Dec 1;93:790-799. PMID: 30274113


7.

Double-layer perfusable collagen microtube device for heterogeneous cell culture.Itai S, Tajima H, Onoe H.Biofabrication. 2018 Nov 30;11(1):015010. PMID: 30499456


8.

An allogeneic 'off the shelf' therapeutic strategy for peripheral nerve tissue engineering using clinical grade human neural stem cells.O'Rourke C, Day AGE, Murray-Dunning C, Thanabalasundaram L, Cowan J, Stevanato L, Grace N, Cameron G, Drake RAL, Sinden J, Phillips JB.Sci Rep. 2018 Feb 13;8(1):2951. PMID: 29440680


9.

Anchorage-dependent cell expansion in fiber-shaped microcarrier aggregates.Ikeda K, Takeuchi S.Biotechnol Prog. 2019 Mar;35(2):e2755. PMID: 30468323.


10.

Optimal biomaterials for tracheal epithelial grafts: an in vitro systematic comparative analysis.Varma R, Aoki FG, Soon K, Karoubi G, Waddell TK.Acta Biomater. 2018 Nov;81:146-157. PMID: 30268918


11.

The Effect of Hypothermic and Cryogenic Preservation on Engineered Neural Tissue.Day AGE, Bhangra KS, Murray-Dunning C, Stevanato L, Phillips J.Tissue Eng Part C Methods. 2017 Oct;23(10):575-582. PMID: 28877649


12.

Functionalized core-shell hydrogel microsprings by anisotropic gelation with bevel-tip capillary.Yoshida K, Onoe H.Sci Rep. 2017 Apr 5;7:45987. doi: 10.1038/srep45987. PMID: 28378803


13.

Compartmentalized Spherical Collagen Microparticles for Anisotropic Cell Culture Microenvironments.Yoshida S, Takinoue M, Onoe H.Adv Healthc Mater. 2017 Apr;6(8). PMID: 28322015


14.

Collagen Vitrigels with Low-fibril Density Enhance Human Embryonic Stem. Cell-Derived Retinal Pigment Epithelial Cell Maturation.Wang X, Maruotti J, Majumdar S, Roman J, Mao HQ, Zack D, Elisseeff J.J Tissue Eng Regen Med. 2018 Mar;12(3):821-829. PMID: 29049869


15.

3D Tissue Formation of Unilocular Adipocytes in Hydrogel Microfibers.Hsiao AY, Okitsu T, Teramae H, Takeuchi S. Adv Healthc Mater. 2016 Mar 9;5(5):548-56. PMID: 26680212


16.

Influence of collagen source on fibrillar architecture and properties of vitrified collagen membranes.Majumdar S, Guo Q, Garza-Madrid M, Calderon-Colon X, Duan D, Carbajal P, Schein O, Trexler M, Elisseeff J.J Biomed Mater Res B Appl Biomater. 2016 Feb;104(2):300-7. PMID: 25766399


17.

An electrically resistive sheet of glial cells for amplifying signals of neuronal extracellular recordings.Matsumura R, Yamamoto H, Niwano M, Hirano-Iwata A.Appl Phys Lett. 2016 Jan 11;108(2):023701.PMID: 27703279


18.

Vessel-like channels supported by poly-l-lysine tubes.Mori N, Morimoto Y, Takeuchi S.J BiosciBioeng. 2016 Dec;122(6):753-757 PMID: 27323931


19.

Formation of Highly Aligned Collagen Nanofibers by Continuous Cyclic Stretch of a Collagen Hydrogel Sheet.Nam , Lee WC, Takeuchi S.MacromolBiosci. 2016 Jul;16(7):995-1000. PMID: 27136124


20.

Regeneration of corneal epithelium utilizing a collagen vitrigel membrane in rabbit models for corneal stromal wound and limbal stem cell deficiency.Chae JJ, Ambrose WM, Espinoza FA, Mulreany DG, Ng S, Takezawa T, Trexler MM, Schein OD, Chuck RS, Elisseeff JH.


21.

Acta Ophthalmol. 2015 Feb;93(1):e57-66. PMID: 25495158. Smooth muscle-like tissue constructs with circumferentially oriented cells formed by the cell fiber technology.Hsiao AY, Okitsu T, Onoe H, Kiyosawa M, Teramae H, Iwanaga S, Kazama T, Matsumoto T, Takeuchi S.PLoS One. 2015 Mar 3;10(3):e0119010. PMID: 25734774


22.

Optimization of optical and mechanical properties of Real Architecture for 3-Dimensional Tissue equivalents: Towards treatment of limbal epithelial stem cell deficiency.Massie I, Kureshi AK, Schrader S, Shortt AJ, Daniels JT.Acta Biomater. 2015 Sep 15;24:241-50. PMID: 2609235

2

23.

Fabrication of fibrillized collagen microspheres with the microstructure resembling an extracellular matrix.Matsuhashi A, Nam K, Kimura T, Kishida A.Soft Matter. 2015 Apr 14;11(14):2844-51. PMID: 25708876


24.

Preparation Fibrillized Collagen-Glycosaminoglycan Complex Matrix Using Fibrillogenesis.Nam, K., Kimura, T. and Kishida, A.MacromolSymp. 2015 358:95–105.


25.

Neural stem/progenitor cell-laden microfibers promote transplant survival in a mouse transected spinal cord injury model.Sugai K, Nishimura S, Kato-Negishi M, Onoe H, Iwanaga S, Toyama Y, Matsumoto M, Takeuchi S, Okano H, Nakamura M.J Neurosci Res. 2015 Dec;93(12):1826-38. PMID: 26301451


26.

Activation of Yes-Associated Protein in Low-Grade Meningiomas Is Regulated by Merlin, Cell Density, and Extracellular Matrix Stiffness.Tanahashi K, Natsume A, Ohka F, Motomura K, Alim A, Tanaka I, Senga T, Harada I, Fukuyama R, Sumiyoshi N, Sekido Y, Wakabayashi T.J Neuropathol Exp Neurol. 2015 Jul;74(7):704-9. PMID: 26049897


27.

Application of a collagen-based membrane and chondroitin sulfate-based hydrogel adhesive for the potential repair of severe ocular surface injuries.Chae JJ, Mulreany DG, Guo Q, Lu Q, Choi JS, Strehin I, Espinoza FA, Schein O, Trexler MM, Bower KS, Elisseeff JH.Mil Med. 2014 Jun;179(6):686-94. PMID: 24902138


28.

Design and construction of an equibiaxial cell stretching system that is improved for biochemical analysis.Ursekar CP, Teo SK, Hirata H, Harada I, Chiam KH, Sawada Y.PLoS One. 2014 Mar 13;9(3):e90665. PMID: 24626190


29.

Banded structures in collagen vitrigels for corneal injury repair.Xia Z, Calderón-Colón X, McCally R, Maranchi J, Rong L, Hsiao B, Elisseeff J, Trexler M.Acta Biomater. 2014 Aug;10(8):3615-9. PMID: 24859294


30.

Vitrified collagen-based conjunctival equivalent for ocular surface reconstruction.Zhou H, Lu Q, Guo Q, Chae J, Fan X, Elisseeff JH, Grant MP.Biomaterials. 2014 Aug;35(26):7398-406. PMID: 24933512


31.

Modulation of keratocyte phenotype by collagen fibril nanoarchitecture in membranes for corneal repair.Guo Q, Phillip JM, Majumdar S, Wu PH, Chen J, Calderón-Colón X, Schein O, Smith BJ, Trexler MM, Wirtz D, Elisseeff JH.Biomaterials. 2013 Dec;34(37):9365-72. PMID: 24041426


32.

Substrate stiffness regulates temporary NF-κB activation via actomyosin contractions.Ishihara S, Yasuda M, Harada I, Mizutani T, Kawabata K, Haga H.Exp Cell Res. 2013 Nov 15;319(19):2916-27. PMID: 24113574


33.

Metre-long cell-laden microfibres exhibit tissue morphologies and functions. Onoe H, Okitsu T, Itou A, Kato-Negishi M, Gojo R, Kiriya D, Sato K, Miura S, Iwanaga S, Kuribayashi-Shigetomi K, Matsunaga YT, Shimoyama Y, Takeuchi S. Nat Mater. 2013 Jun;12(6):584-90. PMID: 23542870


34.

Regenerative process of tracheal epithelium using a collagen vitrigel sponge scaffold.Tani A, Tada Y, Takezawa T, Wada I, Imaizumi M, Nomoto Y, Nomoto M, Omori K.Laryngoscope. 2013 Jun;123(6):1469-73. PMID: 23625522


35.

Cellular response to substrate rigidity is governed by either stress or strain.Yip AK, Iwasaki K, Ursekar C, Machiyama H, Saxena M, Chen H, Harada I, Chiam KH, Sawada Y.Biophys J. 2013 Jan 8;104(1):19-29. PMID: 23332055


36.

Structure and properties of collagen vitrigel membranes for ocular repair and regeneration applications.Calderón-Colón X, Xia Z, Breidenich JL, Mulreany DG, Guo Q, Uy OM, Tiffany JE, Freund DE, McCally RL, Schein OD, Elisseeff JH, Trexler MM.Biomaterials. 2012 Nov;33(33):8286-95. PMID: 22920579


37.

Local mechanical stimulation of mardin-darby canine kidney cell sheets on temperature-responsive hydrogel.Harada I, Yanagisawa S, Iwasaki K, Cho CS, Akaike T.Int J Mol Sci. 2012;13(1):1095-108. PMID:22312306


38.

Hybrid scaffolds composed of hyaluronic acid and collagen for cartilage regeneration.Hyun Jung Kim, KabKeun Kim, Il Kyu Park, Baek Sun Choi, Jae Ho Kim and Moon Suk Kim. Tissue Engineering and Regenerative Medicine. Volume 9, Number 2 (2012), 57-62.


39.

Fabrication of a heterostructural fibrillated collagen matrix for the regeneration of soft tissue function.Kwangwoo Nam, Yuuki Sakai, Yoshihide Hashimoto, Tsuyoshi Kimura and Akio Kishida. Soft Matter, 2012, 8, 472-480.


40.

Matrix compliance and RhoA direct the differentiation of mammary progenitor cells.Lui C, Lee K, Nelson CM.Biomech Model Mechanobiol. 2012 Nov;11(8):1241-9. PMID: 22161021


41.

Regulation of growth factors-associated cell migration by C-phycocyanin scaffold in dermal wound healing.Madhyastha H, Madhyastha R, Nakajima Y, Omura S, Maruyama M.Clin Exp Pharmacol Physiol. 2012 Jan;39(1):13-9. PMID:21995435


42.

Heterofunctional nanosheet controlling cell adhesion properties by collagen coating.Niwa D, Fujie T, Lang T, Goda N, Takeoka S.J Biomater Appl. 2012 Aug;27(2):131-41. PMID: 21343215


43..

Thermal denaturation of type I collagen vitrified gels.Zhiyong Xia, Xiomara Calderon-Colona, Morgana Trexlera, Jennifer Elisseeffb, QiongyuGuob. ThermochimicaActaVolume 527, 10 January 2012, Pages 172–179.


44.

Engineering a collagen matrix that replicates the biological properties of native extracellular matrix.

Nam K, Sakai Y, Funamoto S, Kimura T, Kishida A.J Biomater Sci Polym Ed. 2011;22(15):1963-82. PMID: 20961498


45.

A nano-fibrous assembly of collagen–hyaluronic acid for controlling cell-adhesive properties.ToshinoriFujie, ShoFurutate, Daisuke Niwaa and Shinji Takeoka. Soft Matter, 2010,6, 4672-4676


46.

Preparation of a collagen/polymer hybrid gel designed for tissue membranes. Part I: controlling the polymer-collagen cross-linking process using an ethanol/water co-solvent.Nam K, Kimura T, Funamoto S, Kishida A.Acta Biomater. 2010 Feb;6(2):403-8. PMID: 19531383


47.

Preparation of a collagen/polymer hybrid gel for tissue membranes. Part II: in vitro and in vivo biological properties of the collagen gels.Nam K, Kimura T, Funamoto S, Kishida A.Acta Biomater. 2010 Feb;6(2):409-17. PMID: 19539060


48.

Micro 3D Culture System using Hyaluronan-Collagen Capsule for Skeletal Muscle-Derived Stem Cells.Tono-Okada K, Okada Y, Masuda Y, Akio Hoshi, Akira Akatsuka, Akira Teramoto, Koji Abe and Tetsuro Tamaki.Open Tissue Eng Regen Med J, 2010, 3, 18-27.


49.

Construction and Biofunction of 3-Dimensional Self-assembly Collagen Nanostructure on PLLA Substrate.Shouhong Xu, Aiping Liu, Xiaoxiao Lin, Honglai Liu and MasakastuYonese. Chin J Chem. 2010 28: 1565–1574.


50.

Cryopreservation in situ of cell monolayers on collagen vitrigel membrane culture substrata: ready-to-use preparation of primary hepatocytes and ES cells.Miyamoto Y, Enosawa S, Takeuchi T, Takezawa T.Cell Transplant. 2009;18(5):619-26. PMID: 19775524


51.

Reconstruction of three-dimensional human skin model composed of dendritic cells, keratinocytes and fibroblasts utilizing a handy scaffold of collagen vitrigel membrane.Uchino T, Takezawa T, Ikarashi Y.Toxicol In Vitro. 2009 Mar;23(2):333-7. PMID: 19121381


52.

Bone regeneration using collagen type I vitrigel with bone morphogenetic protein-2.Zhao J, Shinkai M, Takezawa T, Ohba S, Chung UI, Nagamune T. J BiosciBioeng. 2009 Mar;107(3):318-23. PMID: 19269600


53.

The osteogenic differentiation of adipose tissue-derived precursor cells in a 3D scaffold/matrix environment.Leong DT, Nah WK, Gupta A, Hutmacher DW, Woodruff MA.Curr Drug Discov Technol. 2008 Dec;5(4):319-27. PMID: 19075612


54.

Physical and biological properties of collagen-phospholipid polymer hybrid gels.Nam K, Kimura T, Kishida A.Biomaterials. 2007 Jul;28(20):3153-62. PMID: 17391753


55.

Preparation and characterization of cross-linked collagen-phospholipid polymer hybrid gels.Nam K, Kimura T, Kishida A.Biomaterials. 2007 Jan;28(1):1-8. PMID: 16959313


56.

Reconstruction of a hard connective tissue utilizing a pressed silk sheet and type-I collagen as the scaffold for fibroblasts.Takezawa T, Ozaki K, Takabayashi C.Tissue Eng. 2007 Jun;13(6):1357-66. PMID: 17518702


57.

Collagen vitrigel membrane useful for paracrine assays in vitro and drug delivery systems in vivo.Takezawa T, Takeuchi T, Nitani A, Takayama Y, Kino-Oka M, Taya M, Enosawa S.J Biotechnol. 2007 Aug 1;131(1):76-83. PMID: 17624459


58.

Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis.Bosnakovski D, Mizuno M, Kim G, Takagi S, Okumura M, Fujinaga T.BiotechnolBioeng. 2006 Apr 20;93(6):1152-63. PMID: 16470881


59.

Electrochemical properties of 316L stainless steel with culturing L929 fibroblasts.Hiromoto S, Hanawa T.J R Soc Interface. 2006 Aug 22;3(9):495-505. PMID: 16849246


60.

Fabrication of a new tubular fibrous PLCL scaffold for vascular tissue engineering.Kim SH, Kwon JH, Chung MS, Chung E, Jung Y, Kim SH, Kim YH.J Biomater Sci Polym Ed. 2006;17(12):1359-74. PMID: 17260508


61.

In vitro assays for adhesion and migration of osteoblastic cells (Saos-2) on titanium surfaces.Li CY, Gao SY, Terashita T, Shimokawa T, Kawahara H, Matsuda S, Kobayashi N.Cell Tissue Res. 2006 Jun;324(3):369-75. PMID: 16450122


62.

Novel tissue-engineered biodegradable material for reconstruction of vascular wall.Iwai S, Sawa Y, Taketani S, Torikai K, Hirakawa K, Matsuda H.Ann Thorac Surg. 2005 Nov;80(5):1821-7. PMID: 16242461


63.

Co-electrospun nanofiber fabrics of poly(L-lactide-co-epsilon-caprolactone) with type I collagen or heparin.Kwon IK, Matsuda T.Biomacromolecules. 2005 Jul-Aug;6(4):2096-105. PMID: 16004450


64.

In vitro and in vivo study of He+ ion irradiated collagen for development of small diameter stent graft material.Y. Suzuki, M. Iwaki, N. Takahashi, T. Yotoriyama, K. Kurotobi, H. Ujiie, T. Hori.Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms, Volume 232, Issues 1–4, May 2005, Pages 353-357.


65.

The changes of cell adhesion to collagen-coated Al2O3 by ion bombardment.Y. Yokoyama, T. Tsukamoto, T. Kobayashi, M. Iwaki.Surface and Coatings Technology, Volume 196, Issues 1–3, 22 June 2005, Pages 298-302.


66.

Collagen vitrigel: a novel scaffold that can facilitate a three-dimensional culture for reconstructing organoids.Takezawa T, Ozaki K, Nitani A, Takabayashi C, Shimo-Oka T. Cell Transplant. 2004;13(4):463-73. PMID: 15468688

I-AC凝胶上培养、其他

1.

Mouse skin fibroblasts with mesenchymal stem cell marker p75 neurotrophin receptor proliferate in response to prolyl-hydroxyproline.Tomoko T. Asai, Kazunobu Yoshikawa, Kazuhiro Sawada, KazunaFukamizu, Yoh-ichi Koyama, Yasutaka Shigemura, Shiro Jimi, Kenji Sato.Journal of Functional Foods, Volume 66, 2020.


2.

Discovery of Ti-Binding Abilities of Phosphorylated-Chitin and -Collagen.Yoshinori Kuboki, Seiichi Tokura, KimitoshiYagami, ToshitakeFurusawa, Kouichi Morimoto, Qin Song, Souhei (Xiaobing) Iku, Masaaki Kurasaki.Journal of Hard Tissue Biology, 2020 29(1):45-48.


3.

Food-Derived Collagen Peptides, Prolyl-Hydroxyproline (Pro-Hyp), and Hydroxyprolyl-Glycine (Hyp-Gly) Enhance Growth of Primary Cultured Mouse Skin Fibroblast Using Fetal Bovine Serum Free from Hydroxyprolyl Peptide.Asai TT, Oikawa F, Yoshikawa K, Inoue N, Sato K.Int J Mol Sci. 2019 Dec 28;21(1). PMID: 31905705


4.

Development of a collagen-like peptide polymer via end-to-end disulfide cross-linking and its application as a biomaterial.Ichise SF, Takeuchi S, Aoki S, Kuroda KC, Nose H, Masuda R, Koide T.Acta Biomater. 2019 Aug;94:361-371. PMID: 31200119


5.

Analysis of Ultraviolet Radiation Wavelengths Causing Hardening and Reduced Elasticity of Collagen Gels In Vitro.Kazuhisa Maeda.Cosmetics 2018, 5(1), 14.


6.

Three-dimensional printed microfluidic modules for design changeable coaxial microfluidic devices.Yuya Morimoto, Mahiro Kiyosawa, Shoji Takeuchi.Sensors and Actuators B: Chemical, Volume 274, 2018, Pages 491-500.


7.

Amino Carbonylation of Epidermal Basement Membrane Inhibits Epidermal Cell Function and Is Suppressed by Methylparaben.HarukaMorimoto ,Lihao Gu , Haifeng Zeng and Kazuhisa Maeda.Cosmetics 2017, 4(4), 38.


8.

Vascularized Tissue-Engineered Model for Studying Drug Resistance in Neuroblastoma.Villasante A, Sakaguchi K, Kim J, Cheung NK, Nakayama M, Parsa H, Okano T, Shimizu T, Vunjak-Novakovic G.Theranostics 2017; 7(17):4099-4117.


9.

Ultrastructural analysis of the decellularized cornea after interlamellar keratoplasty and microkeratome-assisted anterior lamellar keratoplasty in a rabbit model.Hashimoto Y, Hattori S, Sasaki S, Honda T, Kimura T, Funamoto S, Kobayashi H, Kishida A.Sci Rep. 2016 Jun 13;6:27734. PMID: 27291975


10.

Thermal denaturation behavior of collagen fibrils in wet and dry environment.Suwa Y, Nam K, Ozeki K, Kimura T, Kishida A, Masuzawa T.J Biomed Mater Res B Appl Biomater. 2016 Apr;104(3):538-45 PMID: 25952296


11.

Synergistic rate boosting of collagen fibrillogenesis in heterogeneous mixtures of crowding agents.Dewavrin JY, Abdurrahiem M, Blocki A, Musib M, Piazza F, Raghunath M.J Phys Chem B. 2015 Mar 26;119(12):4350-8. PMID: 25730613.


12.

Cellular characterization of thrombocytes in Xenopus laevis with specific monoclonal antibodies.Tanizaki Y, Ishida-Iwata T, Obuchi-Shimoji M, Kato T.Exp Hematol. 2015 Feb;43(2):125-36. PMID: 25448492


13.

Tuning the architecture of three-dimensional collagen hydrogels by physiological macromolecular crowding.Dewavrin JY, Hamzavi N, Shim VP, Raghunath M.Acta Biomater. 2014 Oct;10(10):4351-9. PMID: 24932771


14.

Migration of breast cancer cells into reconstituted type I collagen gels assessed via a combination of frozen sectioning and azan staining.Fukuda K, Kamoshida Y, Kurokawa T, Yoshida M, Fujita-Yamaguchi Y, Nakata M.Biosci Trends. 2014 Aug;8(4):212-6. PMID: 25224627


15.

Overexpression of integrin αv facilitates proliferation and invasion of oral squamous cell carcinoma cells via MEK/ERK signaling pathway that is activated by interaction of integrin αvβ8 with type Ⅰ collagen.Hayashido Y, Kitano H, Sakaue T, Fujii T, Suematsu M, Sakurai S, Okamoto T.Int J Oncol. 2014 Nov;45(5):1875-82. PMID: 25190218


16.

Relationships between molecular mobility, fibrillogenesis of collagen molecules, and the inflammatory response: An experimental study in vitro and in vivo.Nam K, Seo JH, Kimura T, Yui N, Kishida A.J Colloid Interface Sci. 2014 Jul 1;433C:16-25. PMID: 25112908


17.

In vitro engineering of vascularized tissue surrogates.Sakaguchi K, Shimizu T, Horaguchi S, Sekine H, Yamato M, Umezu M, Okano T.Sci Rep. 2013 Feb 19;3:1316. PMID: 23419835


18.

High-throughput turbidimetric screening for heparin-neutralizing agents and low-molecular-weight heparin mimetics.Sekiya A, Oishi S, Fujii N, Koide T.Chem Pharm Bull (Tokyo). 2012;60(3):371-6. PMID:22382418


19.

Rapid formation of size-controlled three dimensional hetero-cell aggregates using micro-rotation flow for spheroid study.Ota H, Kodama T, Miki N.Biomicrofluidics. 2011 Sep;5(3):34105-3410515. PMID: 22662035


20.

Invasion of carcinoma cells into reconstituted type I collagen gels: visual real-time analysis by time-lapse microscopy.Sakai K, Kurokawa T, Furui Y, Kuronuma Y, Sekiguchi M, Ando J, Inagaki Y, Tang W, Nakata M, Fujita-Yamaguchi Y.Biosci Trends. 2011;5(1):10-6. PMID: 21422595


21.

TGF-β regulates isoform switching of FGF receptors and epithelial-mesenchymal transition.Shirakihara T, Horiguchi K, Miyazawa K, Ehata S, Shibata T, Morita I, Miyazono K, Saitoh M.EMBO J. 2011 Feb 16;30(4):783-95. PMID: 21224849


22.

Essential modification of the Sircol Collagen Assay for the accurate quantification of collagen content in complex protein solutions.Lareu RR, Zeugolis DI, Abu-Rub M, Pandit A, Raghunath M.Acta Biomater. 2010 Aug;6(8):3146-51. PMID: 20144751


23.

Immortalization of normal human gingival keratinocytes and cytological and cytogenetic characterization of the cells.Kubo C, Tsutsui TW, Tamura Y, Kumakura S, Tsutsui T.Odontology. 2009 Jan;97(1):18-31. PMID: 19184294


24.

Effect of Prolyl-hydroxyproline (Pro-Hyp), a food-derived collagen peptide in human blood, on growth of fibroblasts from mouse skin.Shigemura Y, Iwai K, Morimatsu F, Iwamoto T, Mori T, Oda C, Taira T, Park EY, Nakamura Y, Sato K.J Agric Food Chem. 2009 Jan 28;57(2):444-9. PMID: 19128041


25.

Self-assembly nano-structure of type I collagen adsorbed on Gemini surfactant LB monolayers.Xu S, Liu A, Chen Q, Lv M, Yonese M, Liu H.Colloids Surf B Biointerfaces. 2009 Apr 1;70(1):124-31. PMID: 19157808


26.

Auto-organized nano-structure of collagen on Gemini surfactant monolayer.Lv M, Chen Q, Yonese M, Xu S, Liu H.Colloids Surf B Biointerfaces. 2008 Feb 15;61(2):282-9. PMID: 17933500


27.

Controlling coupling reaction of EDC and NHS for preparation of collagen gels using ethanol/water co-solvents.Nam K, Kimura T, Kishida A.MacromolBiosci. 2008 Jan 9;8(1):32-7. PMID: 18023082


28.

Network structure of collagen layers absorbed on LB film.Chen Q, Xu S, Li R, Liang X, Liu H.J Colloid Interface Sci. 2007 Dec 1;316(1):1-9. PMID: 17727873


29.

Transplantation of engineered bone tissue using a rotary three-dimensional culture system.Hidaka M, Su GN, Chen JK, Mukaisho K, Hattori T, Yamamoto G.In Vitro Cell Dev Biol Anim. 2007 Feb;43(2):49-58. PMID: 17570019


30.

Differentiation of tracheal basal cells to ciliated cells and tissue reconstruction on the synthesized basement membrane substratum in vitro.Hosokawa T, Betsuyaku T, Nishimura M, Furuyama A, Katagiri K, Mochitate K.Connect Tissue Res. 2007;48(1):9-18. PMID: 17364662


31.

Intracellular events in retinal glial cells exposed to ICG and BBG.Kawahara S, Hata Y, Miura M, Kita T, Sengoku A, Nakao S, Mochizuki Y, Enaida H, Ueno A, Hafezi-Moghadam A, Ishibashi T.Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4426-32. PMID: 17898261


32.

Collagen matrix deposition is dramatically enhanced in vitro when crowded with charged macromolecules: the biological relevance of the excluded volume effect.Lareu RR, Subramhanya KH, Peng Y, Benny P, Chen C, Wang Z, Rajagopalan R, Raghunath M.FEBS Lett. 2007 Jun 12;581(14):2709-14. PMID: 17531987


33.

Targeted mutation of serine 697 in the Ret tyrosine kinase causes migration defect of enteric neural crest cells.Asai N, Fukuda T, Wu Z, Enomoto A, Pachnis V, Takahashi M, Costantini F.Development. 2006 Nov;133(22):4507-16. PMID: 17050626


34.

The effect of natural extracellular matrix deposited on synthetic polymers on cultured primary hepatocytes.Hoshiba T, Cho CS, Murakawa A, Okahata Y, Akaike T.Biomaterials. 2006 Sep;27(26):4519-28. PMID: 16697038


35.

Initial bFGF Distribution Affects the Depth of Three-dimensional Microvessel Networks in Vitro.Akinori UEDA, Ryo SUDO, Mariko IKEDA, Susumu KUDO and Kazuo TANISHITA.Journal of Biomechanical Science and Engineering, Vol. 1, No. 1 (2006), pp.136-146.


36.

Hepatocyte growth factor inhibits the formation of the basement membrane of alveolar epithelial cells in vitro.Furuyama A1, Mochitate K.Am J Physiol Lung Cell Mol Physiol. 2004 May;286(5):L939-46. PMID: 14672920


37.

The combination of SOX5, SOX6, and SOX9 (the SOX trio) provides signals sufficient for induction of permanent cartilage.Ikeda T, Kamekura S, Mabuchi A, Kou I, Seki S, Takato T, Nakamura K, Kawaguchi H, Ikegawa S, Chung UI.Arthritis Rheum. 2004 Nov;50(11):3561-73. PMID: 15529345


38.

Inhibitory effects of 9-(4-thio-beta-D-ribo-pentofuranosyl)guanine on tumor growth and angiogenesis.Miura S, Yamada K, Kano F, Yoshimura Y.Biol Pharm Bull. 2004 Apr;27(4):520-3. PMID: 15056858


39.

Stimulation of in vitro angiogenesis by nitric oxide through the induction of transcription factor ETS-1.Shimizu S, Kageyama M, Yasuda M, Sasaki D, Naito S, Yamamoto T, Kiuchi Y.Int J Biochem Cell Biol. 2004 Jan;36(1):114-22. PMID: 14592537


40.

Immunohistochemical Identification of HSP47 and Type I Procollagen-expressing Cells in Mongolian Gerbil Salivary Glands: Correlation with Age-related Fibrotic Changes.Harumi Tomisaki, JojiSekine, TsugioInokuchi, Shin-ichi Izumi, Kunio Takano.Oral Medicine & Pathology. 9(4), 141-148, 2004.


41.

Effect on endothelial cell gene expression of shear stress, oxygen concentration, and low-density lipoprotein as studied by a novel flow cell culture system.Warabi E, Wada Y, Kajiwara H, Kobayashi M, Koshiba N, Hisada T, Shibata M, Ando J, Tsuchiya M, Kodama T, Noguchi N.Free Radic Biol Med. 2004 Sep 1;37(5):682-94. PMID: 15288125


42.

The involvement of integrin alphavbeta3 in polymorphonuclear leukocyte-induced angiogenesis in bovine aortic endothelial cells.Yasuda M, Ohbayashi M, Ohhinata K, Yamamoto T.Life Sci. 2004 Jun 11;75(4):421-34. PMID: 15147829


43.

Intralumenal tissue-engineered therapeutic stent using endothelial progenitor cell-inoculated hybrid tissue and in vitro performance.Shirota T, Yasui H, Matsuda T.Tissue Eng. 2003 Jun;9(3):473-85. PMID: 12857415


44.

Newly designed compliant hierarchic hybrid vascular graft wrapped with microprocessed elastomeric film–II: Morphogenesis and compliance change upon implantation.He H, Matsuda T.Cell Transplant. 2002;11(1):75-87. PMID: 12095223


45.

Effect of dexamethasone on invasion of human squamous cell carcinoma cells into collagen gel.Hayashido Y, Shirasuna K, Sugiura T, Nakashima M, Matsuya T.Cancer Lett. 1996 Nov 12;108(1):81-6. PMID: 8950213


46.

Serum-free medium conditions for steroidogenesis of bovine follicular thecal cells cultured on collagen gel matrix.Ikeda H.In Vitro Cell Dev Biol. 1990 Feb;26(2):193-200. PMID: 2312503

产品列表
产品编号 产品名称 产品规格 产品等级 备注
KOU-IPC-30 Atelocollagen, Bovine dermis, 3mg/mL 
去端肽胶原,牛皮来源,3 mg/mL
50ml/btl
KOU-IPC-50 Atelocollagen Bovine dermis 5mg/ml pH3.0 Steril 
去端肽胶原,牛皮来源,5 mg/mL
50ml/btl
KOU-IAC-30 Native collagen Bovine dermis 3mg/ml pH3.0 Steril 
天然胶原,牛皮来源,3 mg/mL
50ml/btl
KOU-IAC-50 Native collagen Bovine dermis 5mg/ml pH3.0 Steril 
天然胶原,牛皮来源,5 mg/mL
50ml/btl

AvantiPricelist-2013-20价目表【第4001条-第6000条】

 860358P-10mg10mg8400 16:0 PC D75 181041-62-3

860358P-25mg25mg16650 16:0 PC D75 181041-62-3

860358P-100mg100mg46800 16:0 PC D75 181041-62-3

860365C-10mg10mg1155 18:0 PC D70 56952-01-3

860365C-25mg25mg2100 18:0 PC D70 56952-01-3

860365C-100mg100mg5625 18:0 PC D70 56952-01-3

860365C-200mg200mg8550 18:0 PC D70 56952-01-3

860365P-10mg10mg1005 18:0 PC D70 56952-01-3

860365P-25mg25mg1950 18:0 PC D70 56952-01-3

860365P-100mg100mg5475 18:0 PC D70 56952-01-3

860365P-200mg200mg8400 18:0 PC D70 56952-01-3

860368C-10mg10mg8550 18:0 PC D83 326495-40-3

860368C-25mg25mg16800 18:0 PC D83 326495-40-3

860368C-100mg100mg46950 18:0 PC D83 326495-40-3

860368P-10mg10mg8400 18:0 PC D83 326495-40-3

860368P-25mg25mg16650 18:0 PC D83 326495-40-3

860368P-100mg100mg46800 18:0 PC D83 326495-40-3

860371P-10mg10mg10050 14:0 PE D54 326495-41-4

860371P-25mg25mg16050 14:0 PE D54 326495-41-4

860371P-100mg100mg31950 14:0 PE D54 326495-41-4

860371P-200mg200mg49800 14:0 PE D54 326495-41-4

860372P-10mg10mg10050 16:0 PE D62 326495-42-5

860372P-25mg25mg16050 16:0 PE D62 326495-42-5

860372P-100mg100mg31950 16:0 PE D62 326495-42-5

860372P-200mg200mg49800 16:0 PE D62 326495-42-5

860374C-10mg10mg1950 16:0 D31-18:1 PE 326495-44-7

860374C-25mg25mg3825 16:0 D31-18:1 PE 326495-44-7

860374C-100mg100mg13800 16:0 D31-18:1 PE 326495-44-7

860374C-200mg200mg24900 16:0 D31-18:1 PE 326495-44-7

860374P-10mg10mg2100 16:0 D31-18:1 PE 326495-44-7

860374P-25mg25mg3975 16:0 D31-18:1 PE 326495-44-7

860374P-100mg100mg13950 16:0 D31-18:1 PE 326495-44-7

860374P-200mg200mg25050 16:0 D31-18:1 PE 326495-44-7

860381P-10mg10mg10050 14:0 PG D54 326495-45-8

860381P-25mg25mg16050 14:0 PG D54 326495-45-8

860381P-100mg100mg31950 14:0 PG D54 326495-45-8

860381P-200mg200mg49800 14:0 PG D54 326495-45-8

860382P-10mg10mg10050 16:0 PG D62 326495-46-9

860382P-25mg25mg16050 16:0 PG D62 326495-46-9

860382P-100mg100mg31950 16:0 PG D62 326495-46-9

860382P-200mg200mg49800 16:0 PG D62 326495-46-9

860384C-10mg10mg1950 16:0 D31-18:1 PG 327178-87-0

860384C-25mg25mg3825 16:0 D31-18:1 PG 327178-87-0

860384C-100mg100mg13800 16:0 D31-18:1 PG 327178-87-0

860384C-200mg200mg24900 16:0 D31-18:1 PG 327178-87-0

860384P-10mg10mg2100 16:0 D31-18:1 PG 327178-87-0

860384P-25mg25mg3975 16:0 D31-18:1 PG 327178-87-0

860384P-100mg100mg13950 16:0 D31-18:1 PG 327178-87-0

860384P-200mg200mg25050 16:0 D31-18:1 PG 327178-87-0

860389P-1mg1mg4500 26:0 D4 Lyso PC 1246303-15-0

860389P-5mg5mg17700 26:0 D4 Lyso PC 1246303-15-0

860399C-10mg10mg1290 16:0 D31-18:1 PC 179093-76-6

860399C-25mg25mg2550 16:0 D31-18:1 PC 179093-76-6

860399C-100mg100mg7050 16:0 D31-18:1 PC 179093-76-6

860399C-200mg200mg10650 16:0 D31-18:1 PC 179093-76-6

860399P-10mg10mg1440 16:0 D31-18:1 PC 179093-76-6

860399P-25mg25mg2700 16:0 D31-18:1 PC 179093-76-6

860399P-100mg100mg7200 16:0 D31-18:1 PC 179093-76-6

860399P-200mg200mg10800 16:0 D31-18:1 PC 179093-76-6

860400P-10mg10mg10050 14:0 PS D54 327178-93-8

860400P-25mg25mg16050 14:0 PS D54 327178-93-8

860400P-100mg100mg31950 14:0 PS D54 327178-93-8

860400P-200mg200mg49800 14:0 PS D54 327178-93-8

860401P-10mg10mg10050 16:0 PS D62 327178-94-9

860401P-25mg25mg16050 16:0 PS D62 327178-94-9

860401P-100mg100mg31950 16:0 PS D62 327178-94-9

860401P-200mg200mg49800 16:0 PS D62 327178-94-9

860403C-10mg10mg2700 16:0 D31-18:1 PS 327178-96-1

860403C-25mg25mg6000 16:0 D31-18:1 PS 327178-96-1

860403C-100mg100mg21150 16:0 D31-18:1 PS 327178-96-1

860403C-200mg200mg37650 16:0 D31-18:1 PS 327178-96-1

860403P-10mg10mg2850 16:0 D31-18:1 PS 327178-96-1

860403P-25mg25mg6150 16:0 D31-18:1 PS 327178-96-1

860403P-100mg100mg21300 16:0 D31-18:1 PS 327178-96-1

860403P-200mg200mg37800 16:0 D31-18:1 PS 327178-96-1

860453C-10mg10mg1950 16:0 D31-18:1 PA 474943-59-4

860453C-25mg25mg3825 16:0 D31-18:1 PA 474943-59-4

860453C-100mg100mg13800 16:0 D31-18:1 PA 474943-59-4

860453C-200mg200mg24900 16:0 D31-18:1 PA 474943-59-4

860453P-10mg10mg2100 16:0 D31-18:1 PA 474943-59-4

860453P-25mg25mg3975 16:0 D31-18:1 PA 474943-59-4

860453P-100mg100mg13950 16:0 D31-18:1 PA 474943-59-4

860453P-200mg200mg25050 16:0 D31-18:1 PA 474943-59-4

860455P-1mg1mg2850 N-C12-deoxysphingosine 1246298-54-3

860455P-5mg5mg7950 N-C12-deoxysphingosine 1246298-54-3

860455P-10mg10mg11250 N-C12-deoxysphingosine 1246298-54-3

860455P-25mg25mg20250 N-C12-deoxysphingosine 1246298-54-3

860456P-1mg1mg2850 N-C16-deoxysphingosine 1246298-56-5

860456P-5mg5mg7950 N-C16-deoxysphingosine 1246298-56-5

860456P-10mg10mg11250 N-C16-deoxysphingosine 1246298-56-5

860456P-25mg25mg20250 N-C16-deoxysphingosine 1246298-56-5

860457P-1mg1mg2850 N-C24:1-deoxysphingosine 1246298-58-7

860457P-5mg5mg7950 N-C24:1-deoxysphingosine 1246298-58-7

860457P-10mg10mg11250 N-C24:1-deoxysphingosine 1246298-58-7

860457P-25mg25mg20250 N-C24:1-deoxysphingosine 1246298-58-7

860460P-1mg1mg2850 N-C12-deoxysphinganine 1246298-40-7

860460P-5mg5mg7950 N-C12-deoxysphinganine 1246298-40-7

860460P-10mg10mg11250 N-C12-deoxysphinganine 1246298-40-7

860460P-25mg25mg20250 N-C12-deoxysphinganine 1246298-40-7

860461P-1mg1mg3075 N-C12-desoxymethylsphinganine 1246298-41-8

860461P-5mg5mg9000 N-C12-desoxymethylsphinganine 1246298-41-8

860461P-10mg10mg16200 N-C12-desoxymethylsphinganine 1246298-41-8

860461P-25mg25mg34200 N-C12-desoxymethylsphinganine 1246298-41-8

860462P-1mg1mg2850 N-C16-deoxysphinganine 378755-69-2

860462P-5mg5mg7950 N-C16-deoxysphinganine 378755-69-2

860462P-10mg10mg11250 N-C16-deoxysphinganine 378755-69-2

860462P-25mg25mg20250 N-C16-deoxysphinganine 378755-69-2

860463P-1mg1mg3075 N-C16-desoxymethylsphinganine 1246298-42-9

860463P-5mg5mg9000 N-C16-desoxymethylsphinganine 1246298-42-9

860463P-10mg10mg16200 N-C16-desoxymethylsphinganine 1246298-42-9

860463P-25mg25mg34200 N-C16-desoxymethylsphinganine 1246298-42-9

860464P-1mg1mg2850 N-C24:1-deoxysphinganine 1246298-60-1

860464P-5mg5mg7950 N-C24:1-deoxysphinganine 1246298-60-1

860464P-10mg10mg11250 N-C24:1-deoxysphinganine 1246298-60-1

860464P-25mg25mg20250 N-C24:1-deoxysphinganine 1246298-60-1

860465P-1mg1mg3075 N-C24:1-desoxymethylsphinganine 1246298-61-2

860465P-5mg5mg9000 N-C24:1-desoxymethylsphinganine 1246298-61-2

860465P-10mg10mg16200 N-C24:1-desoxymethylsphinganine 1246298-61-2

860465P-25mg25mg34200 N-C24:1-desoxymethylsphinganine 1246298-61-2

860466P-1mg1mg3075 N-C12-desoxymethylsphingosine 1246298-55-4

860466P-5mg5mg9000 N-C12-desoxymethylsphingosine 1246298-55-4

860466P-10mg10mg16200 N-C12-desoxymethylsphingosine 1246298-55-4

860466P-25mg25mg34200 N-C12-desoxymethylsphingosine 1246298-55-4

860467P-1mg1mg3075 N-C16-desoxymethylsphingosine 1246298-57-6

860467P-5mg5mg9000 N-C16-desoxymethylsphingosine 1246298-57-6

860467P-10mg10mg16200 N-C16-desoxymethylsphingosine 1246298-57-6

860467P-25mg25mg34200 N-C16-desoxymethylsphingosine 1246298-57-6

860468P-1mg1mg3075 N-C24:1-desoxymethylsphingosine 1246298-59-8

860468P-5mg5mg9000 N-C24:1-desoxymethylsphingosine 1246298-59-8

860468P-10mg10mg16200 N-C24:1-desoxymethylsphingosine 1246298-59-8

860468P-25mg25mg34200 N-C24:1-desoxymethylsphingosine 1246298-59-8

860470P-1mg1mg2250 1-deoxysphingosine 193222-34-3

860470P-5mg5mg6300 1-deoxysphingosine 193222-34-3

860470P-10mg10mg9000 1-deoxysphingosine 193222-34-3

860470P-25mg25mg16350 1-deoxysphingosine 193222-34-3

860470P-50mg50mg25350 1-deoxysphingosine 193222-34-3

860473P-1mg1mg2400 1-desoxymethylsphinganine 1219484-98-6

860473P-5mg5mg7200 1-desoxymethylsphinganine 1219484-98-6

860473P-10mg10mg12900 1-desoxymethylsphinganine 1219484-98-6

860473P-25mg25mg27450 1-desoxymethylsphinganine 1219484-98-6

860476P-1mg1mg3525 1-desoxymethylsphinganine (D5) 1246298-43-0

860476P-5mg5mg14250 1-desoxymethylsphinganine (D5) 1246298-43-0

860476P-10mg10mg25500 1-desoxymethylsphinganine (D5) 1246298-43-0

860477P-1mg1mg2400 1-desoxymethylsphingosine 1246303-16-1

860477P-5mg5mg7200 1-desoxymethylsphingosine 1246303-16-1

860477P-10mg10mg12900 1-desoxymethylsphingosine 1246303-16-1

860477P-25mg25mg27450 1-desoxymethylsphingosine 1246303-16-1

860478P-5mg5mg1185 cis-4-methylsphingosine

860478P-10mg10mg1950 cis-4-methylsphingosine

860478P-25mg25mg4200 cis-4-methylsphingosine

860478P-50mg50mg7500 cis-4-methylsphingosine

860480P-500μg500μg870 C10 bisphosphonate

860480P-1mg1mg1575 C10 bisphosphonate

860480P-5mg5mg5550 C10 bisphosphonate

860488P-5mg5mg2850 Safingol 15639-50-6

860488P-10mg10mg4350 Safingol 15639-50-6

860488P-25mg25mg8700 Safingol 15639-50-6

860488P-50mg50mg14250 Safingol 15639-50-6

860489P-5mg5mg2850 L-threo-sphingosine (d18:1) 25695-95-8

860489P-10mg10mg4350 L-threo-sphingosine (d18:1) 25695-95-8

860489P-25mg25mg8700 L-threo-sphingosine (d18:1) 25695-95-8

860489P-50mg50mg14250 L-threo-sphingosine (d18:1) 25695-95-8

860490P-10mg10mg1380 Sphingosine (d18:1) 123-78-4

860490P-25mg25mg2025 Sphingosine (d18:1) 123-78-4

860490P-100mg100mg6750 Sphingosine (d18:1) 123-78-4

860490P-200mg200mg11250 Sphingosine (d18:1) 123-78-4

860490P-500mg500mg14250 Sphingosine (d18:1) 123-78-4

860491P-1mg1mg2250 D-ribo-Phytosphingosine-1-Phosphate 383908-62-1

860491P-5mg5mg6225 D-ribo-Phytosphingosine-1-Phosphate 383908-62-1

860491P-10mg10mg9000 D-ribo-Phytosphingosine-1-Phosphate 383908-62-1

860491P-25mg25mg16350 D-ribo-Phytosphingosine-1-Phosphate 383908-62-1

860492P-1mg1mg2250 Sphingosine-1-Phosphate (d18:1) 26993-30-6

860492P-5mg5mg6300 Sphingosine-1-Phosphate (d18:1) 26993-30-6

860492P-10mg10mg9000 Sphingosine-1-Phosphate (d18:1) 26993-30-6

860492P-25mg25mg16350 Sphingosine-1-Phosphate (d18:1) 26993-30-6

860492P-50mg50mg25350 Sphingosine-1-Phosphate (d18:1) 26993-30-6

860493P-1mg1mg2250 1-deoxysphinganine 196497-48-0

860493P-5mg5mg6300 1-deoxysphinganine 196497-48-0

860493P-10mg10mg9000 1-deoxysphinganine 196497-48-0

860493P-25mg25mg16350 1-deoxysphinganine 196497-48-0

860493P-50mg50mg25350 1-deoxysphinganine 196497-48-0

860494C-1mg1mg2250 Sphingosine-1-Phosphate (DMA Adduct) 474943-63-0

860494C-5mg5mg6300 Sphingosine-1-Phosphate (DMA Adduct) 474943-63-0

860494C-10mg10mg9000 Sphingosine-1-Phosphate (DMA Adduct) 474943-63-0

860494C-25mg25mg16350 Sphingosine-1-Phosphate (DMA Adduct) 474943-63-0

860494C-50mg50mg25350 Sphingosine-1-Phosphate (DMA Adduct) 474943-63-0

860495P-5mg5mg1125 Monomethyl Sphingosine (d18:1) 2700-62-1

860495P-10mg10mg1875 Monomethyl Sphingosine (d18:1) 2700-62-1

860495P-25mg25mg4575 Monomethyl Sphingosine (d18:1) 2700-62-1

860495P-50mg50mg8850 Monomethyl Sphingosine (d18:1) 2700-62-1

860495P-100mg100mg16350 Monomethyl Sphingosine (d18:1) 2700-62-1

860496C-5mg5mg1275 Dimethyl Sphingosine (d18:1) 119567-63-4

860496C-10mg10mg2025 Dimethyl Sphingosine (d18:1) 119567-63-4

860496C-25mg25mg4725 Dimethyl Sphingosine (d18:1) 119567-63-4

860496C-50mg50mg9000 Dimethyl Sphingosine (d18:1) 119567-63-4

860496C-100mg100mg16500 Dimethyl Sphingosine (d18:1) 119567-63-4

860496O-5mg5mg1125 Dimethyl Sphingosine (d18:1) 119567-63-4

860496O-10mg10mg1875 Dimethyl Sphingosine (d18:1) 119567-63-4

860496O-25mg25mg4575 Dimethyl Sphingosine (d18:1) 119567-63-4

860496O-50mg50mg8850 Dimethyl Sphingosine (d18:1) 119567-63-4

860496O-100mg100mg16350 Dimethyl Sphingosine (d18:1) 119567-63-4

860497P-5mg5mg1125 Trimethyl Sphingosine (d18:1) 133561-52-1

860497P-10mg10mg1875 Trimethyl Sphingosine (d18:1) 133561-52-1

860497P-25mg25mg4575 Trimethyl Sphingosine (d18:1) 133561-52-1

860497P-50mg50mg8850 Trimethyl Sphingosine (d18:1) 133561-52-1

860497P-100mg100mg16350 Trimethyl Sphingosine (d18:1) 133561-52-1

860498P-10mg10mg1380 Sphinganine (d18:0) 764-22-7

860498P-25mg25mg2025 Sphinganine (d18:0) 764-22-7

860498P-100mg100mg6750 Sphinganine (d18:0) 764-22-7

860498P-200mg200mg11250 Sphinganine (d18:0) 764-22-7

860499P-25mg25mg1380 D-ribo-Phytosphingosine 388566-94-7

860499P-200mg200mg3375 D-ribo-Phytosphingosine 388566-94-7

860499P-500mg500mg6825 D-ribo-Phytosphingosine 388566-94-7

860499P-1g1g12000 D-ribo-Phytosphingosine 388566-94-7

860501P-5mg5mg1650 C22 Ceramide (d18:1/22:0) 27888-44-4

860501P-10mg10mg3075 C22 Ceramide (d18:1/22:0) 27888-44-4

860501P-25mg25mg6825 C22 Ceramide (d18:1/22:0) 27888-44-4

860501P-50mg50mg12000 C22 Ceramide (d18:1/22:0) 27888-44-4

860502P-5mg5mg870 C2 Ceramide (d18:1/2:0) 195194-58-2

860502P-10mg10mg1500 C2 Ceramide (d18:1/2:0) 195194-58-2

860502P-25mg25mg3375 C2 Ceramide (d18:1/2:0) 195194-58-2

860502P-50mg50mg6000 C2 Ceramide (d18:1/2:0) 195194-58-2

860502P-100mg100mg9600 C2 Ceramide (d18:1/2:0) 195194-58-2

860504P-5mg5mg870 C4 Ceramide (d18:1/4:0) 74713-58-9

860504P-10mg10mg1500 C4 Ceramide (d18:1/4:0) 74713-58-9

860504P-25mg25mg3375 C4 Ceramide (d18:1/4:0) 74713-58-9

860504P-50mg50mg6000 C4 Ceramide (d18:1/4:0) 74713-58-9

860504P-100mg100mg9600 C4 Ceramide (d18:1/4:0) 74713-58-9

860506P-5mg5mg870 C6 Ceramide (d18:1/6:0) 124753-97-5

860506P-10mg10mg1500 C6 Ceramide (d18:1/6:0) 124753-97-5

860506P-25mg25mg3375 C6 Ceramide (d18:1/6:0) 124753-97-5

860506P-50mg50mg6000 C6 Ceramide (d18:1/6:0) 124753-97-5

860506P-100mg100mg9600 C6 Ceramide (d18:1/6:0) 124753-97-5

860508P-5mg5mg870 C8 Ceramide (d18:1/8:0) 74713-59-0

860508P-10mg10mg1500 C8 Ceramide (d18:1/8:0) 74713-59-0

860508P-25mg25mg3375 C8 Ceramide (d18:1/8:0) 74713-59-0

860508P-50mg50mg6000 C8 Ceramide (d18:1/8:0) 74713-59-0

860508P-100mg100mg9600 C8 Ceramide (d18:1/8:0) 74713-59-0

860510P-5mg5mg870 C10 Ceramide (d18:1/10:0) 111122-57-7

860510P-10mg10mg1500 C10 Ceramide (d18:1/10:0) 111122-57-7

860510P-25mg25mg3375 C10 Ceramide (d18:1/10:0) 111122-57-7

860510P-50mg50mg6000 C10 Ceramide (d18:1/10:0) 111122-57-7

860510P-100mg100mg9600 C10 Ceramide (d18:1/10:0) 111122-57-7

860512P-5mg5mg870 C12 Ceramide (d18:1/12:0) 74713-60-3

860512P-10mg10mg1500 C12 Ceramide (d18:1/12:0) 74713-60-3

860512P-25mg25mg3375 C12 Ceramide (d18:1/12:0) 74713-60-3

860512P-50mg50mg6000 C12 Ceramide (d18:1/12:0) 74713-60-3

860512P-100mg100mg9600 C12 Ceramide (d18:1/12:0) 74713-60-3

860514P-5mg5mg780 C14 Ceramide (d18:1/14:0) 123408-74-2

860514P-10mg10mg1380 C14 Ceramide (d18:1/14:0) 123408-74-2

860514P-25mg25mg3075 C14 Ceramide (d18:1/14:0) 123408-74-2

860514P-50mg50mg5550 C14 Ceramide (d18:1/14:0) 123408-74-2

860514P-100mg100mg8700 C14 Ceramide (d18:1/14:0) 123408-74-2

860516P-5mg5mg780 C16 Ceramide (d18:1/16:0) 24696-26-2

860516P-10mg10mg1380 C16 Ceramide (d18:1/16:0) 24696-26-2

860516P-25mg25mg3075 C16 Ceramide (d18:1/16:0) 24696-26-2

860516P-50mg50mg5550 C16 Ceramide (d18:1/16:0) 24696-26-2

860516P-100mg100mg8700 C16 Ceramide (d18:1/16:0) 24696-26-2

860517P-5mg5mg780 C17 Ceramide (d18:1/17:0) 67492-16-4

860517P-10mg10mg1380 C17 Ceramide (d18:1/17:0) 67492-16-4

860517P-25mg25mg3075 C17 Ceramide (d18:1/17:0) 67492-16-4

860517P-50mg50mg5550 C17 Ceramide (d18:1/17:0) 67492-16-4

860517P-100mg100mg8700 C17 Ceramide (d18:1/17:0) 67492-16-4

860518P-5mg5mg780 C18 Ceramide (d18:1/18:0) 2304-81-6

860518P-10mg10mg1380 C18 Ceramide (d18:1/18:0) 2304-81-6

860518P-25mg25mg3075 C18 Ceramide (d18:1/18:0) 2304-81-6

860518P-50mg50mg5550 C18 Ceramide (d18:1/18:0) 2304-81-6

860518P-100mg100mg8700 C18 Ceramide (d18:1/18:0) 2304-81-6

860519C-5mg5mg780 C18:1 Ceramide (d18:1/18:1(9Z)) 5966-28-9

860519C-10mg10mg1380 C18:1 Ceramide (d18:1/18:1(9Z)) 5966-28-9

860519C-25mg25mg3075 C18:1 Ceramide (d18:1/18:1(9Z)) 5966-28-9

860519C-50mg50mg5550 C18:1 Ceramide (d18:1/18:1(9Z)) 5966-28-9

860519C-100mg100mg8700 C18:1 Ceramide (d18:1/18:1(9Z)) 5966-28-9

860519P-5mg5mg930 C18:1 Ceramide (d18:1/18:1(9Z)) 5966-28-9

860519P-10mg10mg1530 C18:1 Ceramide (d18:1/18:1(9Z)) 5966-28-9

860519P-25mg25mg3225 C18:1 Ceramide (d18:1/18:1(9Z)) 5966-28-9

860519P-50mg50mg5700 C18:1 Ceramide (d18:1/18:1(9Z)) 5966-28-9

860519P-100mg100mg8850 C18:1 Ceramide (d18:1/18:1(9Z)) 5966-28-9

860520P-5mg5mg1650 C20 Ceramide (d18:1/20:0) 123482-93-9

860520P-10mg10mg3075 C20 Ceramide (d18:1/20:0) 123482-93-9

860520P-25mg25mg6825 C20 Ceramide (d18:1/20:0) 123482-93-9

860520P-50mg50mg12000 C20 Ceramide (d18:1/20:0) 123482-93-9

860521P-5mg5mg2025 C16 Galactosyl(ß) Ceramide (d18:1/16:0) 34324-89-5

860521P-25mg25mg8250 C16 Galactosyl(ß) Ceramide (d18:1/16:0) 34324-89-5

860521P-50mg50mg13650 C16 Galactosyl(ß) Ceramide (d18:1/16:0) 34324-89-5

860521P-100mg100mg21750 C16 Galactosyl(ß) Ceramide (d18:1/16:0) 34324-89-5

860522P-1mg1mg1650 C16 Dihydroceramide-1-Phosphate (d18:0/16:0) 1246303-17-2

860522P-5mg5mg6900 C16 Dihydroceramide-1-Phosphate (d18:0/16:0) 1246303-17-2

860522P-10mg10mg12450 C16 Dihydroceramide-1-Phosphate (d18:0/16:0) 1246303-17-2

860523P-1mg1mg1650 C24 Dihydroceramide-1-Phosphate (d18:0/24:0) 1246303-18-3

860523P-5mg5mg6900 C24 Dihydroceramide-1-Phosphate (d18:0/24:0) 1246303-18-3

860523P-10mg10mg12450 C24 Dihydroceramide-1-Phosphate (d18:0/24:0) 1246303-18-3

860524P-5mg5mg1650 C24 Ceramide (d18:1/24:0) 102917-80-6

860524P-10mg10mg3075 C24 Ceramide (d18:1/24:0) 102917-80-6

860524P-25mg25mg6825 C24 Ceramide (d18:1/24:0) 102917-80-6

860524P-50mg50mg12000 C24 Ceramide (d18:1/24:0) 102917-80-6

860525C-5mg5mg1950 C24:1 Ceramide (d18:1/24:1(15Z)) 54164-50-0

860525C-10mg10mg3300 C24:1 Ceramide (d18:1/24:1(15Z)) 54164-50-0

860525C-25mg25mg7125 C24:1 Ceramide (d18:1/24:1(15Z)) 54164-50-0

860525C-50mg50mg12450 C24:1 Ceramide (d18:1/24:1(15Z)) 54164-50-0

860525P-5mg5mg2100 C24:1 Ceramide (d18:1/24:1(15Z)) 54164-50-0

860525P-10mg10mg3450 C24:1 Ceramide (d18:1/24:1(15Z)) 54164-50-0

860525P-25mg25mg7275 C24:1 Ceramide (d18:1/24:1(15Z)) 54164-50-0

860525P-50mg50mg12600 C24:1 Ceramide (d18:1/24:1(15Z)) 54164-50-0

860526P-5mg5mg2025 1-O-Acyl-Ceramide 1246303-19-4

860526P-25mg25mg8250 1-O-Acyl-Ceramide 1246303-19-4

860526P-50mg50mg13650 1-O-Acyl-Ceramide 1246303-19-4

860526P-100mg100mg21750 1-O-Acyl-Ceramide 1246303-19-4

860527P-1mg1mg1650 C24 Ceramide-1-Phosphate (d18:1/24:0) 1246303-20-7

860527P-5mg5mg6900 C24 Ceramide-1-Phosphate (d18:1/24:0) 1246303-20-7

860527P-10mg10mg12450 C24 Ceramide-1-Phosphate (d18:1/24:0) 1246303-20-7

860529P-5mg5mg4125 C12 Sphingosyl PE (d17:1/12:0) 1246303-21-8

860529P-10mg10mg6525 C12 Sphingosyl PE (d17:1/12:0) 1246303-21-8

860529P-25mg25mg12000 C12 Sphingosyl PE (d17:1/12:0) 1246303-21-8

860529P-50mg50mg21450 C12 Sphingosyl PE (d17:1/12:0) 1246303-21-8

860530P-1mg1mg1650 C2 Ceramide-1-Phosphate (d18:1/2:0) 474943-68-5

860530P-5mg5mg6900 C2 Ceramide-1-Phosphate (d18:1/2:0) 474943-68-5

860530P-10mg10mg12450 C2 Ceramide-1-Phosphate (d18:1/2:0) 474943-68-5

860531P-1mg1mg1650 C12 Ceramide-1-Phosphate (d18:1/12:0) 799812-62-7

860531P-5mg5mg6900 C12 Ceramide-1-Phosphate (d18:1/12:0) 799812-62-7

860531P-10mg10mg12450 C12 Ceramide-1-Phosphate (d18:1/12:0) 799812-62-7

860532P-1mg1mg1650 C8 Ceramide-1-Phosphate (d18:1/8:0) 474943-70-9

860532P-5mg5mg6900 C8 Ceramide-1-Phosphate (d18:1/8:0) 474943-70-9

860532P-10mg10mg12450 C8 Ceramide-1-Phosphate (d18:1/8:0) 474943-70-9

860533P-1mg1mg1650 C16 Ceramide-1-Phosphate (d18:1/16:0) 1246303-22-9

860533P-5mg5mg6900 C16 Ceramide-1-Phosphate (d18:1/16:0) 1246303-22-9

860533P-10mg10mg12450 C16 Ceramide-1-Phosphate (d18:1/16:0) 1246303-22-9

860535P-5mg5mg2850 Glucosyl(ß) Sphingosine (d18:1) 52050-17-6

860535P-25mg25mg10500 Glucosyl(ß) Sphingosine (d18:1) 52050-17-6

860535P-50mg50mg18000 Glucosyl(ß) Sphingosine (d18:1) 52050-17-6

860535P-100mg100mg28650 Glucosyl(ß) Sphingosine (d18:1) 52050-17-6

860536P-1mg1mg2250 Sphinganine-1-Phosphate (d18:0) 19794-97-9

860536P-5mg5mg6300 Sphinganine-1-Phosphate (d18:0) 19794-97-9

860536P-10mg10mg9000 Sphinganine-1-Phosphate (d18:0) 19794-97-9

860536P-25mg25mg16350 Sphinganine-1-Phosphate (d18:0) 19794-97-9

860536P-50mg50mg25350 Sphinganine-1-Phosphate (d18:0) 19794-97-9

860537P-5mg5mg2850 Galactosyl(ß) Sphingosine (d18:1) 2238-90-6

860537P-25mg25mg10500 Galactosyl(ß) Sphingosine (d18:1) 2238-90-6

860537P-50mg50mg18000 Galactosyl(ß) Sphingosine (d18:1) 2238-90-6

860537P-100mg100mg28650 Galactosyl(ß) Sphingosine (d18:1) 2238-90-6

860538P-5mg5mg2025 C8 Galactosyl(ß) Ceramide (d18:1/8:0) 41613-16-5

860538P-25mg25mg8250 C8 Galactosyl(ß) Ceramide (d18:1/8:0) 41613-16-5

860538P-50mg50mg13650 C8 Galactosyl(ß) Ceramide (d18:1/8:0) 41613-16-5

860538P-100mg100mg21750 C8 Galactosyl(ß) Ceramide (d18:1/8:0) 41613-16-5

860539P-5mg5mg2025 C16 Glucosyl(ß) Ceramide (d18:1/16:0) 74365-77-8

860539P-25mg25mg8250 C16 Glucosyl(ß) Ceramide (d18:1/16:0) 74365-77-8

860539P-50mg50mg13650 C16 Glucosyl(ß) Ceramide (d18:1/16:0) 74365-77-8

860539P-100mg100mg21750 C16 Glucosyl(ß) Ceramide (d18:1/16:0) 74365-77-8

860540P-5mg5mg2025 C8 Glucosyl(ß) Ceramide (d18:1/8:0) 111956-47-9

860540P-25mg25mg8250 C8 Glucosyl(ß) Ceramide (d18:1/8:0) 111956-47-9

860540P-50mg50mg13650 C8 Glucosyl(ß) Ceramide (d18:1/8:0) 111956-47-9

860540P-100mg100mg21750 C8 Glucosyl(ß) Ceramide (d18:1/8:0) 111956-47-9

860541P-5mg5mg2025 C8 Lactosyl(ß) Ceramide (d18:1/8:0) 384842-72-2

860541P-25mg25mg8250 C8 Lactosyl(ß) Ceramide (d18:1/8:0) 384842-72-2

860541P-50mg50mg13650 C8 Lactosyl(ß) Ceramide (d18:1/8:0) 384842-72-2

860541P-100mg100mg21750 C8 Lactosyl(ß) Ceramide (d18:1/8:0) 384842-72-2

860542P-5mg5mg2850 Lactosyl(ß) Sphingosine (d18:1) 109785-20-8

860542P-25mg25mg10500 Lactosyl(ß) Sphingosine (d18:1) 109785-20-8

860542P-50mg50mg18000 Lactosyl(ß) Sphingosine (d18:1) 109785-20-8

860542P-100mg100mg28650 Lactosyl(ß) Sphingosine (d18:1) 109785-20-8

860543P-5mg5mg2025 C12 Glucosyl(ß) Ceramide (d18:1/12:0) 111956-48-0

860543P-25mg25mg8250 C12 Glucosyl(ß) Ceramide (d18:1/12:0) 111956-48-0

860543P-50mg50mg13650 C12 Glucosyl(ß) Ceramide (d18:1/12:0) 111956-48-0

860543P-100mg100mg21750 C12 Glucosyl(ß) Ceramide (d18:1/12:0) 111956-48-0

860544P-5mg5mg2025 C12 Galactosyl(ß) Ceramide (d18:1/12:0) 41613-14-3

860544P-25mg25mg8250 C12 Galactosyl(ß) Ceramide (d18:1/12:0) 41613-14-3

860544P-50mg50mg13650 C12 Galactosyl(ß) Ceramide (d18:1/12:0) 41613-14-3

860544P-100mg100mg21750 C12 Galactosyl(ß) Ceramide (d18:1/12:0) 41613-14-3

860545P-5mg5mg2025 C12 Lactosyl(ß) Ceramide  (d18:1/12:0) 474943-80-1

860545P-25mg25mg8250 C12 Lactosyl(ß) Ceramide  (d18:1/12:0) 474943-80-1

860545P-50mg50mg13650 C12 Lactosyl(ß) Ceramide  (d18:1/12:0) 474943-80-1

860545P-100mg100mg21750 C12 Lactosyl(ß) Ceramide  (d18:1/12:0) 474943-80-1

860546P-5mg5mg2550 C24:1 Galactosyl(ß) Ceramide  (d18:1/24:1(15Z)) 17283-91-9

860546P-25mg25mg10350 C24:1 Galactosyl(ß) Ceramide  (d18:1/24:1(15Z)) 17283-91-9

860546P-50mg50mg17400 C24:1 Galactosyl(ß) Ceramide  (d18:1/24:1(15Z)) 17283-91-9

860546P-100mg100mg27150 C24:1 Galactosyl(ß) Ceramide  (d18:1/24:1(15Z)) 17283-91-9

860547P-5mg5mg2025 C18 Glucosyl(ß) Ceramide (d18:1/18:0) 95119-86-1

860547P-25mg25mg8250 C18 Glucosyl(ß) Ceramide (d18:1/18:0) 95119-86-1

860547P-50mg50mg13650 C18 Glucosyl(ß) Ceramide (d18:1/18:0) 95119-86-1

860547P-100mg100mg21750 C18 Glucosyl(ß) Ceramide (d18:1/18:0) 95119-86-1

860548P-5mg5mg2025 C18:1 Glucosyl(ß) Ceramide (d18:1/18:1(9Z)) 852060-65-2

860548P-25mg25mg8250 C18:1 Glucosyl(ß) Ceramide (d18:1/18:1(9Z)) 852060-65-2

860548P-50mg50mg13650 C18:1 Glucosyl(ß) Ceramide (d18:1/18:1(9Z)) 852060-65-2

860548P-100mg100mg21750 C18:1 Glucosyl(ß) Ceramide (d18:1/18:1(9Z)) 852060-65-2

860549P-5mg5mg2550 C24:1 Glucosyl(ß) Ceramide (d18:1/24:1(15Z)) 887907-50-8

860549P-25mg25mg10350 C24:1 Glucosyl(ß) Ceramide (d18:1/24:1(15Z)) 887907-50-8

860549P-50mg50mg17400 C24:1 Glucosyl(ß) Ceramide (d18:1/24:1(15Z)) 887907-50-8

860549P-100mg100mg27150 C24:1 Glucosyl(ß) Ceramide (d18:1/24:1(15Z)) 887907-50-8

860550P-1mg1mg6750 Biotin Sphingosine 752987-57-8

860550P-5mg5mg26100 Biotin Sphingosine 752987-57-8

860550P-10mg10mg47250 Biotin Sphingosine 752987-57-8

860552P-100μg100μg4050 Biotin S1P 799812-63-8

860552P-500μg500μg16050 Biotin S1P 799812-63-8

860552P-1000μg1000μg28350 Biotin S1P 799812-63-8

860555P-1mg1mg5700 12:0 Biotinyl MG 799812-64-9

860555P-5mg5mg22350 12:0 Biotinyl MG 799812-64-9

860555P-10mg10mg39900 12:0 Biotinyl MG 799812-64-9

860556C-1mg1mg5700 18:1-12:0 Biotin DG 799812-65-0

860556C-5mg5mg22350 18:1-12:0 Biotin DG 799812-65-0

860556C-10mg10mg39900 18:1-12:0 Biotin DG 799812-65-0

860557P-1mg1mg2925 12:0 N-Biotinyl Fatty Acid 135447-73-3

860557P-5mg5mg13500 12:0 N-Biotinyl Fatty Acid 135447-73-3

860557P-10mg10mg23700 12:0 N-Biotinyl Fatty Acid 135447-73-3

860560C-1mg1mg5700 18:1-12:0 Biotin PS 799812-66-1

860560C-5mg5mg22350 18:1-12:0 Biotin PS 799812-66-1

860560C-10mg10mg39900 18:1-12:0 Biotin PS 799812-66-1

860560P-1mg1mg5850 18:1-12:0 Biotin PS 799812-66-1

860560P-5mg5mg22500 18:1-12:0 Biotin PS 799812-66-1

860560P-10mg10mg40050 18:1-12:0 Biotin PS 799812-66-1

860561C-1mg1mg5925 18:1-12:0 Biotin PA

860561C-5mg5mg23700 18:1-12:0 Biotin PA

860561C-10mg10mg42600 18:1-12:0 Biotin PA

860561P-1mg1mg6075 18:1-12:0 Biotin PA

860561P-5mg5mg23850 18:1-12:0 Biotin PA

860561P-10mg10mg42750 18:1-12:0 Biotin PA

860562C-1mg1mg5700 18:1-12:0 Biotin PE 799812-67-2

860562C-5mg5mg22350 18:1-12:0 Biotin PE 799812-67-2

860562C-10mg10mg39900 18:1-12:0 Biotin PE 799812-67-2

860562P-1mg1mg5850 18:1-12:0 Biotin PE 799812-67-2

860562P-5mg5mg22500 18:1-12:0 Biotin PE 799812-67-2

860562P-10mg10mg40050 18:1-12:0 Biotin PE 799812-67-2

860563C-1mg1mg5700 18:1-12:0 Biotin PC

860563C-5mg5mg22350 18:1-12:0 Biotin PC

860563C-10mg10mg39900 18:1-12:0 Biotin PC

860563P-1mg1mg5850 18:1-12:0 Biotin PC

860563P-5mg5mg22500 18:1-12:0 Biotin PC

860563P-10mg10mg40050 18:1-12:0 Biotin PC

860564C-1mg1mg6750 18:1-12:0 Biotin CA 799812-68-3

860564C-5mg5mg26100 18:1-12:0 Biotin CA 799812-68-3

860564C-10mg10mg47250 18:1-12:0 Biotin CA 799812-68-3

860564P-1mg1mg6900 18:1-12:0 Biotin CA 799812-68-3

860564P-5mg5mg26250 18:1-12:0 Biotin CA 799812-68-3

860564P-10mg10mg47400 18:1-12:0 Biotin CA 799812-68-3

860566P-1mg1mg6750 12:0 Biotinyl LPA 799812-69-4

860566P-5mg5mg26100 12:0 Biotinyl LPA 799812-69-4

860566P-10mg10mg47250 12:0 Biotinyl LPA 799812-69-4

860568P-10μg10μg2850 18:1-12:0 Biotin PIP3 799812-70-7

860568P-25μg25μg6000 18:1-12:0 Biotin PIP3 799812-70-7

860568P-50μg50μg9750 18:1-12:0 Biotin PIP3 799812-70-7

860568P-100μg100μg15450 18:1-12:0 Biotin PIP3 799812-70-7

860570P-1mg1mg5025 12:0 Biotinyl Coenzyme A

860570P-5mg5mg19500 12:0 Biotinyl Coenzyme A

860570P-10mg10mg34800 12:0 Biotinyl Coenzyme A

860571P-1mg1mg4050 C24:1 Mono-Sulfo Galactosyl(ß) Ceramide (d18:1/24:1) 1246355-69-0

860572P-1mg1mg4050 C17 Mono-Sulfo Galactosyl(ß) Ceramide  (d18:1/17:0) 1246303-23-0

860573P-1mg1mg4050 C12 Mono-Sulfo Galactosyl(ß) Ceramide  (d18:1/12:0) 852043-39-1

860574P-1mg1mg4050 C12 Di-Sulfo Galactosyl(ß) Ceramide (d18:1/12:0) 852043-40-4

860575P-1mg1mg1500 C8 L-threo-Lactosyl(ß) Ceramide (d18:1/8:0) 939036-94-9

860575P-5mg5mg5325 C8 L-threo-Lactosyl(ß) Ceramide (d18:1/8:0) 939036-94-9

860575P-10mg10mg9600 C8 L-threo-Lactosyl(ß) Ceramide (d18:1/8:0) 939036-94-9

860575P-25mg25mg19950 C8 L-threo-Lactosyl(ß) Ceramide (d18:1/8:0) 939036-94-9

860576P-5mg5mg2025 C16 Lactosyl(ß) Ceramide  (d18:1/16:0) 4201-62-1

860576P-25mg25mg8250 C16 Lactosyl(ß) Ceramide  (d18:1/16:0) 4201-62-1

860576P-50mg50mg13650 C16 Lactosyl(ß) Ceramide  (d18:1/16:0) 4201-62-1

860576P-100mg100mg21750 C16 Lactosyl(ß) Ceramide  (d18:1/16:0) 4201-62-1

860577P-5mg5mg2025 C24 Lactosyl(ß) Ceramide  (d18:1/24:0) 105087-85-2

860577P-25mg25mg8250 C24 Lactosyl(ß) Ceramide  (d18:1/24:0) 105087-85-2

860577P-50mg50mg13650 C24 Lactosyl(ß) Ceramide  (d18:1/24:0) 105087-85-2

860577P-100mg100mg21750 C24 Lactosyl(ß) Ceramide  (d18:1/24:0) 105087-85-2

860578P-1mg1mg4050 C24 Mono-Sulfo Galactosyl(ß) Ceramide (d18:1/24:0) 1246304-32-4

860579P-5mg5mg3975 Galactosyl(ß) Dimethyl Sphingosine (d18:1) 240491-19-4

860579P-10mg10mg7125 Galactosyl(ß) Dimethyl Sphingosine (d18:1) 240491-19-4

860579P-25mg25mg15000 Galactosyl(ß) Dimethyl Sphingosine (d18:1) 240491-19-4

860580C-5mg5mg4200 02:0 SM (d18:1/2:0) 148306-05-2

860580C-10mg10mg7425 02:0 SM (d18:1/2:0) 148306-05-2

860580C-25mg25mg16200 02:0 SM (d18:1/2:0) 148306-05-2

860580C-50mg50mg25800 02:0 SM (d18:1/2:0) 148306-05-2

860580P-5mg5mg4050 02:0 SM (d18:1/2:0) 148306-05-2

860580P-10mg10mg7275 02:0 SM (d18:1/2:0) 148306-05-2

860580P-25mg25mg16050 02:0 SM (d18:1/2:0) 148306-05-2

860580P-50mg50mg25650 02:0 SM (d18:1/2:0) 148306-05-2

860582C-5mg5mg4200 06:0 SM (d18:1/6:0) 182493-45-4

860582C-10mg10mg7425 06:0 SM (d18:1/6:0) 182493-45-4

860582C-25mg25mg16200 06:0 SM (d18:1/6:0) 182493-45-4

860582C-50mg50mg25800 06:0 SM (d18:1/6:0) 182493-45-4

860582P-5mg5mg4050 06:0 SM (d18:1/6:0) 182493-45-4

860582P-10mg10mg7275 06:0 SM (d18:1/6:0) 182493-45-4

860582P-25mg25mg16050 06:0 SM (d18:1/6:0) 182493-45-4

860582P-50mg50mg25650 06:0 SM (d18:1/6:0) 182493-45-4

860583P-5mg5mg4050 12:0 SM (d18:1/12:0) 474923-21-2

860583P-10mg10mg7275 12:0 SM (d18:1/12:0) 474923-21-2

860583P-25mg25mg16050 12:0 SM (d18:1/12:0) 474923-21-2

860583P-50mg50mg25650 12:0 SM (d18:1/12:0) 474923-21-2

860584P-5mg5mg4050 16:0 SM (d18:1/16:0) 6254-89-3

860584P-10mg10mg7275 16:0 SM (d18:1/16:0) 6254-89-3

860584P-25mg25mg16050 16:0 SM (d18:1/16:0) 6254-89-3

860584P-50mg50mg25650 16:0 SM (d18:1/16:0) 6254-89-3

860585P-5mg5mg4050 17:0 SM (d18:1/17:0) 121999-64-2

860585P-10mg10mg7275 17:0 SM (d18:1/17:0) 121999-64-2

860585P-25mg25mg16050 17:0 SM (d18:1/17:0) 121999-64-2

860585P-50mg50mg25650 17:0 SM (d18:1/17:0) 121999-64-2

860586P-5mg5mg4050 18:0 SM (d18:1/18:0) 58909-84-5

860586P-10mg10mg7275 18:0 SM (d18:1/18:0) 58909-84-5

860586P-25mg25mg16050 18:0 SM (d18:1/18:0) 58909-84-5

860586P-50mg50mg25650 18:0 SM (d18:1/18:0) 58909-84-5

860587C-5mg5mg4200 18:1 SM (d18:1/18:1(9Z)) 108392-10-5

860587C-10mg10mg7425 18:1 SM (d18:1/18:1(9Z)) 108392-10-5

860587C-25mg25mg16200 18:1 SM (d18:1/18:1(9Z)) 108392-10-5

860587C-50mg50mg25800 18:1 SM (d18:1/18:1(9Z)) 108392-10-5

860587P-5mg5mg4050 18:1 SM (d18:1/18:1(9Z)) 108392-10-5

860587P-10mg10mg7275 18:1 SM (d18:1/18:1(9Z)) 108392-10-5

860587P-25mg25mg16050 18:1 SM (d18:1/18:1(9Z)) 108392-10-5

860587P-50mg50mg25650 18:1 SM (d18:1/18:1(9Z)) 108392-10-5

860592P-5mg5mg4050 24:0 SM 60037-60-7

860592P-10mg10mg7275 24:0 SM 60037-60-7

860592P-25mg25mg16050 24:0 SM 60037-60-7

860592P-50mg50mg25650 24:0 SM 60037-60-7

860593P-5mg5mg4050 24:1 SM 94359-13-4

860593P-10mg10mg7275 24:1 SM 94359-13-4

860593P-25mg25mg16050 24:1 SM 94359-13-4

860593P-50mg50mg25650 24:1 SM 94359-13-4

860597P-5mg5mg2025 C24:1 Lactosyl(ß) Ceramide (d18:1/24:1) 483370-78-1

860597P-25mg25mg8250 C24:1 Lactosyl(ß) Ceramide (d18:1/24:1) 483370-78-1

860597P-50mg50mg13650 C24:1 Lactosyl(ß) Ceramide (d18:1/24:1) 483370-78-1

860597P-100mg100mg21750 C24:1 Lactosyl(ß) Ceramide (d18:1/24:1) 483370-78-1

860599C-1mg1mg1650 C18:1 Ceramide-1-Phosphate (d18:1/18:1(9Z)) 1246304-33-5

860599C-5mg5mg6900 C18:1 Ceramide-1-Phosphate (d18:1/18:1(9Z)) 1246304-33-5

860599C-10mg10mg12450 C18:1 Ceramide-1-Phosphate (d18:1/18:1(9Z)) 1246304-33-5

860599P-1mg1mg1800 C18:1 Ceramide-1-Phosphate (d18:1/18:1(9Z)) 1246304-33-5

860599P-5mg5mg7050 C18:1 Ceramide-1-Phosphate (d18:1/18:1(9Z)) 1246304-33-5

860599P-10mg10mg12600 C18:1 Ceramide-1-Phosphate (d18:1/18:1(9Z)) 1246304-33-5

860600P-5mg5mg2850 Lyso SM (d18:1) 1670-26-4

860600P-10mg10mg4350 Lyso SM (d18:1) 1670-26-4

860600P-25mg25mg8100 Lyso SM (d18:1) 1670-26-4

860600P-50mg50mg14400 Lyso SM (d18:1) 1670-26-4

860602P-5mg5mg4125 D-ribo-phytosphingosine  (C17 base) 40289-37-0

860602P-10mg10mg6525 D-ribo-phytosphingosine  (C17 base) 40289-37-0

860602P-25mg25mg12000 D-ribo-phytosphingosine  (C17 base) 40289-37-0

860602P-50mg50mg21450 D-ribo-phytosphingosine  (C17 base) 40289-37-0

860608P-5mg5mg2850 N-02:0 Phytosphingosine 475995-69-8

860608P-10mg10mg4350 N-02:0 Phytosphingosine 475995-69-8

860608P-25mg25mg8700 N-02:0 Phytosphingosine 475995-69-8

860608P-50mg50mg14250 N-02:0 Phytosphingosine 475995-69-8

860609P-5mg5mg2850 N-08:0 Phytosphingosine 475995-74-5

860609P-10mg10mg4350 N-08:0 Phytosphingosine 475995-74-5

860609P-25mg25mg8700 N-08:0 Phytosphingosine 475995-74-5

860609P-50mg50mg14250 N-08:0 Phytosphingosine 475995-74-5

860610P-5mg5mg2850 N-18:0 Phytosphingosine 475995-75-6

860610P-10mg10mg4350 N-18:0 Phytosphingosine 475995-75-6

860610P-25mg25mg8700 N-18:0 Phytosphingosine 475995-75-6

860610P-50mg50mg14250 N-18:0 Phytosphingosine 475995-75-6

860615P-5mg5mg2850 Sphingosyl PE (d18:1) 90850-31-0

860615P-10mg10mg4350 Sphingosyl PE (d18:1) 90850-31-0

860615P-25mg25mg8700 Sphingosyl PE (d18:1) 90850-31-0

860615P-50mg50mg14250 Sphingosyl PE (d18:1) 90850-31-0

860616P-1mg1mg5250 Sphingosyl PI (d18:1) 799812-72-9

860616P-5mg5mg21150 Sphingosyl PI (d18:1) 799812-72-9

860616P-10mg10mg37800 Sphingosyl PI (d18:1) 799812-72-9

860617P-5mg5mg1650 N-16:0 Phytosphingosine

860617P-10mg10mg3075 N-16:0 Phytosphingosine

860617P-25mg25mg6825 N-16:0 Phytosphingosine

860617P-50mg50mg12000 N-16:0 Phytosphingosine

860624P-5mg5mg870 C18:1 Dihydroceramide (d18:0/18:1(9Z)) 34227-83-3

860624P-10mg10mg1500 C18:1 Dihydroceramide (d18:0/18:1(9Z)) 34227-83-3

860624P-25mg25mg3375 C18:1 Dihydroceramide (d18:0/18:1(9Z)) 34227-83-3

860624P-50mg50mg6000 C18:1 Dihydroceramide (d18:0/18:1(9Z)) 34227-83-3

860625P-5mg5mg870 C2 Dihydroceramide (d18:0/2:0) 13031-64-6

860625P-10mg10mg1500 C2 Dihydroceramide (d18:0/2:0) 13031-64-6

860625P-25mg25mg3375 C2 Dihydroceramide (d18:0/2:0) 13031-64-6

860625P-50mg50mg6000 C2 Dihydroceramide (d18:0/2:0) 13031-64-6

860626P-5mg5mg870 C8 Dihydroceramide (d18:0/8:0) 145774-33-0

860626P-10mg10mg1500 C8 Dihydroceramide (d18:0/8:0) 145774-33-0

860626P-25mg25mg3375 C8 Dihydroceramide (d18:0/8:0) 145774-33-0

860626P-50mg50mg6000 C8 Dihydroceramide (d18:0/8:0) 145774-33-0

860627P-5mg5mg870 C18 Dihydroceramide (d18:0/18:0) 2304-80-5

860627P-10mg10mg1500 C18 Dihydroceramide (d18:0/18:0) 2304-80-5

860627P-25mg25mg3375 C18 Dihydroceramide (d18:0/18:0) 2304-80-5

860627P-50mg50mg6000 C18 Dihydroceramide (d18:0/18:0) 2304-80-5

860628P-5mg5mg870 C24 Dihydroceramide (d18:0/24:0) 6063-36-1

860628P-10mg10mg1500 C24 Dihydroceramide (d18:0/24:0) 6063-36-1

860628P-25mg25mg3375 C24 Dihydroceramide (d18:0/24:0) 6063-36-1

860628P-50mg50mg6000 C24 Dihydroceramide (d18:0/24:0) 6063-36-1

860629P-5mg5mg870 C24:1 Dihydroceramide (d18:0/24:1(15Z)) 352518-80-0

860629P-10mg10mg1500 C24:1 Dihydroceramide (d18:0/24:1(15Z)) 352518-80-0

860629P-25mg25mg3375 C24:1 Dihydroceramide (d18:0/24:1(15Z)) 352518-80-0

860629P-50mg50mg6000 C24:1 Dihydroceramide (d18:0/24:1(15Z)) 352518-80-0

860633P-5mg5mg870 C6 Dihydroceramide (d18:0/6:0) 171039-13-7

860633P-10mg10mg1500 C6 Dihydroceramide (d18:0/6:0) 171039-13-7

860633P-25mg25mg3375 C6 Dihydroceramide (d18:0/6:0) 171039-13-7

860633P-50mg50mg6000 C6 Dihydroceramide (d18:0/6:0) 171039-13-7

860634P-5mg5mg870 C16 Dihydroceramide (d18:0/16:0) 5966-29-0

860634P-10mg10mg1500 C16 Dihydroceramide (d18:0/16:0) 5966-29-0

860634P-25mg25mg3375 C16 Dihydroceramide (d18:0/16:0) 5966-29-0

860634P-50mg50mg6000 C16 Dihydroceramide (d18:0/16:0) 5966-29-0

860635P-5mg5mg870 C12 Dihydroceramide (d18:0/12:0)

860635P-10mg10mg1500 C12 Dihydroceramide (d18:0/12:0)

860635P-25mg25mg3375 C12 Dihydroceramide (d18:0/12:0)

860635P-50mg50mg6000 C12 Dihydroceramide (d18:0/12:0)

860640P-5mg5mg1950 Sphingosine (d17:1) 6918-48-5

860640P-10mg10mg3375 Sphingosine (d17:1) 6918-48-5

860640P-25mg25mg7350 Sphingosine (d17:1) 6918-48-5

860640P-50mg50mg13500 Sphingosine (d17:1) 6918-48-5

860641P-1mg1mg2250 Sphingosine-1-Phosphate (d17:1) 474923-27-8

860641P-5mg5mg9300 Sphingosine-1-Phosphate (d17:1) 474923-27-8

860641P-10mg10mg12450 Sphingosine-1-Phosphate (d17:1) 474923-27-8

860654P-5mg5mg1950 sphinganine (d17:0) 32164-02-6

860654P-10mg10mg3375 sphinganine (d17:0) 32164-02-6

860654P-25mg25mg7350 sphinganine (d17:0) 32164-02-6

860654P-50mg50mg13500 sphinganine (d17:0) 32164-02-6

860655P-1mg1mg2250 sphinganine-1-phosphate (d17:0) 474923-29-0

860655P-5mg5mg9300 sphinganine-1-phosphate (d17:0) 474923-29-0

860655P-10mg10mg12450 sphinganine-1-phosphate (d17:0) 474923-29-0

860656P-5mg5mg4125 Lyso SM (d17:1) 118540-32-2

860656P-10mg10mg6525 Lyso SM (d17:1) 118540-32-2

860656P-25mg25mg12000 Lyso SM (d17:1) 118540-32-2

860656P-50mg50mg21450 Lyso SM (d17:1) 118540-32-2

860657P-1mg1mg2250 sphingosine (D7) 1246304-34-6

860657P-5mg5mg9600 sphingosine (D7) 1246304-34-6

860657P-10mg10mg17100 sphingosine (D7) 1246304-34-6

860658P-1mg1mg2250 sphinganine (D7) 1246304-35-7

860658P-5mg5mg9600 sphinganine (D7) 1246304-35-7

860658P-10mg10mg17100 sphinganine (D7) 1246304-35-7

860659P-1mg1mg6825 sphingosine-1-phosphate (D7)

860659P-5mg5mg28800 sphingosine-1-phosphate (D7)

860660P-5mg5mg2550 Sphingosine (d20:1) 6918-49-6

860660P-10mg10mg4875 Sphingosine (d20:1) 6918-49-6

860660P-25mg25mg11100 Sphingosine (d20:1) 6918-49-6

860662P-1mg1mg2250 Sphingosine-1-Phosphate (d20:1) 799812-75-2

860662P-5mg5mg9300 Sphingosine-1-Phosphate (d20:1) 799812-75-2

860662P-10mg10mg12450 Sphingosine-1-Phosphate (d20:1) 799812-75-2

860674P-5mg5mg2550 Sphinganine (d20:0) 24006-62-0

860674P-10mg10mg4875 Sphinganine (d20:0) 24006-62-0

860674P-25mg25mg11100 Sphinganine (d20:0) 24006-62-0

860675P-1mg1mg2250 Sphinganine-1-Phosphate (d20:0) 436846-91-2

860675P-5mg5mg9300 Sphinganine-1-Phosphate (d20:0) 436846-91-2

860675P-10mg10mg12450 Sphinganine-1-Phosphate (d20:0) 436846-91-2

860683P-5mg5mg4050 12:0 Dihydro SM (d18:0/12:0) 474923-31-4

860683P-10mg10mg7275 12:0 Dihydro SM (d18:0/12:0) 474923-31-4

860683P-25mg25mg16050 12:0 Dihydro SM (d18:0/12:0) 474923-31-4

860683P-50mg50mg25650 12:0 Dihydro SM (d18:0/12:0) 474923-31-4

860724P-5mg5mg1650 N-24:0 Phytosphingosine

860724P-10mg10mg3075 N-24:0 Phytosphingosine

860724P-25mg25mg6825 N-24:0 Phytosphingosine

860724P-50mg50mg12000 N-24:0 Phytosphingosine

860811P-5mg5mg2700 12:0(2R-OH) Ceramide 1246298-44-1

860811P-10mg10mg4800 12:0(2R-OH) Ceramide 1246298-44-1

860811P-25mg25mg10050 12:0(2R-OH) Ceramide 1246298-44-1

860811P-50mg50mg16350 12:0(2R-OH) Ceramide 1246298-44-1

860812P-5mg5mg2700 12:0(2S-OH) Ceramide 1246298-45-2

860812P-10mg10mg4800 12:0(2S-OH) Ceramide 1246298-45-2

860812P-25mg25mg10050 12:0(2S-OH) Ceramide 1246298-45-2

860812P-50mg50mg16350 12:0(2S-OH) Ceramide 1246298-45-2

860815P-5mg5mg2700 16:0(2R-OH) Ceramide 34839-02-6

860815P-10mg10mg4800 16:0(2R-OH) Ceramide 34839-02-6

860815P-25mg25mg10050 16:0(2R-OH) Ceramide 34839-02-6

860815P-50mg50mg16350 16:0(2R-OH) Ceramide 34839-02-6

860816P-5mg5mg2700 16:0(2S-OH) Ceramide 890041-50-6

860816P-10mg10mg4800 16:0(2S-OH) Ceramide 890041-50-6

860816P-25mg25mg10050 16:0(2S-OH) Ceramide 890041-50-6

860816P-50mg50mg16350 16:0(2S-OH) Ceramide 890041-50-6

860817P-5mg5mg2700 17:0(2R-OH) Ceramide 1246298-46-3

860817P-10mg10mg4800 17:0(2R-OH) Ceramide 1246298-46-3

860817P-25mg25mg10050 17:0(2R-OH) Ceramide 1246298-46-3

860817P-50mg50mg16350 17:0(2R-OH) Ceramide 1246298-46-3

860818P-5mg5mg2700 17:0(2S-OH) Ceramide 1246298-47-4

860818P-10mg10mg4800 17:0(2S-OH) Ceramide 1246298-47-4

860818P-25mg25mg10050 17:0(2S-OH) Ceramide 1246298-47-4

860818P-50mg50mg16350 17:0(2S-OH) Ceramide 1246298-47-4

860819P-5mg5mg2700 20:0(2R-OH) Ceramide 943147-54-4

860819P-10mg10mg4800 20:0(2R-OH) Ceramide 943147-54-4

860819P-25mg25mg10050 20:0(2R-OH) Ceramide 943147-54-4

860819P-50mg50mg16350 20:0(2R-OH) Ceramide 943147-54-4

860820P-5mg5mg2700 20:0(2S-OH) Ceramide 1246298-48-5

860820P-10mg10mg4800 20:0(2S-OH) Ceramide 1246298-48-5

860820P-25mg25mg10050 20:0(2S-OH) Ceramide 1246298-48-5

860820P-50mg50mg16350 20:0(2S-OH) Ceramide 1246298-48-5

860821P-5mg5mg2700 22:0(2R-OH) Ceramide 31417-10-4

860821P-10mg10mg4800 22:0(2R-OH) Ceramide 31417-10-4

860821P-25mg25mg10050 22:0(2R-OH) Ceramide 31417-10-4

860821P-50mg50mg16350 22:0(2R-OH) Ceramide 31417-10-4

860822P-5mg5mg2700 22:0(2S-OH) Ceramide 1246298-49-6

860822P-10mg10mg4800 22:0(2S-OH) Ceramide 1246298-49-6

860822P-25mg25mg10050 22:0(2S-OH) Ceramide 1246298-49-6

860822P-50mg50mg16350 22:0(2S-OH) Ceramide 1246298-49-6

860823P-5mg5mg2700 24:0(2R-OH) Ceramide 64655-47-6

860823P-10mg10mg4800 24:0(2R-OH) Ceramide 64655-47-6

860823P-25mg25mg10050 24:0(2R-OH) Ceramide 64655-47-6

860823P-50mg50mg16350 24:0(2R-OH) Ceramide 64655-47-6

860824P-5mg5mg2700 24:0(2S-OH) Ceramide 112317-53-0

860824P-10mg10mg4800 24:0(2S-OH) Ceramide 112317-53-0

860824P-25mg25mg10050 24:0(2S-OH) Ceramide 112317-53-0

860824P-50mg50mg16350 24:0(2S-OH) Ceramide 112317-53-0

860825P-5mg5mg2700 24:1(2R-OH) Ceramide 1246298-50-9

860825P-10mg10mg4800 24:1(2R-OH) Ceramide 1246298-50-9

860825P-25mg25mg10050 24:1(2R-OH) Ceramide 1246298-50-9

860825P-50mg50mg16350 24:1(2R-OH) Ceramide 1246298-50-9

860826P-5mg5mg2700 24:1(2S-OH) Ceramide 1246298-51-0

860826P-10mg10mg4800 24:1(2S-OH) Ceramide 1246298-51-0

860826P-25mg25mg10050 24:1(2S-OH) Ceramide 1246298-51-0

860826P-50mg50mg16350 24:1(2S-OH) Ceramide 1246298-51-0

860827P-5mg5mg2700 18:1(2R-OH) Ceramide 1246298-52-1

860827P-10mg10mg4800 18:1(2R-OH) Ceramide 1246298-52-1

860827P-25mg25mg10050 18:1(2R-OH) Ceramide 1246298-52-1

860827P-50mg50mg16350 18:1(2R-OH) Ceramide 1246298-52-1

860828P-5mg5mg2700 18:1(2S-OH) Ceramide 1246298-53-2

860828P-10mg10mg4800 18:1(2S-OH) Ceramide 1246298-53-2

860828P-25mg25mg10050 18:1(2S-OH) Ceramide 1246298-53-2

860828P-50mg50mg16350 18:1(2S-OH) Ceramide 1246298-53-2

860829P-5mg5mg2700 18:0(2R-OH) Ceramide 34249-40-6

860829P-10mg10mg4800 18:0(2R-OH) Ceramide 34249-40-6

860829P-25mg25mg10050 18:0(2R-OH) Ceramide 34249-40-6

860829P-50mg50mg16350 18:0(2R-OH) Ceramide 34249-40-6

860830P-5mg5mg2700 18:0(2S-OH) Ceramide 34839-04-8

860830P-10mg10mg4800 18:0(2S-OH) Ceramide 34839-04-8

860830P-25mg25mg10050 18:0(2S-OH) Ceramide 34839-04-8

860830P-50mg50mg16350 18:0(2S-OH) Ceramide 34839-04-8

860924P-5mg5mg2700 N-24:0(2R-OH) Phytosphingosine

860924P-10mg10mg4800 N-24:0(2R-OH) Phytosphingosine

860924P-25mg25mg10050 N-24:0(2R-OH) Phytosphingosine

860924P-50mg50mg16350 N-24:0(2R-OH) Phytosphingosine

867000P-1mg1mg4500 KRN7000 158021-47-7

868516P-5mg5mg2175 16:0 D31 Ceramide 852043-41-5

868516P-10mg10mg4050 16:0 D31 Ceramide 852043-41-5

868516P-25mg25mg9000 16:0 D31 Ceramide 852043-41-5

868516P-50mg50mg16350 16:0 D31 Ceramide 852043-41-5

868584P-1mg1mg2250 16:0 D31 SM 807617-46-5

868584P-5mg5mg9600 16:0 D31 SM 807617-46-5

868584P-10mg10mg17100 16:0 D31 SM 807617-46-5

870012C-25mg25mg6000 18:1 MPB PE 384835-49-8

870012C-100mg100mg19500 18:1 MPB PE 384835-49-8

870012C-200mg200mg34800 18:1 MPB PE 384835-49-8

870012C-500mg500mg72750 18:1 MPB PE 384835-49-8

870012C-1g1g120900 18:1 MPB PE 384835-49-8

870012P-25mg25mg6150 18:1 MPB PE 384835-49-8

870012P-100mg100mg19650 18:1 MPB PE 384835-49-8

870012P-200mg200mg34950 18:1 MPB PE 384835-49-8

870012P-500mg500mg72900 18:1 MPB PE 384835-49-8

870012P-1g1g121050 18:1 MPB PE 384835-49-8

870013C-25mg25mg6150 16:0 MPB PE 384835-50-1

870013C-100mg100mg19650 16:0 MPB PE 384835-50-1

870013C-200mg200mg34950 16:0 MPB PE 384835-50-1

870013C-500mg500mg72900 16:0 MPB PE 384835-50-1

870013C-1g1g121050 16:0 MPB PE 384835-50-1

870013P-25mg25mg6000 16:0 MPB PE 384835-50-1

870013P-100mg100mg19500 16:0 MPB PE 384835-50-1

870013P-200mg200mg34800 16:0 MPB PE 384835-50-1

870013P-500mg500mg72750 16:0 MPB PE 384835-50-1

870013P-1g1g120900 16:0 MPB PE 384835-50-1

870016P-25mg25mg870 23:2 Diyne PC [DC(8,9)PC] 76078-28-9

870016P-200mg200mg1650 23:2 Diyne PC [DC(8,9)PC] 76078-28-9

870016P-500mg500mg3300 23:2 Diyne PC [DC(8,9)PC] 76078-28-9

870016P-1g1g5175 23:2 Diyne PC [DC(8,9)PC] 76078-28-9

870122C-25mg25mg1230 18:1 Caproylamine PE 110796-31-1

870122C-100mg100mg4050 18:1 Caproylamine PE 110796-31-1

870122C-200mg200mg6675 18:1 Caproylamine PE 110796-31-1

870122C-500mg500mg13050 18:1 Caproylamine PE 110796-31-1

870122C-1g1g17850 18:1 Caproylamine PE 110796-31-1

870122P-25mg25mg1380 18:1 Caproylamine PE 110796-31-1

870122P-100mg100mg4200 18:1 Caproylamine PE 110796-31-1

870122P-200mg200mg6825 18:1 Caproylamine PE 110796-31-1

870122P-500mg500mg13200 18:1 Caproylamine PE 110796-31-1

870122P-1g1g18000 18:1 Caproylamine PE 110796-31-1

870125C-25mg25mg1380 16:0 Caproylamine PE 115288-21-6

870125C-100mg100mg4200 16:0 Caproylamine PE 115288-21-6

870125C-200mg200mg6825 16:0 Caproylamine PE 115288-21-6

870125C-500mg500mg13200 16:0 Caproylamine PE 115288-21-6

870125C-1g1g18000 16:0 Caproylamine PE 115288-21-6

870125P-25mg25mg1230 16:0 Caproylamine PE 115288-21-6

870125P-100mg100mg4050 16:0 Caproylamine PE 115288-21-6

870125P-200mg200mg6675 16:0 Caproylamine PE 115288-21-6

870125P-500mg500mg13050 16:0 Caproylamine PE 115288-21-6

870125P-1g1g17850 16:0 Caproylamine PE 115288-21-6

870140C-25mg25mg1380 16:0 Dodecanylamine PE 474944-08-6

870140C-100mg100mg4200 16:0 Dodecanylamine PE 474944-08-6

870140C-200mg200mg6825 16:0 Dodecanylamine PE 474944-08-6

870140C-500mg500mg13200 16:0 Dodecanylamine PE 474944-08-6

870140C-1g1g18000 16:0 Dodecanylamine PE 474944-08-6

870140P-25mg25mg1230 16:0 Dodecanylamine PE 474944-08-6

870140P-100mg100mg4050 16:0 Dodecanylamine PE 474944-08-6

870140P-200mg200mg6675 16:0 Dodecanylamine PE 474944-08-6

870140P-500mg500mg13050 16:0 Dodecanylamine PE 474944-08-6

870140P-1g1g17850 16:0 Dodecanylamine PE 474944-08-6

870142C-25mg25mg1230 18:1 Dodecanylamine PE 474944-10-0

870142C-100mg100mg4050 18:1 Dodecanylamine PE 474944-10-0

870142C-200mg200mg6675 18:1 Dodecanylamine PE 474944-10-0

870142C-500mg500mg13050 18:1 Dodecanylamine PE 474944-10-0

870142C-1g1g17850 18:1 Dodecanylamine PE 474944-10-0

870142P-25mg25mg1380 18:1 Dodecanylamine PE 474944-10-0

870142P-100mg100mg4200 18:1 Dodecanylamine PE 474944-10-0

870142P-200mg200mg6825 18:1 Dodecanylamine PE 474944-10-0

870142P-500mg500mg13200 18:1 Dodecanylamine PE 474944-10-0

870142P-1g1g18000 18:1 Dodecanylamine PE 474944-10-0

870160C-25mg25mg1380 16:0 Ptd Thioethanol 474923-39-2

870160C-100mg100mg3750 16:0 Ptd Thioethanol 474923-39-2

870160C-200mg200mg5325 16:0 Ptd Thioethanol 474923-39-2

870160C-500mg500mg8250 16:0 Ptd Thioethanol 474923-39-2

870160C-1g1g13650 16:0 Ptd Thioethanol 474923-39-2

870160P-25mg25mg1230 16:0 Ptd Thioethanol 474923-39-2

870160P-100mg100mg3600 16:0 Ptd Thioethanol 474923-39-2

870160P-200mg200mg5175 16:0 Ptd Thioethanol 474923-39-2

870160P-500mg500mg8100 16:0 Ptd Thioethanol 474923-39-2

870160P-1g1g13500 16:0 Ptd Thioethanol 474923-39-2

870202C-25mg25mg6000 18:1 PDP PE 474944-13-3

870202C-100mg100mg19500 18:1 PDP PE 474944-13-3

870202C-200mg200mg34800 18:1 PDP PE 474944-13-3

870202C-500mg500mg72750 18:1 PDP PE 474944-13-3

870202C-1g1g120900 18:1 PDP PE 474944-13-3

870202O-25mg25mg6150 18:1 PDP PE 474944-13-3

870202O-100mg100mg19650 18:1 PDP PE 474944-13-3

870202O-200mg200mg34950 18:1 PDP PE 474944-13-3

870202O-500mg500mg72900 18:1 PDP PE 474944-13-3

870202O-1g1g121050 18:1 PDP PE 474944-13-3

870205C-25mg25mg6150 16:0 PDP PE 474944-16-6

870205C-100mg100mg19650 16:0 PDP PE 474944-16-6

870205C-200mg200mg34950 16:0 PDP PE 474944-16-6

870205C-500mg500mg72900 16:0 PDP PE 474944-16-6

870205C-1g1g121050 16:0 PDP PE 474944-16-6

870205P-25mg25mg6000 16:0 PDP PE 474944-16-6

870205P-100mg100mg19500 16:0 PDP PE 474944-16-6

870205P-200mg200mg34800 16:0 PDP PE 474944-16-6

870205P-500mg500mg72750 16:0 PDP PE 474944-16-6

870205P-1g1g120900 16:0 PDP PE 474944-16-6

870222C-25mg25mg1230 18:1 Succinyl PE 111613-33-3

870222C-100mg100mg3600 18:1 Succinyl PE 111613-33-3

870222C-200mg200mg5175 18:1 Succinyl PE 111613-33-3

870222C-500mg500mg8100 18:1 Succinyl PE 111613-33-3

870222C-1g1g13500 18:1 Succinyl PE 111613-33-3

870222P-25mg25mg1380 18:1 Succinyl PE 111613-33-3

870222P-100mg100mg3750 18:1 Succinyl PE 111613-33-3

870222P-200mg200mg5325 18:1 Succinyl PE 111613-33-3

870222P-500mg500mg8250 18:1 Succinyl PE 111613-33-3

870222P-1g1g13650 18:1 Succinyl PE 111613-33-3

870225P-25mg25mg1230 16:0 Succinyl PE 186800-61-3

870225P-100mg100mg3600 16:0 Succinyl PE 186800-61-3

870225P-200mg200mg5175 16:0 Succinyl PE 186800-61-3

870225P-500mg500mg8100 16:0 Succinyl PE 186800-61-3

870225P-1g1g13500 16:0 Succinyl PE 186800-61-3

870225X-25mg25mg1380 16:0 Succinyl PE 186800-61-3

870225X-100mg100mg3750 16:0 Succinyl PE 186800-61-3

870225X-200mg200mg5325 16:0 Succinyl PE 186800-61-3

870225X-500mg500mg8250 16:0 Succinyl PE 186800-61-3

870225X-1g1g13650 16:0 Succinyl PE 186800-61-3

870242C-25mg25mg1230 18:1 Glutaryl PE 111516-02-0

870242C-100mg100mg3600 18:1 Glutaryl PE 111516-02-0

870242C-200mg200mg5175 18:1 Glutaryl PE 111516-02-0

870242C-500mg500mg8100 18:1 Glutaryl PE 111516-02-0

870242C-1g1g13500 18:1 Glutaryl PE 111516-02-0

870242P-25mg25mg1380 18:1 Glutaryl PE 111516-02-0

870242P-100mg100mg3750 18:1 Glutaryl PE 111516-02-0

870242P-200mg200mg5325 18:1 Glutaryl PE 111516-02-0

870242P-500mg500mg8250 18:1 Glutaryl PE 111516-02-0

870242P-1g1g13650 18:1 Glutaryl PE 111516-02-0

870245C-25mg25mg1380 16:0 Glutaryl PE 474923-45-0

870245C-100mg100mg3750 16:0 Glutaryl PE 474923-45-0

870245C-200mg200mg5325 16:0 Glutaryl PE 474923-45-0

870245C-500mg500mg8250 16:0 Glutaryl PE 474923-45-0

870245C-1g1g13650 16:0 Glutaryl PE 474923-45-0

870245P-25mg25mg1230 16:0 Glutaryl PE 474923-45-0

870245P-100mg100mg3600 16:0 Glutaryl PE 474923-45-0

870245P-200mg200mg5175 16:0 Glutaryl PE 474923-45-0

870245P-500mg500mg8100 16:0 Glutaryl PE 474923-45-0

870245P-1g1g13500 16:0 Glutaryl PE 474923-45-0

870262C-25mg25mg1230 18:1 Dodecanyl PE 474923-47-2

870262C-100mg100mg4050 18:1 Dodecanyl PE 474923-47-2

870262C-200mg200mg6675 18:1 Dodecanyl PE 474923-47-2

870262C-500mg500mg13050 18:1 Dodecanyl PE 474923-47-2

870262C-1g1g17850 18:1 Dodecanyl PE 474923-47-2

870262P-25mg25mg1380 18:1 Dodecanyl PE 474923-47-2

870262P-100mg100mg4200 18:1 Dodecanyl PE 474923-47-2

870262P-200mg200mg6825 18:1 Dodecanyl PE 474923-47-2

870262P-500mg500mg13200 18:1 Dodecanyl PE 474923-47-2

870262P-1g1g18000 18:1 Dodecanyl PE 474923-47-2

870265C-25mg25mg1380 16:0 Dodecanoyl PE 474923-49-4

870265C-100mg100mg4200 16:0 Dodecanoyl PE 474923-49-4

870265C-200mg200mg6825 16:0 Dodecanoyl PE 474923-49-4

870265C-500mg500mg13200 16:0 Dodecanoyl PE 474923-49-4

870265C-1g1g18000 16:0 Dodecanoyl PE 474923-49-4

870265P-25mg25mg1230 16:0 Dodecanoyl PE 474923-49-4

870265P-100mg100mg4050 16:0 Dodecanoyl PE 474923-49-4

870265P-200mg200mg6675 16:0 Dodecanoyl PE 474923-49-4

870265P-500mg500mg13050 16:0 Dodecanoyl PE 474923-49-4

870265P-1g1g17850 16:0 Dodecanoyl PE 474923-49-4

870273C-25mg25mg1395 18:1 Biotinyl Cap PE 384835-51-2

870273C-100mg100mg4275 18:1 Biotinyl Cap PE 384835-51-2

870273C-200mg200mg6825 18:1 Biotinyl Cap PE 384835-51-2

870273C-500mg500mg13350 18:1 Biotinyl Cap PE 384835-51-2

870273C-1g1g18000 18:1 Biotinyl Cap PE 384835-51-2

870273P-25mg25mg1545 18:1 Biotinyl Cap PE 384835-51-2

870273P-100mg100mg4425 18:1 Biotinyl Cap PE 384835-51-2

870273P-200mg200mg6975 18:1 Biotinyl Cap PE 384835-51-2

870273P-500mg500mg13500 18:1 Biotinyl Cap PE 384835-51-2

870273P-1g1g18150 18:1 Biotinyl Cap PE 384835-51-2

870275P-25mg25mg1230 16:0 Cyanur Cap PE 1246304-36-8

870275P-100mg100mg4050 16:0 Cyanur Cap PE 1246304-36-8

870275P-200mg200mg6675 16:0 Cyanur Cap PE 1246304-36-8

870275P-500mg500mg13050 16:0 Cyanur Cap PE 1246304-36-8

870275P-1g1g17850 16:0 Cyanur Cap PE 1246304-36-8

870277P-25mg25mg1395 16:0 Biotinyl Cap PE 384835-52-3

870277P-100mg100mg4275 16:0 Biotinyl Cap PE 384835-52-3

870277P-200mg200mg6825 16:0 Biotinyl Cap PE 384835-52-3

870277P-500mg500mg13350 16:0 Biotinyl Cap PE 384835-52-3

870277P-1g1g18000 16:0 Biotinyl Cap PE 384835-52-3

870277X-25mg25mg1545 16:0 Biotinyl Cap PE 384835-52-3

870277X-100mg100mg4425 16:0 Biotinyl Cap PE 384835-52-3

870277X-200mg200mg6975 16:0 Biotinyl Cap PE 384835-52-3

870277X-500mg500mg13500 16:0 Biotinyl Cap PE 384835-52-3

870277X-1g1g18150 16:0 Biotinyl Cap PE 384835-52-3

870282C-25mg25mg1230 18:1 Biotinyl PE 384835-53-4

870282C-100mg100mg3600 18:1 Biotinyl PE 384835-53-4

870282C-200mg200mg5175 18:1 Biotinyl PE 384835-53-4

870282C-500mg500mg8100 18:1 Biotinyl PE 384835-53-4

870282C-1g1g13500 18:1 Biotinyl PE 384835-53-4

870282P-25mg25mg1380 18:1 Biotinyl PE 384835-53-4

870282P-100mg100mg3750 18:1 Biotinyl PE 384835-53-4

870282P-200mg200mg5325 18:1 Biotinyl PE 384835-53-4

870282P-500mg500mg8250 18:1 Biotinyl PE 384835-53-4

870282P-1g1g13650 18:1 Biotinyl PE 384835-53-4

870285P-25mg25mg1230 16:0 Biotinyl PE 384835-54-5

870285P-100mg100mg3600 16:0 Biotinyl PE 384835-54-5

870285P-200mg200mg5175 16:0 Biotinyl PE 384835-54-5

870285P-500mg500mg8100 16:0 Biotinyl PE 384835-54-5

870285P-1g1g13500 16:0 Biotinyl PE 384835-54-5

870285X-25mg25mg1380 16:0 Biotinyl PE 384835-54-5

870285X-100mg100mg3750 16:0 Biotinyl PE 384835-54-5

870285X-200mg200mg5325 16:0 Biotinyl PE 384835-54-5

870285X-500mg500mg8250 16:0 Biotinyl PE 384835-54-5

870285X-1g1g13650 16:0 Biotinyl PE 384835-54-5

870287P-25mg25mg1230 16:0 Cyanur PE 1246304-37-9

870287P-100mg100mg3600 16:0 Cyanur PE 1246304-37-9

870287P-200mg200mg5175 16:0 Cyanur PE 1246304-37-9

870287P-500mg500mg8100 16:0 Cyanur PE 1246304-37-9

870287P-1g1g13500 16:0 Cyanur PE 1246304-37-9

870302C-25mg25mg1230 18:1 Ptd Ethylene Glycol 474923-51-8

870302C-100mg100mg3600 18:1 Ptd Ethylene Glycol 474923-51-8

870302C-200mg200mg5175 18:1 Ptd Ethylene Glycol 474923-51-8

870302C-500mg500mg8100 18:1 Ptd Ethylene Glycol 474923-51-8

870302C-1g1g13500 18:1 Ptd Ethylene Glycol 474923-51-8

870302P-25mg25mg1380 18:1 Ptd Ethylene Glycol 474923-51-8

870302P-100mg100mg3750 18:1 Ptd Ethylene Glycol 474923-51-8

870302P-200mg200mg5325 18:1 Ptd Ethylene Glycol 474923-51-8

870302P-500mg500mg8250 18:1 Ptd Ethylene Glycol 474923-51-8

870302P-1g1g13650 18:1 Ptd Ethylene Glycol 474923-51-8

870305C-25mg25mg1380 16:0 Ptd Ethylene Glycol 148439-06-9

870305C-100mg100mg3750 16:0 Ptd Ethylene Glycol 148439-06-9

870305C-200mg200mg5325 16:0 Ptd Ethylene Glycol 148439-06-9

870305C-500mg500mg8250 16:0 Ptd Ethylene Glycol 148439-06-9

870305C-1g1g13650 16:0 Ptd Ethylene Glycol 148439-06-9

870305P-25mg25mg1230 16:0 Ptd Ethylene Glycol 148439-06-9

870305P-100mg100mg3600 16:0 Ptd Ethylene Glycol 148439-06-9

870305P-200mg200mg5175 16:0 Ptd Ethylene Glycol 148439-06-9

870305P-500mg500mg8100 16:0 Ptd Ethylene Glycol 148439-06-9

870305P-1g1g13500 16:0 Ptd Ethylene Glycol 148439-06-9

870312C-25mg25mg1635 16:0 DGS 108032-13-9

870312C-200mg200mg7350 16:0 DGS 108032-13-9

870312C-500mg500mg14550 16:0 DGS 108032-13-9

870312C-1g1g21450 16:0 DGS 108032-13-9

870312P-25mg25mg1485 16:0 DGS 108032-13-9

870312P-200mg200mg7200 16:0 DGS 108032-13-9

870312P-500mg500mg14400 16:0 DGS 108032-13-9

870312P-1g1g21300 16:0 DGS 108032-13-9

870314C-25mg25mg1485 18:1 DGS 127640-49-7

870314C-200mg200mg7200 18:1 DGS 127640-49-7

870314C-500mg500mg14400 18:1 DGS 127640-49-7

870314C-1g1g21300 18:1 DGS 127640-49-7

870314O-25mg25mg1635 18:1 DGS 127640-49-7

870314O-200mg200mg7350 18:1 DGS 127640-49-7

870314O-500mg500mg14550 18:1 DGS 127640-49-7

870314O-1g1g21450 18:1 DGS 127640-49-7

870320P-25mg25mg2400 N-palmitoyl homocysteine (PHC) 474942-73-9

870320P-200mg200mg12000 N-palmitoyl homocysteine (PHC) 474942-73-9

870320P-500mg500mg24000 N-palmitoyl homocysteine (PHC) 474942-73-9

870320P-1g1g34800 N-palmitoyl homocysteine (PHC) 474942-73-9

870336C-25mg25mg4350 Soy PS 383908-63-2

870336C-200mg200mg13050 Soy PS 383908-63-2

870336C-500mg500mg19500 Soy PS 383908-63-2

870336C-1g1g30900 Soy PS 383908-63-2

870336P-25mg25mg4500 Soy PS 383908-63-2

870336P-200mg200mg13200 Soy PS 383908-63-2

870336P-500mg500mg19650 Soy PS 383908-63-2

870336P-1g1g31050 Soy PS 383908-63-2

870412C-25mg25mg1380 16:0 DG Galloyl 799812-76-3

870412C-200mg200mg6075 16:0 DG Galloyl 799812-76-3

870412C-500mg500mg12000 16:0 DG Galloyl 799812-76-3

870412C-1g1g18000 16:0 DG Galloyl 799812-76-3

870412P-25mg25mg1230 16:0 DG Galloyl 799812-76-3

870412P-200mg200mg5925 16:0 DG Galloyl 799812-76-3

870412P-500mg500mg11850 16:0 DG Galloyl 799812-76-3

870412P-1g1g17850 16:0 DG Galloyl 799812-76-3

870430O-5mg5mg675 C20:4 anandamide (AEA) 913692-69-0

870430O-10mg10mg1140 C20:4 anandamide (AEA) 913692-69-0

870430O-25mg25mg2250 C20:4 anandamide (AEA) 913692-69-0

870430O-50mg50mg4125 C20:4 anandamide (AEA) 913692-69-0

870430O-100mg100mg7425 C20:4 anandamide (AEA) 913692-69-0

870431P-5mg5mg675 C17:1 anandamide 1094209-17-2

870431P-10mg10mg1140 C17:1 anandamide 1094209-17-2

870431P-25mg25mg2250 C17:1 anandamide 1094209-17-2

870431P-50mg50mg4125 C17:1 anandamide 1094209-17-2

870431P-100mg100mg7425 C17:1 anandamide 1094209-17-2

870432P-5mg5mg510 C18:1 anandamide 7545-20-2

870432P-10mg10mg780 C18:1 anandamide 7545-20-2

870432P-25mg25mg1500 C18:1 anandamide 7545-20-2

870432P-50mg50mg2700 C18:1 anandamide 7545-20-2

870432P-100mg100mg4875 C18:1 anandamide 7545-20-2

870450O-5mg5mg1425 2-AG 53847-30-6

870450O-10mg10mg2175 2-AG 53847-30-6

870450O-25mg25mg4125 2-AG 53847-30-6

870451O-5mg5mg1425 2-OG 3443-84-3

870451O-10mg10mg2175 2-OG 3443-84-3

870451O-25mg25mg4125 2-OG 3443-84-3

870510C-5mg5mg2175 16:0 CDP DG 384835-55-6

870510C-10mg10mg3450 16:0 CDP DG 384835-55-6

870510C-25mg25mg6975 16:0 CDP DG 384835-55-6

870510C-50mg50mg13200 16:0 CDP DG 384835-55-6

870510C-100mg100mg24600 16:0 CDP DG 384835-55-6

870510P-5mg5mg2025 16:0 CDP DG 384835-55-6

870510P-10mg10mg3300 16:0 CDP DG 384835-55-6

870510P-25mg25mg6825 16:0 CDP DG 384835-55-6

870510P-50mg50mg13050 16:0 CDP DG 384835-55-6

870510P-100mg100mg24450 16:0 CDP DG 384835-55-6

870520C-5mg5mg2025 18:1 CDP DG 799812-77-4

870520C-10mg10mg3300 18:1 CDP DG 799812-77-4

870520C-25mg25mg6825 18:1 CDP DG 799812-77-4

870520C-50mg50mg13050 18:1 CDP DG 799812-77-4

870520C-100mg100mg24450 18:1 CDP DG 799812-77-4

870520P-5mg5mg2175 18:1 CDP DG 799812-77-4

870520P-10mg10mg3450 18:1 CDP DG 799812-77-4

870520P-25mg25mg6975 18:1 CDP DG 799812-77-4

870520P-50mg50mg13200 18:1 CDP DG 799812-77-4

870520P-100mg100mg24600 18:1 CDP DG 799812-77-4

870600C-1mg1mg975 PAzPC 117746-89-1

870600C-5mg5mg3600 PAzPC 117746-89-1

870600C-10mg10mg5625 PAzPC 117746-89-1

870600C-25mg25mg12600 PAzPC 117746-89-1

870600P-1mg1mg1125 PAzPC 117746-89-1

870600P-5mg5mg3750 PAzPC 117746-89-1

870600P-10mg10mg5775 PAzPC 117746-89-1

870600P-25mg25mg12750 PAzPC 117746-89-1

870601C-1mg1mg975 C16-09:0 (COOH) PC 354583-69-0

870601C-5mg5mg3600 C16-09:0 (COOH) PC 354583-69-0

870601C-10mg10mg5625 C16-09:0 (COOH) PC 354583-69-0

870601C-25mg25mg12600 C16-09:0 (COOH) PC 354583-69-0

870601P-1mg1mg1125 C16-09:0 (COOH) PC 354583-69-0

870601P-5mg5mg3750 C16-09:0 (COOH) PC 354583-69-0

870601P-10mg10mg5775 C16-09:0 (COOH) PC 354583-69-0

870601P-25mg25mg12750 C16-09:0 (COOH) PC 354583-69-0

870602C-1mg1mg975 PGPC 89947-79-5

870602C-5mg5mg3600 PGPC 89947-79-5

870602C-10mg10mg5625 PGPC 89947-79-5

870602C-25mg25mg12600 PGPC 89947-79-5

870602P-1mg1mg1125 PGPC 89947-79-5

870602P-5mg5mg3750 PGPC 89947-79-5

870602P-10mg10mg5775 PGPC 89947-79-5

870602P-25mg25mg12750 PGPC 89947-79-5

870605P-1mg1mg1950 16:0-09:0 (ALDO) PC 117746-89-1

870605P-5mg5mg8250 16:0-09:0 (ALDO) PC 117746-89-1

870605P-10mg10mg12600 16:0-09:0 (ALDO) PC 117746-89-1

870606P-1mg1mg1350 POVPC 121324-31-0

870606P-5mg5mg5250 POVPC 121324-31-0

870606P-10mg10mg9600 POVPC 121324-31-0

870606P-25mg25mg20250 POVPC 121324-31-0

870606P-50mg50mg36600 POVPC 121324-31-0

870608H-1Ea1Ea1725 4-HNE-dimethylacetal 119009-01-7

870608H-2Ea2Ea3225 4-HNE-dimethylacetal 119009-01-7

870608H-5Ea5Ea6675 4-HNE-dimethylacetal 119009-01-7

870700P-10mg10mg870 Coenzyme A (free acid) 85-61-0

870700P-25mg25mg1245 Coenzyme A (free acid) 85-61-0

870700P-100mg100mg3375 Coenzyme A (free acid) 85-61-0

870700P-250mg250mg7425 Coenzyme A (free acid) 85-61-0

870700P-500mg500mg15750 Coenzyme A (free acid) 85-61-0

870700P-1g1g27150 Coenzyme A (free acid) 85-61-0

870701P-10mg10mg870 Coenzyme A (Li salt) 18439-24-2

870701P-25mg25mg1245 Coenzyme A (Li salt) 18439-24-2

870701P-100mg100mg3375 Coenzyme A (Li salt) 18439-24-2

870701P-250mg250mg7425 Coenzyme A (Li salt) 18439-24-2

870701P-500mg500mg15750 Coenzyme A (Li salt) 18439-24-2

870701P-1g1g27150 Coenzyme A (Li salt) 18439-24-2

870703P-5mg5mg3375 03:0 Coenzyme A

870703P-10mg10mg5100 03:0 Coenzyme A

870703P-25mg25mg9600 03:0 Coenzyme A

870703P-50mg50mg14400 03:0 Coenzyme A

870703P-100mg100mg21300 03:0 Coenzyme A

870703P-200mg200mg31800 03:0 Coenzyme A

870704P-5mg5mg3375 04:0 Coenzyme A 799812-79-6

870704P-10mg10mg5100 04:0 Coenzyme A 799812-79-6

870704P-25mg25mg9600 04:0 Coenzyme A 799812-79-6

870704P-50mg50mg14400 04:0 Coenzyme A 799812-79-6

870704P-100mg100mg21300 04:0 Coenzyme A 799812-79-6

870704P-200mg200mg31800 04:0 Coenzyme A 799812-79-6

870706P-5mg5mg3375 06:0 Coenzyme A 799812-81-0

870706P-10mg10mg5100 06:0 Coenzyme A 799812-81-0

870706P-25mg25mg9600 06:0 Coenzyme A 799812-81-0

870706P-50mg50mg14400 06:0 Coenzyme A 799812-81-0

870706P-100mg100mg21300 06:0 Coenzyme A 799812-81-0

870706P-200mg200mg31800 06:0 Coenzyme A 799812-81-0

870708P-5mg5mg3375 08:0 Coenzyme A 799812-82-1

870708P-10mg10mg5100 08:0 Coenzyme A 799812-82-1

870708P-25mg25mg9600 08:0 Coenzyme A 799812-82-1

870708P-50mg50mg14400 08:0 Coenzyme A 799812-82-1

870708P-100mg100mg21300 08:0 Coenzyme A 799812-82-1

870708P-200mg200mg31800 08:0 Coenzyme A 799812-82-1

870710P-5mg5mg3375 10:0 Coenzyme A 799812-83-2

870710P-10mg10mg5100 10:0 Coenzyme A 799812-83-2

870710P-25mg25mg9600 10:0 Coenzyme A 799812-83-2

870710P-50mg50mg14400 10:0 Coenzyme A 799812-83-2

870710P-100mg100mg21300 10:0 Coenzyme A 799812-83-2

870710P-200mg200mg31800 10:0 Coenzyme A 799812-83-2

870712P-5mg5mg3375 12:0 Coenzyme A 799812-84-3

870712P-10mg10mg5100 12:0 Coenzyme A 799812-84-3

870712P-25mg25mg9600 12:0 Coenzyme A 799812-84-3

870712P-50mg50mg14400 12:0 Coenzyme A 799812-84-3

870712P-100mg100mg21300 12:0 Coenzyme A 799812-84-3

870712P-200mg200mg31800 12:0 Coenzyme A 799812-84-3

870713P-5mg5mg3375 13:0 Coenzyme A 1246304-38-0

870713P-10mg10mg5100 13:0 Coenzyme A 1246304-38-0

870713P-25mg25mg9600 13:0 Coenzyme A 1246304-38-0

870713P-50mg50mg14400 13:0 Coenzyme A 1246304-38-0

870713P-100mg100mg21300 13:0 Coenzyme A 1246304-38-0

870713P-200mg200mg31800 13:0 Coenzyme A 1246304-38-0

870714P-5mg5mg3375 14:0 Coenzyme A 799812-85-4

870714P-10mg10mg5100 14:0 Coenzyme A 799812-85-4

870714P-25mg25mg9600 14:0 Coenzyme A 799812-85-4

870714P-50mg50mg14400 14:0 Coenzyme A 799812-85-4

870714P-100mg100mg21300 14:0 Coenzyme A 799812-85-4

870714P-200mg200mg31800 14:0 Coenzyme A 799812-85-4

870715P-5mg5mg3375 15:0 Coenzyme A

870715P-10mg10mg5100 15:0 Coenzyme A

870715P-25mg25mg9600 15:0 Coenzyme A

870715P-50mg50mg14400 15:0 Coenzyme A

870715P-100mg100mg21300 15:0 Coenzyme A

870715P-200mg200mg31800 15:0 Coenzyme A

870716P-5mg5mg3375 16:0 Coenzyme A 799812-86-5

870716P-10mg10mg5100 16:0 Coenzyme A 799812-86-5

870716P-25mg25mg9600 16:0 Coenzyme A 799812-86-5

870716P-50mg50mg14400 16:0 Coenzyme A 799812-86-5

870716P-100mg100mg21300 16:0 Coenzyme A 799812-86-5

870716P-200mg200mg31800 16:0 Coenzyme A 799812-86-5

870717P-5mg5mg3375 17:0 Coenzyme A

870717P-10mg10mg5100 17:0 Coenzyme A

870717P-25mg25mg9600 17:0 Coenzyme A

870717P-50mg50mg14400 17:0 Coenzyme A

870717P-100mg100mg21300 17:0 Coenzyme A

870717P-200mg200mg31800 17:0 Coenzyme A

870718P-5mg5mg3375 18:0 Coenzyme A 799812-87-6

870718P-10mg10mg5100 18:0 Coenzyme A 799812-87-6

870718P-25mg25mg9600 18:0 Coenzyme A 799812-87-6

870718P-50mg50mg14400 18:0 Coenzyme A 799812-87-6

870718P-100mg100mg21300 18:0 Coenzyme A 799812-87-6

870718P-200mg200mg31800 18:0 Coenzyme A 799812-87-6

870719P-5mg5mg3375 18:1 (n9) Coenzyme A 799812-89-8

870719P-10mg10mg5100 18:1 (n9) Coenzyme A 799812-89-8

870719P-25mg25mg9600 18:1 (n9) Coenzyme A 799812-89-8

870719P-50mg50mg14400 18:1 (n9) Coenzyme A 799812-89-8

870719P-100mg100mg21300 18:1 (n9) Coenzyme A 799812-89-8

870719P-200mg200mg31800 18:1 (n9) Coenzyme A 799812-89-8

870720P-5mg5mg3375 20:0 Coenzyme A 799812-91-2

870720P-10mg10mg5100 20:0 Coenzyme A 799812-91-2

870720P-25mg25mg9600 20:0 Coenzyme A 799812-91-2

870720P-50mg50mg14400 20:0 Coenzyme A 799812-91-2

870720P-100mg100mg21300 20:0 Coenzyme A 799812-91-2

870720P-200mg200mg31800 20:0 Coenzyme A 799812-91-2

870721P-5mg5mg3375 20:4 Coenzyme A 799812-93-4

870721P-10mg10mg5100 20:4 Coenzyme A 799812-93-4

870721P-25mg25mg9600 20:4 Coenzyme A 799812-93-4

870721P-50mg50mg14400 20:4 Coenzyme A 799812-93-4

870721P-100mg100mg21300 20:4 Coenzyme A 799812-93-4

870721P-200mg200mg31800 20:4 Coenzyme A 799812-93-4

870722P-5mg5mg3375 22:0 Coenzyme A 799812-95-6

870722P-10mg10mg5100 22:0 Coenzyme A 799812-95-6

870722P-25mg25mg9600 22:0 Coenzyme A 799812-95-6

870722P-50mg50mg14400 22:0 Coenzyme A 799812-95-6

870722P-100mg100mg21300 22:0 Coenzyme A 799812-95-6

870722P-200mg200mg31800 22:0 Coenzyme A 799812-95-6

870723P-5mg5mg3375 23:0 Coenzyme A 799812-97-8

870723P-10mg10mg5100 23:0 Coenzyme A 799812-97-8

870723P-25mg25mg9600 23:0 Coenzyme A 799812-97-8

870723P-50mg50mg14400 23:0 Coenzyme A 799812-97-8

870723P-100mg100mg21300 23:0 Coenzyme A 799812-97-8

870723P-200mg200mg31800 23:0 Coenzyme A 799812-97-8

870724P-5mg5mg3375 24:0 Coenzyme A 799812-99-0

870724P-10mg10mg5100 24:0 Coenzyme A 799812-99-0

870724P-25mg25mg9600 24:0 Coenzyme A 799812-99-0

870724P-50mg50mg14400 24:0 Coenzyme A 799812-99-0

870724P-100mg100mg21300 24:0 Coenzyme A 799812-99-0

870724P-200mg200mg31800 24:0 Coenzyme A 799812-99-0

870725P-5mg5mg3375 24:1 Coenzyme A 800376-90-3

870725P-10mg10mg5100 24:1 Coenzyme A 800376-90-3

870725P-25mg25mg9600 24:1 Coenzyme A 800376-90-3

870725P-50mg50mg14400 24:1 Coenzyme A 800376-90-3

870725P-100mg100mg21300 24:1 Coenzyme A 800376-90-3

870725P-200mg200mg31800 24:1 Coenzyme A 800376-90-3

870726P-5mg5mg3375 26:0 Coenzyme A 799813-02-8

870726P-10mg10mg5100 26:0 Coenzyme A 799813-02-8

870726P-25mg25mg9600 26:0 Coenzyme A 799813-02-8

870726P-50mg50mg14400 26:0 Coenzyme A 799813-02-8

870726P-100mg100mg21300 26:0 Coenzyme A 799813-02-8

870726P-200mg200mg31800 26:0 Coenzyme A 799813-02-8

870728P-5mg5mg3375 22:6 Coenzyme A

870728P-10mg10mg5100 22:6 Coenzyme A

870728P-25mg25mg9600 22:6 Coenzyme A

870728P-50mg50mg14400 22:6 Coenzyme A

870728P-100mg100mg21300 22:6 Coenzyme A

870728P-200mg200mg31800 22:6 Coenzyme A

870729P-5mg5mg3375 25:0 Coenzyme A

870729P-10mg10mg5100 25:0 Coenzyme A

870729P-25mg25mg9600 25:0 Coenzyme A

870729P-50mg50mg14400 25:0 Coenzyme A

870729P-100mg100mg21300 25:0 Coenzyme A

870729P-200mg200mg31800 25:0 Coenzyme A

870730P-5mg5mg3375 18:1(n7) Coenzyme A

870730P-10mg10mg5100 18:1(n7) Coenzyme A

870730P-25mg25mg9600 18:1(n7) Coenzyme A

870730P-50mg50mg14400 18:1(n7) Coenzyme A

870730P-100mg100mg21300 18:1(n7) Coenzyme A

870730P-200mg200mg31800 18:1(n7) Coenzyme A

870731P-5mg5mg3375 18:1 (n12) Coenzyme A

870731P-10mg10mg5100 18:1 (n12) Coenzyme A

870731P-25mg25mg9600 18:1 (n12) Coenzyme A

870731P-50mg50mg14400 18:1 (n12) Coenzyme A

870731P-100mg100mg21300 18:1 (n12) Coenzyme A

870731P-200mg200mg31800 18:1 (n12) Coenzyme A

870732P-5mg5mg3375 18:3 (n3) Coenzyme A

870732P-10mg10mg5100 18:3 (n3) Coenzyme A

870732P-25mg25mg9600 18:3 (n3) Coenzyme A

870732P-50mg50mg14400 18:3 (n3) Coenzyme A

870732P-100mg100mg21300 18:3 (n3) Coenzyme A

870732P-200mg200mg31800 18:3 (n3) Coenzyme A

870733P-5mg5mg3375 18:3 (n6) Coenzyme A

870733P-10mg10mg5100 18:3 (n6) Coenzyme A

870733P-25mg25mg9600 18:3 (n6) Coenzyme A

870733P-50mg50mg14400 18:3 (n6) Coenzyme A

870733P-100mg100mg21300 18:3 (n6) Coenzyme A

870733P-200mg200mg31800 18:3 (n6) Coenzyme A

870734P-5mg5mg3375 18:0(α-OH) Coenzyme A

870734P-10mg10mg5100 18:0(α-OH) Coenzyme A

870734P-25mg25mg9600 18:0(α-OH) Coenzyme A

870734P-50mg50mg14400 18:0(α-OH) Coenzyme A

870734P-100mg100mg21300 18:0(α-OH) Coenzyme A

870734P-200mg200mg31800 18:0(α-OH) Coenzyme A

870735P-5mg5mg3375 14:0 Ether Coenzyme A

870735P-10mg10mg5100 14:0 Ether Coenzyme A

870735P-25mg25mg9600 14:0 Ether Coenzyme A

870735P-50mg50mg14400 14:0 Ether Coenzyme A

870735P-100mg100mg21300 14:0 Ether Coenzyme A

870735P-200mg200mg31800 14:0 Ether Coenzyme A

870736P-5mg5mg3375 18:2 (n6) Coenzyme A 1246304-39-1

870736P-10mg10mg5100 18:2 (n6) Coenzyme A 1246304-39-1

870736P-25mg25mg9600 18:2 (n6) Coenzyme A 1246304-39-1

870736P-50mg50mg14400 18:2 (n6) Coenzyme A 1246304-39-1

870736P-100mg100mg21300 18:2 (n6) Coenzyme A 1246304-39-1

870736P-200mg200mg31800 18:2 (n6) Coenzyme A 1246304-39-1

870737P-5mg5mg3375 17:1 (n7) Coenzyme A 1246304-40-4

870737P-10mg10mg5100 17:1 (n7) Coenzyme A 1246304-40-4

870737P-25mg25mg9600 17:1 (n7) Coenzyme A 1246304-40-4

870737P-50mg50mg14400 17:1 (n7) Coenzyme A 1246304-40-4

870737P-100mg100mg21300 17:1 (n7) Coenzyme A 1246304-40-4

870737P-200mg200mg31800 17:1 (n7) Coenzyme A 1246304-40-4

870738P-5mg5mg3375 19:0 Coenzyme A

870738P-10mg10mg5100 19:0 Coenzyme A

870738P-25mg25mg9600 19:0 Coenzyme A

870738P-50mg50mg14400 19:0 Coenzyme A

870738P-100mg100mg21300 19:0 Coenzyme A

870738P-200mg200mg31800 19:0 Coenzyme A

870739P-5mg5mg3375 21:0 Coenzyme A

870739P-10mg10mg5100 21:0 Coenzyme A

870739P-25mg25mg9600 21:0 Coenzyme A

870739P-50mg50mg14400 21:0 Coenzyme A

870739P-100mg100mg21300 21:0 Coenzyme A

870739P-200mg200mg31800 21:0 Coenzyme A

870740P-5mg5mg3375 16:0 Ether Coenzyme A

870740P-10mg10mg5100 16:0 Ether Coenzyme A

870740P-25mg25mg9600 16:0 Ether Coenzyme A

870740P-50mg50mg14400 16:0 Ether Coenzyme A

870740P-100mg100mg21300 16:0 Ether Coenzyme A

870740P-200mg200mg31800 16:0 Ether Coenzyme A

870741P-5mg5mg3375 18:1 ether Coenzyme A

870741P-10mg10mg5100 18:1 ether Coenzyme A

870741P-25mg25mg9600 18:1 ether Coenzyme A

870741P-50mg50mg14400 18:1 ether Coenzyme A

870741P-100mg100mg21300 18:1 ether Coenzyme A

870741P-200mg200mg31800 18:1 ether Coenzyme A

870742P-5mg5mg3375 4ME 16:0 Coenzyme A

870742P-10mg10mg5100 4ME 16:0 Coenzyme A

870742P-25mg25mg9600 4ME 16:0 Coenzyme A

870742P-50mg50mg14400 4ME 16:0 Coenzyme A

870742P-100mg100mg21300 4ME 16:0 Coenzyme A

870742P-200mg200mg31800 4ME 16:0 Coenzyme A

870743P-5mg5mg3375 16:1 (n7) Coenzyme A 1246304-41-5

870743P-10mg10mg5100 16:1 (n7) Coenzyme A 1246304-41-5

870743P-25mg25mg9600 16:1 (n7) Coenzyme A 1246304-41-5

870743P-50mg50mg14400 16:1 (n7) Coenzyme A 1246304-41-5

870743P-100mg100mg21300 16:1 (n7) Coenzyme A 1246304-41-5

870743P-200mg200mg31800 16:1 (n7) Coenzyme A 1246304-41-5

870744P-5mg5mg3375 20:5 Coenzyme A 1246522-05-3

870744P-10mg10mg5100 20:5 Coenzyme A 1246522-05-3

870744P-25mg25mg9600 20:5 Coenzyme A 1246522-05-3

870744P-50mg50mg14400 20:5 Coenzyme A 1246522-05-3

870744P-100mg100mg21300 20:5 Coenzyme A 1246522-05-3

870744P-200mg200mg31800 20:5 Coenzyme A 1246522-05-3

870792P-5mg5mg1875 D-threo-PPMP 139889-53-5

870792P-10mg10mg3225 D-threo-PPMP 139889-53-5

870792P-25mg25mg6750 D-threo-PPMP 139889-53-5

870792P-50mg50mg11850 D-threo-PPMP 139889-53-5

870792P-100mg100mg21450 D-threo-PPMP 139889-53-5

870817P-10mg10mg465 N-palmitoylglycine 2441-41-0

870817P-25mg25mg900 N-palmitoylglycine 2441-41-0

870817P-50mg50mg1575 N-palmitoylglycine 2441-41-0

870817P-100mg100mg2850 N-palmitoylglycine 2441-41-0

870817P-200mg200mg5025 N-palmitoylglycine 2441-41-0

870817P-500mg500mg10500 N-palmitoylglycine 2441-41-0

870818M-10mg10mg900 N-arachidonoylglycine 179113-91-8

870818M-50mg50mg3525 N-arachidonoylglycine 179113-91-8

870818M-100mg100mg6375 N-arachidonoylglycine 179113-91-8

870818M-200mg200mg11550 N-arachidonoylglycine 179113-91-8

870819P-10mg10mg465 N-oleoylglycine 2601-90-3

870819P-25mg25mg900 N-oleoylglycine 2601-90-3

870819P-50mg50mg1575 N-oleoylglycine 2601-90-3

870819P-100mg100mg2850 N-oleoylglycine 2601-90-3

870819P-200mg200mg5025 N-oleoylglycine 2601-90-3

870819P-500mg500mg10500 N-oleoylglycine 2601-90-3

870850P-5mg5mg1425 C12 Carnitine 7023-3-2

870850P-10mg10mg2400 C12 Carnitine 7023-3-2

870850P-25mg25mg4875 C12 Carnitine 7023-3-2

870850P-50mg50mg7650 C12 Carnitine 7023-3-2

870851P-5mg5mg1425 C16 Carnitine 1935-18-8

870851P-10mg10mg2400 C16 Carnitine 1935-18-8

870851P-25mg25mg4875 C16 Carnitine 1935-18-8

870851P-50mg50mg7650 C16 Carnitine 1935-18-8

870852C-5mg5mg1425 C18:1(Δ9-cis) Carnitine 13962-05-5

870852C-10mg10mg2400 C18:1(Δ9-cis) Carnitine 13962-05-5

870852C-25mg25mg4875 C18:1(Δ9-cis) Carnitine 13962-05-5

870852C-50mg50mg7650 C18:1(Δ9-cis) Carnitine 13962-05-5

870852P-5mg5mg1575 C18:1(Δ9-cis) Carnitine 13962-05-5

870852P-10mg10mg2550 C18:1(Δ9-cis) Carnitine 13962-05-5

870852P-25mg25mg5025 C18:1(Δ9-cis) Carnitine 13962-05-5

870852P-50mg50mg7800 C18:1(Δ9-cis) Carnitine 13962-05-5

87085-5mg5mg1575 3-Me-Glutaryl Carnitine

872100C-5mg5mg630 18:1 PE-N-20:4 1246304-42-6

872100C-10mg10mg1080 18:1 PE-N-20:4 1246304-42-6

872100C-25mg25mg2175 18:1 PE-N-20:4 1246304-42-6

872100C-50mg50mg3900 18:1 PE-N-20:4 1246304-42-6

872100C-100mg100mg7050 18:1 PE-N-20:4 1246304-42-6

878101P-10mg10mg2025 C17 Lyso PAF 111858-52-7

878101P-25mg25mg4350 C17 Lyso PAF 111858-52-7

878110C-5mg5mg1125 C16-02:0 PC 74389-68-7

878110C-25mg25mg4350 C16-02:0 PC 74389-68-7

878110P-5mg5mg1275 C16-02:0 PC 74389-68-7

878110P-25mg25mg4500 C16-02:0 PC 74389-68-7

878112C-5mg5mg1065 C16-18:1 PC 95403-34-2

878112C-25mg25mg4125 C16-18:1 PC 95403-34-2

878112P-5mg5mg1215 C16-18:1 PC 95403-34-2

878112P-25mg25mg4275 C16-18:1 PC 95403-34-2

878113C-5mg5mg4050 C16-20:4 PC 86288-11-1

878113C-25mg25mg16350 C16-20:4 PC 86288-11-1

878113P-5mg5mg4200 C16-20:4 PC 86288-11-1

878113P-25mg25mg16500 C16-20:4 PC 86288-11-1

878114C-5mg5mg1125 C18-02:0 PC 74389-69-8

878114C-25mg25mg4350 C18-02:0 PC 74389-69-8

878114P-5mg5mg1275 C18-02:0 PC 74389-69-8

878114P-25mg25mg4500 C18-02:0 PC 74389-69-8

878115C-5mg5mg1125 C16-04:0 PC 85405-03-4

878115C-25mg25mg4350 C16-04:0 PC 85405-03-4

878115P-5mg5mg1275 C16-04:0 PC 85405-03-4

878115P-25mg25mg4500 C16-04:0 PC 85405-03-4

878116C-5mg5mg1125 C18-04:0 PC 83526-67-4

878116C-25mg25mg4350 C18-04:0 PC 83526-67-4

878116P-5mg5mg1275 C18-04:0 PC 83526-67-4

878116P-25mg25mg4500 C18-04:0 PC 83526-67-4

878117C-5mg5mg8700 C16-02:0 PC 77249-80-0

878117C-25mg25mg25800 C16-02:0 PC 77249-80-0

878117P-5mg5mg8850 C16-02:0 PC 77249-80-0

878117P-25mg25mg25950 C16-02:0 PC 77249-80-0

878118C-5mg5mg1380 C16-02:0 DG 77133-35-8

878118C-25mg25mg5550 C16-02:0 DG 77133-35-8

878118P-5mg5mg1530 C16-02:0 DG 77133-35-8

878118P-25mg25mg5700 C16-02:0 DG 77133-35-8

878119C-5mg5mg1275 C16 Lyso PAF 52691-62-0

878119C-25mg25mg4500 C16 Lyso PAF 52691-62-0

878119P-5mg5mg1125 C16 Lyso PAF 52691-62-0

878119P-25mg25mg4350 C16 Lyso PAF 52691-62-0

878120C-5mg5mg1275 C18 Lyso PAF 74430-89-0

878120C-25mg25mg4500 C18 Lyso PAF 74430-89-0

878120P-5mg5mg1125 C18 Lyso PAF 74430-89-0

878120P-25mg25mg4350 C18 Lyso PAF 74430-89-0

878122C-5mg5mg4050 C16-20:3 PC 155575-01-2

878122C-25mg25mg16350 C16-20:3 PC 155575-01-2

878122P-5mg5mg4200 C16-20:3 PC 155575-01-2

878122P-25mg25mg16500 C16-20:3 PC 155575-01-2

878123C-5mg5mg4050 C16-20:5 PC 132196-28-2

878123C-25mg25mg16350 C16-20:5 PC 132196-28-2

878123P-5mg5mg4200 C16-20:5 PC 132196-28-2

878123P-25mg25mg16500 C16-20:5 PC 132196-28-2

878124C-5mg5mg4050 C16-22:6 PC 132213-85-5

878124C-25mg25mg16350 C16-22:6 PC 132213-85-5

878124P-5mg5mg4200 C16-22:6 PC 132213-85-5

878124P-25mg25mg16500 C16-22:6 PC 132213-85-5

878126C-5mg5mg1410 C18:1 Lyso PAF 87907-66-2

878126C-10mg10mg2175 C18:1 Lyso PAF 87907-66-2

878126C-25mg25mg4875 C18:1 Lyso PAF 87907-66-2

878126P-5mg5mg1560 C18:1 Lyso PAF 87907-66-2

878126P-10mg10mg2325 C18:1 Lyso PAF 87907-66-2

878126P-25mg25mg5025 C18:1 Lyso PAF 87907-66-2

880120C-25mg25mg1335 18:0 PEG2000 PE 474922-77-5

880120C-200mg200mg2850 18:0 PEG2000 PE 474922-77-5

880120C-500mg500mg6075 18:0 PEG2000 PE 474922-77-5

880120C-1g1g10500 18:0 PEG2000 PE 474922-77-5

880120P-25mg25mg1185 18:0 PEG2000 PE 474922-77-5

880120P-200mg200mg2700 18:0 PEG2000 PE 474922-77-5

880120P-500mg500mg5925 18:0 PEG2000 PE 474922-77-5

880120P-1g1g10350 18:0 PEG2000 PE 474922-77-5

880121C-10mg10mg1440 DSPE-PEG(2000) Succinyl

880121C-25mg25mg2250 DSPE-PEG(2000) Succinyl

880121C-50mg50mg3675 DSPE-PEG(2000) Succinyl

880121C-100mg100mg6300 DSPE-PEG(2000) Succinyl

880121C-500mg500mg24150 DSPE-PEG(2000) Succinyl

880121P-10mg10mg1290 DSPE-PEG(2000) Succinyl

880121P-25mg25mg2100 DSPE-PEG(2000) Succinyl

880121P-50mg50mg3525 DSPE-PEG(2000) Succinyl

880121P-100mg100mg6150 DSPE-PEG(2000) Succinyl

880121P-500mg500mg24000 DSPE-PEG(2000) Succinyl

880122P-10mg10mg1650 DSPE-PEG(2000) Cyanur 1246304-74-4

880122P-25mg25mg3375 DSPE-PEG(2000) Cyanur 1246304-74-4

880122P-50mg50mg6000 DSPE-PEG(2000) Cyanur 1246304-74-4

880122P-100mg100mg11100 DSPE-PEG(2000) Cyanur 1246304-74-4

880122P-500mg500mg43050 DSPE-PEG(2000) Cyanur 1246304-74-4

880123P-500μg500μg3600 DSPE-PEG(5000) Folate 1236288-25-7

880123P-1mg1mg5025 DSPE-PEG(5000) Folate 1236288-25-7

880123P-5mg5mg17550 DSPE-PEG(5000) Folate 1236288-25-7

880123P-10mg10mg24450 DSPE-PEG(5000) Folate 1236288-25-7

880123X-500μg500μg3750 DSPE-PEG(5000) Folate 1236288-25-7

880123X-1mg1mg5175 DSPE-PEG(5000) Folate 1236288-25-7

880123X-5mg5mg17700 DSPE-PEG(5000) Folate 1236288-25-7

880123X-10mg10mg24600 DSPE-PEG(5000) Folate 1236288-25-7

880124P-500μg500μg3600 DSPE-PEG(2000) Folate 1236288-25-7

880124P-1mg1mg5025 DSPE-PEG(2000) Folate 1236288-25-7

880124P-5mg5mg17550 DSPE-PEG(2000) Folate 1236288-25-7

880124P-10mg10mg24450 DSPE-PEG(2000) Folate 1236288-25-7

880124X-500μg500μg3750 DSPE-PEG(2000) Folate 1236288-25-7

880124X-1mg1mg5175 DSPE-PEG(2000) Folate 1236288-25-7

880124X-5mg5mg17700 DSPE-PEG(2000) Folate 1236288-25-7

880124X-10mg10mg24600 DSPE-PEG(2000) Folate 1236288-25-7

880125C-10mg10mg1950 DSPE-PEG(2000) Carboxylic Acid 474922-20-8

880125C-25mg25mg3675 DSPE-PEG(2000) Carboxylic Acid 474922-20-8

880125C-50mg50mg6225 DSPE-PEG(2000) Carboxylic Acid 474922-20-8

880125C-100mg100mg10950 DSPE-PEG(2000) Carboxylic Acid 474922-20-8

880125C-500mg500mg42300 DSPE-PEG(2000) Carboxylic Acid 474922-20-8

880125P-10mg10mg1800 DSPE-PEG(2000) Carboxylic Acid 474922-20-8

880125P-25mg25mg3525 DSPE-PEG(2000) Carboxylic Acid 474922-20-8

880125P-50mg50mg6075 DSPE-PEG(2000) Carboxylic Acid 474922-20-8

880125P-100mg100mg10800 DSPE-PEG(2000) Carboxylic Acid 474922-20-8

880125P-500mg500mg42150 DSPE-PEG(2000) Carboxylic Acid 474922-20-8

880126C-10mg10mg1800 DSPE-PEG(2000) Maleimide 474922-22-0

880126C-25mg25mg3525 DSPE-PEG(2000) Maleimide 474922-22-0

880126C-50mg50mg6150 DSPE-PEG(2000) Maleimide 474922-22-0

880126C-100mg100mg11250 DSPE-PEG(2000) Maleimide 474922-22-0

880126C-500mg500mg43200 DSPE-PEG(2000) Maleimide 474922-22-0

880126P-10mg10mg1650 DSPE-PEG(2000) Maleimide 474922-22-0

880126P-25mg25mg3375 DSPE-PEG(2000) Maleimide 474922-22-0

880126P-50mg50mg6000 DSPE-PEG(2000) Maleimide 474922-22-0

880126P-100mg100mg11100 DSPE-PEG(2000) Maleimide 474922-22-0

880126P-500mg500mg43050 DSPE-PEG(2000) Maleimide 474922-22-0

880127C-10mg10mg1650 DSPE-PEG(2000) PDP 474922-24-2

880127C-25mg25mg3600 DSPE-PEG(2000) PDP 474922-24-2

880127C-50mg50mg6075 DSPE-PEG(2000) PDP 474922-24-2

880127C-100mg100mg11400 DSPE-PEG(2000) PDP 474922-24-2

880127C-500mg500mg44550 DSPE-PEG(2000) PDP 474922-24-2

880127P-10mg10mg1500 DSPE-PEG(2000) PDP 474922-24-2

880127P-25mg25mg3450 DSPE-PEG(2000) PDP 474922-24-2

880127P-50mg50mg5925 DSPE-PEG(2000) PDP 474922-24-2

880127P-100mg100mg11250 DSPE-PEG(2000) PDP 474922-24-2

880127P-500mg500mg44400 DSPE-PEG(2000) PDP 474922-24-2

880128C-10mg10mg1275 DSPE-PEG(2000) Amine 474922-26-4

880128C-25mg25mg1800 DSPE-PEG(2000) Amine 474922-26-4

880128C-50mg50mg2625 DSPE-PEG(2000) Amine 474922-26-4

880128C-100mg100mg4650 DSPE-PEG(2000) Amine 474922-26-4

880128C-500mg500mg18000 DSPE-PEG(2000) Amine 474922-26-4

880128P-10mg10mg1125 DSPE-PEG(2000) Amine 474922-26-4

880128P-25mg25mg1650 DSPE-PEG(2000) Amine 474922-26-4

880128P-50mg50mg2475 DSPE-PEG(2000) Amine 474922-26-4

880128P-100mg100mg4500 DSPE-PEG(2000) Amine 474922-26-4

880128P-500mg500mg17850 DSPE-PEG(2000) Amine 474922-26-4

880129C-10mg10mg1380 DSPE-PEG(2000) Biotin 385437-57-0

880129C-25mg25mg2850 DSPE-PEG(2000) Biotin 385437-57-0

880129C-50mg50mg4950 DSPE-PEG(2000) Biotin 385437-57-0

880129C-100mg100mg9150 DSPE-PEG(2000) Biotin 385437-57-0

880129C-500mg500mg35550 DSPE-PEG(2000) Biotin 385437-57-0

880129P-10mg10mg1230 DSPE-PEG(2000) Biotin 385437-57-0

880129P-25mg25mg2700 DSPE-PEG(2000) Biotin 385437-57-0

880129P-50mg50mg4800 DSPE-PEG(2000) Biotin 385437-57-0

880129P-100mg100mg9000 DSPE-PEG(2000) Biotin 385437-57-0

880129P-500mg500mg35400 DSPE-PEG(2000) Biotin 385437-57-0

880130C-25mg25mg1275 18:1 PEG2000 PE 474922-90-2

880130C-200mg200mg2925 18:1 PEG2000 PE 474922-90-2

880130C-500mg500mg6375 18:1 PEG2000 PE 474922-90-2

880130C-1g1g11100 18:1 PEG2000 PE 474922-90-2

880130P-25mg25mg1425 18:1 PEG2000 PE 474922-90-2

880130P-200mg200mg3075 18:1 PEG2000 PE 474922-90-2

880130P-500mg500mg6525 18:1 PEG2000 PE 474922-90-2

880130P-1g1g11250 18:1 PEG2000 PE 474922-90-2

880150C-25mg25mg1425 14:0 PEG2000 PE 474922-82-2

880150C-200mg200mg3075 14:0 PEG2000 PE 474922-82-2

880150C-500mg500mg6525 14:0 PEG2000 PE 474922-82-2

880150C-1g1g11250 14:0 PEG2000 PE 474922-82-2

880150P-25mg25mg1275 14:0 PEG2000 PE 474922-82-2

880150P-200mg200mg2925 14:0 PEG2000 PE 474922-82-2

880150P-500mg500mg6375 14:0 PEG2000 PE 474922-82-2

880150P-1g1g11100 14:0 PEG2000 PE 474922-82-2

880160C-25mg25mg1425 16:0 PEG2000 PE 474922-84-4

880160C-200mg200mg3075 16:0 PEG2000 PE 474922-84-4

880160C-500mg500mg6525 16:0 PEG2000 PE 474922-84-4

880160C-1g1g11250 16:0 PEG2000 PE 474922-84-4

880160P-25mg25mg1275 16:0 PEG2000 PE 474922-84-4

880160P-200mg200mg2925 16:0 PEG2000 PE 474922-84-4

880160P-500mg500mg6375 16:0 PEG2000 PE 474922-84-4

880160P-1g1g11100 16:0 PEG2000 PE 474922-84-4

880170C-25mg25mg3975 C8 PEG2000 Ceramide 212116-76-2

880170C-200mg200mg8700 C8 PEG2000 Ceramide 212116-76-2

880170C-500mg500mg19200 C8 PEG2000 Ceramide 212116-76-2

880170C-1g1g35400 C8 PEG2000 Ceramide 212116-76-2

880170P-25mg25mg4125 C8 PEG2000 Ceramide 212116-76-2

880170P-200mg200mg8850 C8 PEG2000 Ceramide 212116-76-2

880170P-500mg500mg19350 C8 PEG2000 Ceramide 212116-76-2

880170P-1g1g35550 C8 PEG2000 Ceramide 212116-76-2

880180C-25mg25mg4125 C16 PEG2000 Ceramide 212116-78-4

880180C-200mg200mg8850 C16 PEG2000 Ceramide 212116-78-4

880180C-500mg500mg19350 C16 PEG2000 Ceramide 212116-78-4

880180C-1g1g35550 C16 PEG2000 Ceramide 212116-78-4

880180P-25mg25mg3975 C16 PEG2000 Ceramide 212116-78-4

880180P-200mg200mg8700 C16 PEG2000 Ceramide 212116-78-4

880180P-500mg500mg19200 C16 PEG2000 Ceramide 212116-78-4

880180P-1g1g35400 C16 PEG2000 Ceramide 212116-78-4

880200C-25mg25mg1425 16:0 PEG5000 PE 474922-84-4

880200C-200mg200mg3075 16:0 PEG5000 PE 474922-84-4

880200C-500mg500mg6525 16:0 PEG5000 PE 474922-84-4

880200C-1g1g11250 16:0 PEG5000 PE 474922-84-4

880200P-25mg25mg1275 16:0 PEG5000 PE 474922-84-4

880200P-200mg200mg2925 16:0 PEG5000 PE 474922-84-4

880200P-500mg500mg6375 16:0 PEG5000 PE 474922-84-4

880200P-1g1g11100 16:0 PEG5000 PE 474922-84-4

880210C-25mg25mg1335 14:0 PEG5000 PE 474922-82-2

880210C-200mg200mg2850 14:0 PEG5000 PE 474922-82-2

880210C-500mg500mg6075 14:0 PEG5000 PE 474922-82-2

880210C-1g1g10500 14:0 PEG5000 PE 474922-82-2

880210P-25mg25mg1185 14:0 PEG5000 PE 474922-82-2

880210P-200mg200mg2700 14:0 PEG5000 PE 474922-82-2

880210P-500mg500mg5925 14:0 PEG5000 PE 474922-82-2

880210P-1g1g10350 14:0 PEG5000 PE 474922-82-2

880220C-25mg25mg1425 18:0 PEG5000 PE 474922-77-5

880220C-200mg200mg3075 18:0 PEG5000 PE 474922-77-5

880220C-500mg500mg6525 18:0 PEG5000 PE 474922-77-5

880220C-1g1g11250 18:0 PEG5000 PE 474922-77-5

880220P-25mg25mg1275 18:0 PEG5000 PE 474922-77-5

880220P-200mg200mg2925 18:0 PEG5000 PE 474922-77-5

880220P-500mg500mg6375 18:0 PEG5000 PE 474922-77-5

880220P-1g1g11100 18:0 PEG5000 PE 474922-77-5

880230C-25mg25mg1275 18:1 PEG5000 PE 474922-90-2

880230C-200mg200mg2925 18:1 PEG5000 PE 474922-90-2

880230C-500mg500mg6375 18:1 PEG5000 PE 474922-90-2

880230C-1g1g11100 18:1 PEG5000 PE 474922-90-2

880230P-25mg25mg1425 18:1 PEG5000 PE 474922-90-2

880230P-200mg200mg3075 18:1 PEG5000 PE 474922-90-2

880230P-500mg500mg6525 18:1 PEG5000 PE 474922-90-2

880230P-1g1g11250 18:1 PEG5000 PE 474922-90-2

880270C-25mg25mg3975 C8 PEG5000 Ceramide 212116-76-2

880270C-200mg200mg8700 C8 PEG5000 Ceramide 212116-76-2

880270C-500mg500mg19200 C8 PEG5000 Ceramide 212116-76-2

880270C-1g1g35400 C8 PEG5000 Ceramide 212116-76-2

880270P-25mg25mg4125 C8 PEG5000 Ceramide 212116-76-2

880270P-200mg200mg8850 C8 PEG5000 Ceramide 212116-76-2

880270P-500mg500mg19350 C8 PEG5000 Ceramide 212116-76-2

880270P-1g1g35550 C8 PEG5000 Ceramide 212116-76-2

880280C-25mg25mg4125 C16 PEG5000 Ceramide 212116-78-4

880280C-200mg200mg8850 C16 PEG5000 Ceramide 212116-78-4

880280C-500mg500mg19350 C16 PEG5000 Ceramide 212116-78-4

880280C-1g1g35550 C16 PEG5000 Ceramide 212116-78-4

880280P-25mg25mg3975 C16 PEG5000 Ceramide 212116-78-4

880280P-200mg200mg8700 C16 PEG5000 Ceramide 212116-78-4

880280P-500mg500mg19200 C16 PEG5000 Ceramide 212116-78-4

880280P-1g1g35400 C16 PEG5000 Ceramide 212116-78-4

880300C-25mg25mg1425 16:0 PEG3000 PE 474922-84-4

880300C-200mg200mg3075 16:0 PEG3000 PE 474922-84-4

880300C-500mg500mg6525 16:0 PEG3000 PE 474922-84-4

880300C-1g1g11250 16:0 PEG3000 PE 474922-84-4

880300P-25mg25mg1275 16:0 PEG3000 PE 474922-84-4

880300P-200mg200mg2925 16:0 PEG3000 PE 474922-84-4

880300P-500mg500mg6375 16:0 PEG3000 PE 474922-84-4

880300P-1g1g11100 16:0 PEG3000 PE 474922-84-4

880310C-25mg25mg1425 14:0 PEG3000 PE 474922-82-2

880310C-200mg200mg3075 14:0 PEG3000 PE 474922-82-2

880310C-500mg500mg6525 14:0 PEG3000 PE 474922-82-2

880310C-1g1g11250 14:0 PEG3000 PE 474922-82-2

880310P-25mg25mg1275 14:0 PEG3000 PE 474922-82-2

880310P-200mg200mg2925 14:0 PEG3000 PE 474922-82-2

880310P-500mg500mg6375 14:0 PEG3000 PE 474922-82-2

880310P-1g1g11100 14:0 PEG3000 PE 474922-82-2

880320C-25mg25mg1425 18:0 PEG3000 PE 474922-77-5

880320C-200mg200mg3075 18:0 PEG3000 PE 474922-77-5

880320C-500mg500mg6525 18:0 PEG3000 PE 474922-77-5

880320C-1g1g11250 18:0 PEG3000 PE 474922-77-5

880320P-25mg25mg1275 18:0 PEG3000 PE 474922-77-5

880320P-200mg200mg2925 18:0 PEG3000 PE 474922-77-5

880320P-500mg500mg6375 18:0 PEG3000 PE 474922-77-5

880320P-1g1g11100 18:0 PEG3000 PE 474922-77-5

880330C-25mg25mg1275 18:1 PEG3000 PE 474922-90-2

880330C-200mg200mg2925 18:1 PEG3000 PE 474922-90-2

880330C-500mg500mg6375 18:1 PEG3000 PE 474922-90-2

880330C-1g1g11100 18:1 PEG3000 PE 474922-90-2

880330P-25mg25mg1425 18:1 PEG3000 PE 474922-90-2

880330P-200mg200mg3075 18:1 PEG3000 PE 474922-90-2

880330P-500mg500mg6525 18:1 PEG3000 PE 474922-90-2

880330P-1g1g11250 18:1 PEG3000 PE 474922-90-2

880341C-10mg10mg1800 16:0-16:0 (16-F) PC 215362-14-4

880341C-25mg25mg3075 16:0-16:0 (16-F) PC 215362-14-4

880341C-100mg100mg7350 16:0-16:0 (16-F) PC 215362-14-4

880341C-500mg500mg17250 16:0-16:0 (16-F) PC 215362-14-4

880341P-10mg10mg1650 16:0-16:0 (16-F) PC 215362-14-4

880341P-25mg25mg2925 16:0-16:0 (16-F) PC 215362-14-4

880341P-100mg100mg7200 16:0-16:0 (16-F) PC 215362-14-4

880341P-500mg500mg17100 16:0-16:0 (16-F) PC 215362-14-4

880342P-10mg10mg2400 16:0-16:0(acrylate) PC 1246304-43-7

880342P-25mg25mg5025 16:0-16:0(acrylate) PC 1246304-43-7

880342P-100mg100mg15750 16:0-16:0(acrylate) PC 1246304-43-7

880343P-25mg25mg2175 PChemsPC 155401-40-4

880343P-200mg200mg7275 PChemsPC 155401-40-4

880343P-500mg500mg13800 PChemsPC 155401-40-4

880343P-1g1g22500 PChemsPC 155401-40-4

880344P-25mg25mg2175 OChemsPC 155401-41-5

880344P-200mg200mg7275 OChemsPC 155401-41-5

880344P-500mg500mg13800 OChemsPC 155401-41-5

880344P-1g1g22500 OChemsPC 155401-41-5

880345P-25mg25mg2175 PChcPC 1085528-78-4

880345P-200mg200mg7275 PChcPC 1085528-78-4

880345P-500mg500mg13800 PChcPC 1085528-78-4

880345P-1g1g22500 PChcPC 1085528-78-4

880346P-25mg25mg2175 DChemsPC 1155878-69-5

880346P-200mg200mg7275 DChemsPC 1155878-69-5

880346P-500mg500mg13800 DChemsPC 1155878-69-5

880346P-1g1g22500 DChemsPC 1155878-69-5

880347C-10mg10mg1500 14:0-14:0(COOH) PC 119766-79-9

880347C-25mg25mg2850 14:0-14:0(COOH) PC 119766-79-9

880347C-100mg100mg5400 14:0-14:0(COOH) PC 119766-79-9

880347C-200mg200mg9150 14:0-14:0(COOH) PC 119766-79-9

880347C-500mg500mg17850 14:0-14:0(COOH) PC 119766-79-9

880347C-1g1g28500 14:0-14:0(COOH) PC 119766-79-9

880347P-10mg10mg1350 14:0-14:0(COOH) PC 119766-79-9

880347P-25mg25mg2700 14:0-14:0(COOH) PC 119766-79-9

880347P-100mg100mg5250 14:0-14:0(COOH) PC 119766-79-9

880347P-200mg200mg9000 14:0-14:0(COOH) PC 119766-79-9

880347P-500mg500mg17700 14:0-14:0(COOH) PC 119766-79-9

880347P-1g1g28350 14:0-14:0(COOH) PC 119766-79-9

880400C-25mg25mg2325 16:0 PEG350 PE 474922-84-4

880400C-200mg200mg5325 16:0 PEG350 PE 474922-84-4

880400C-500mg500mg11850 16:0 PEG350 PE 474922-84-4

880400C-1g1g21150 16:0 PEG350 PE 474922-84-4

880400P-25mg25mg2475 16:0 PEG350 PE 474922-84-4

880400P-200mg200mg5475 16:0 PEG350 PE 474922-84-4

880400P-500mg500mg12000 16:0 PEG350 PE 474922-84-4

880400P-1g1g21300 16:0 PEG350 PE 474922-84-4

880410C-25mg25mg2325 14:0 PEG350 PE 474922-82-2

880410C-200mg200mg5325 14:0 PEG350 PE 474922-82-2

880410C-500mg500mg11850 14:0 PEG350 PE 474922-82-2

880410C-1g1g21150 14:0 PEG350 PE 474922-82-2

880410P-25mg25mg2475 14:0 PEG350 PE 474922-82-2

880410P-200mg200mg5475 14:0 PEG350 PE 474922-82-2

880410P-500mg500mg12000 14:0 PEG350 PE 474922-82-2

880410P-1g1g21300 14:0 PEG350 PE 474922-82-2

880420C-25mg25mg2325 18:0 PEG350 PE 474922-77-5

880420C-200mg200mg5325 18:0 PEG350 PE 474922-77-5

880420C-500mg500mg11850 18:0 PEG350 PE 474922-77-5

880420C-1g1g21150 18:0 PEG350 PE 474922-77-5

880420P-25mg25mg2475 18:0 PEG350 PE 474922-77-5

880420P-200mg200mg5475 18:0 PEG350 PE 474922-77-5

880420P-500mg500mg12000 18:0 PEG350 PE 474922-77-5

880420P-1g1g21300 18:0 PEG350 PE 474922-77-5

880430C-25mg25mg2325 18:1 PEG350 PE 474922-90-2

880430C-200mg200mg5325 18:1 PEG350 PE 474922-90-2

880430C-500mg500mg11850 18:1 PEG350 PE 474922-90-2

880430C-1g1g21150 18:1 PEG350 PE 474922-90-2

880430O-25mg25mg2475 18:1 PEG350 PE 474922-90-2

880430O-200mg200mg5475 18:1 PEG350 PE 474922-90-2

880430O-500mg500mg12000 18:1 PEG350 PE 474922-90-2

880430O-1g1g21300 18:1 PEG350 PE 474922-90-2

880500C-25mg25mg2325 16:0 PEG550 PE 474922-84-4

880500C-200mg200mg5325 16:0 PEG550 PE 474922-84-4

880500C-500mg500mg11850 16:0 PEG550 PE 474922-84-4

880500C-1g1g21150 16:0 PEG550 PE 474922-84-4

880500P-25mg25mg2475 16:0 PEG550 PE 474922-84-4

880500P-200mg200mg5475 16:0 PEG550 PE 474922-84-4

880500P-500mg500mg12000 16:0 PEG550 PE 474922-84-4

880500P-1g1g21300 16:0 PEG550 PE 474922-84-4

880510C-25mg25mg2325 14:0 PEG550 PE 474922-82-2

880510C-200mg200mg5325 14:0 PEG550 PE 474922-82-2

880510C-500mg500mg11850 14:0 PEG550 PE 474922-82-2

880510C-1g1g21150 14:0 PEG550 PE 474922-82-2

880510P-25mg25mg2475 14:0 PEG550 PE 474922-82-2

880510P-200mg200mg5475 14:0 PEG550 PE 474922-82-2

880510P-500mg500mg12000 14:0 PEG550 PE 474922-82-2

880510P-1g1g21300 14:0 PEG550 PE 474922-82-2

880520C-25mg25mg2325 18:0 PEG550 PE 474922-77-5

880520C-200mg200mg5325 18:0 PEG550 PE 474922-77-5

880520C-500mg500mg11850 18:0 PEG550 PE 474922-77-5

880520C-1g1g21150 18:0 PEG550 PE 474922-77-5

880520P-25mg25mg2475 18:0 PEG550 PE 474922-77-5

880520P-200mg200mg5475 18:0 PEG550 PE 474922-77-5

880520P-500mg500mg12000 18:0 PEG550 PE 474922-77-5

880520P-1g1g21300 18:0 PEG550 PE 474922-77-5

880530C-25mg25mg2325 18:1 PEG550 PE 474922-90-2

880530C-200mg200mg5325 18:1 PEG550 PE 474922-90-2

880530C-500mg500mg11850 18:1 PEG550 PE 474922-90-2

880530C-1g1g21150 18:1 PEG550 PE 474922-90-2

880530O-25mg25mg2475 18:1 PEG550 PE 474922-90-2

880530O-200mg200mg5475 18:1 PEG550 PE 474922-90-2

880530O-500mg500mg12000 18:1 PEG550 PE 474922-90-2

880530O-1g1g21300 18:1 PEG550 PE 474922-90-2

880600C-25mg25mg1650 16:0 PEG750 PE 474922-84-4

880600C-200mg200mg3825 16:0 PEG750 PE 474922-84-4

880600C-500mg500mg8550 16:0 PEG750 PE 474922-84-4

880600C-1g1g15600 16:0 PEG750 PE 474922-84-4

880600P-25mg25mg1800 16:0 PEG750 PE 474922-84-4

880600P-200mg200mg3975 16:0 PEG750 PE 474922-84-4

880600P-500mg500mg8700 16:0 PEG750 PE 474922-84-4

880600P-1g1g15750 16:0 PEG750 PE 474922-84-4

880610C-25mg25mg1650 14:0 PEG750 PE 474922-82-2

880610C-200mg200mg3825 14:0 PEG750 PE 474922-82-2

880610C-500mg500mg8550 14:0 PEG750 PE 474922-82-2

880610C-1g1g15600 14:0 PEG750 PE 474922-82-2

880610P-25mg25mg1800 14:0 PEG750 PE 474922-82-2

880610P-200mg200mg3975 14:0 PEG750 PE 474922-82-2

880610P-500mg500mg8700 14:0 PEG750 PE 474922-82-2

880610P-1g1g15750 14:0 PEG750 PE 474922-82-2

880620C-25mg25mg1650 18:0 PEG750 PE 474922-77-5

880620C-200mg200mg3825 18:0 PEG750 PE 474922-77-5

880620C-500mg500mg8550 18:0 PEG750 PE 474922-77-5

880620C-1g1g15600 18:0 PEG750 PE 474922-77-5

880620P-25mg25mg1800 18:0 PEG750 PE 474922-77-5

880620P-200mg200mg3975 18:0 PEG750 PE 474922-77-5

880620P-500mg500mg8700 18:0 PEG750 PE 474922-77-5

880620P-1g1g15750 18:0 PEG750 PE 474922-77-5

880622C-5mg5mg4050 16:0-02:0 PC 79512-78-0

880622C-25mg25mg16350 16:0-02:0 PC 79512-78-0

880630C-25mg25mg1650 18:1 PEG750 PE 474922-90-2

880630C-200mg200mg3825 18:1 PEG750 PE 474922-90-2

880630C-500mg500mg8550 18:1 PEG750 PE 474922-90-2

880630C-1g1g15600 18:1 PEG750 PE 474922-90-2

880630O-25mg25mg1800 18:1 PEG750 PE 474922-90-2

880630O-200mg200mg3975 18:1 PEG750 PE 474922-90-2

880630O-500mg500mg8700 18:1 PEG750 PE 474922-90-2

880630O-1g1g15750 18:1 PEG750 PE 474922-90-2

880670C-25mg25mg3975 C8 PEG750 Ceramide 212116-76-2

880670C-200mg200mg8700 C8 PEG750 Ceramide 212116-76-2

880670C-500mg500mg19200 C8 PEG750 Ceramide 212116-76-2

880670C-1g1g35400 C8 PEG750 Ceramide 212116-76-2

880670P-25mg25mg4125 C8 PEG750 Ceramide 212116-76-2

880670P-200mg200mg8850 C8 PEG750 Ceramide 212116-76-2

880670P-500mg500mg19350 C8 PEG750 Ceramide 212116-76-2

880670P-1g1g35550 C8 PEG750 Ceramide 212116-76-2

880680C-25mg25mg4125 C16 PEG750 Ceramide 212116-78-4

880680C-200mg200mg8850 C16 PEG750 Ceramide 212116-78-4

880680C-500mg500mg19350 C16 PEG750 Ceramide 212116-78-4

880680C-1g1g35550 C16 PEG750 Ceramide 212116-78-4

880680P-25mg25mg3975 C16 PEG750 Ceramide 212116-78-4

880680P-200mg200mg8700 C16 PEG750 Ceramide 212116-78-4

880680P-500mg500mg19200 C16 PEG750 Ceramide 212116-78-4

880680P-1g1g35400 C16 PEG750 Ceramide 212116-78-4

880700C-25mg25mg1800 16:0 PEG1000 PE 474922-84-4

880700C-200mg200mg3975 16:0 PEG1000 PE 474922-84-4

880700C-500mg500mg8700 16:0 PEG1000 PE 474922-84-4

880700C-1g1g15750 16:0 PEG1000 PE 474922-84-4

880700P-25mg25mg1650 16:0 PEG1000 PE 474922-84-4

880700P-200mg200mg3825 16:0 PEG1000 PE 474922-84-4

880700P-500mg500mg8550 16:0 PEG1000 PE 474922-84-4

880700P-1g1g15600 16:0 PEG1000 PE 474922-84-4

880710C-25mg25mg1800 14:0 PEG1000 PE 474922-82-2

880710C-200mg200mg3975 14:0 PEG1000 PE 474922-82-2

880710C-500mg500mg8700 14:0 PEG1000 PE 474922-82-2

880710C-1g1g15750 14:0 PEG1000 PE 474922-82-2

880710P-25mg25mg1650 14:0 PEG1000 PE 474922-82-2

880710P-200mg200mg3825 14:0 PEG1000 PE 474922-82-2

880710P-500mg500mg8550 14:0 PEG1000 PE 474922-82-2

880710P-1g1g15600 14:0 PEG1000 PE 474922-82-2

880720C-25mg25mg1800 18:0 PEG1000 PE 474922-77-5

880720C-200mg200mg3975 18:0 PEG1000 PE 474922-77-5

880720C-500mg500mg8700 18:0 PEG1000 PE 474922-77-5

880720C-1g1g15750 18:0 PEG1000 PE 474922-77-5

880720P-25mg25mg1650 18:0 PEG1000 PE 474922-77-5

880720P-200mg200mg3825 18:0 PEG1000 PE 474922-77-5

880720P-500mg500mg8550 18:0 PEG1000 PE 474922-77-5

880720P-1g1g15600 18:0 PEG1000 PE 474922-77-5

880730C-25mg25mg1650 18:1 PEG1000 PE 474922-90-2

880730C-200mg200mg3825 18:1 PEG1000 PE 474922-90-2

880730C-500mg500mg8550 18:1 PEG1000 PE 474922-90-2

880730C-1g1g15600 18:1 PEG1000 PE 474922-90-2

880730P-25mg25mg1800 18:1 PEG1000 PE 474922-90-2

880730P-200mg200mg3975 18:1 PEG1000 PE 474922-90-2

880730P-500mg500mg8700 18:1 PEG1000 PE 474922-90-2

880730P-1g1g15750 18:1 PEG1000 PE 474922-90-2

888787D-150mg150mg945 PAMPA Lipid Blend I

888787D-750mg750mg3675 PAMPA Lipid Blend I

888787D-1.5g1.5g6750 PAMPA Lipid Blend I

888787D-3g3g12000 PAMPA Lipid Blend I

890700C-10mg10mg1125 12:0 EPC (Cl Salt) 474945-22-7

890700C-25mg25mg1380 12:0 EPC (Cl Salt) 474945-22-7

890700C-100mg100mg4275 12:0 EPC (Cl Salt) 474945-22-7

890700C-200mg200mg7425 12:0 EPC (Cl Salt) 474945-22-7

890700P-10mg10mg1275 12:0 EPC (Cl Salt) 474945-22-7

890700P-25mg25mg1530 12:0 EPC (Cl Salt) 474945-22-7

890700P-100mg100mg4425 12:0 EPC (Cl Salt) 474945-22-7

890700P-200mg200mg7575 12:0 EPC (Cl Salt) 474945-22-7

890701C-10mg10mg1125 14:0 EPC (Cl Salt) 186492-53-5

890701C-25mg25mg1380 14:0 EPC (Cl Salt) 186492-53-5

890701C-100mg100mg4275 14:0 EPC (Cl Salt) 186492-53-5

890701C-200mg200mg7425 14:0 EPC (Cl Salt) 186492-53-5

890701P-10mg10mg1275 14:0 EPC (Cl Salt) 186492-53-5

890701P-25mg25mg1530 14:0 EPC (Cl Salt) 186492-53-5

890701P-100mg100mg4425 14:0 EPC (Cl Salt) 186492-53-5

890701P-200mg200mg7575 14:0 EPC (Cl Salt) 186492-53-5

890702C-10mg10mg1125 16:0 EPC (Cl Salt) 328250-18-6

890702C-25mg25mg1380 16:0 EPC (Cl Salt) 328250-18-6

890702C-100mg100mg4275 16:0 EPC (Cl Salt) 328250-18-6

890702C-200mg200mg7425 16:0 EPC (Cl Salt) 328250-18-6

890702P-10mg10mg1275 16:0 EPC (Cl Salt) 328250-18-6

890702P-25mg25mg1530 16:0 EPC (Cl Salt) 328250-18-6

890702P-100mg100mg4425 16:0 EPC (Cl Salt) 328250-18-6

890702P-200mg200mg7575 16:0 EPC (Cl Salt) 328250-18-6

890703C-10mg10mg1125 18:0 EPC (Cl Salt) 328268-13-9

890703C-25mg25mg1380 18:0 EPC (Cl Salt) 328268-13-9

890703C-100mg100mg4275 18:0 EPC (Cl Salt) 328268-13-9

890703C-200mg200mg7425 18:0 EPC (Cl Salt) 328268-13-9

890703P-10mg10mg1275 18:0 EPC (Cl Salt) 328268-13-9

890703P-25mg25mg1530 18:0 EPC (Cl Salt) 328268-13-9

890703P-100mg100mg4425 18:0 EPC (Cl Salt) 328268-13-9

890703P-200mg200mg7575 18:0 EPC (Cl Salt) 328268-13-9

890704C-10mg10mg1125 18:1 EPC (Cl Salt) 474945-24-9

890704C-25mg25mg1380 18:1 EPC (Cl Salt) 474945-24-9

890704C-100mg100mg4275 18:1 EPC (Cl Salt) 474945-24-9

890704C-200mg200mg7425 18:1 EPC (Cl Salt) 474945-24-9

890704P-10mg10mg1275 18:1 EPC (Cl Salt) 474945-24-9

890704P-25mg25mg1530 18:1 EPC (Cl Salt) 474945-24-9

890704P-100mg100mg4425 18:1 EPC (Cl Salt) 474945-24-9

890704P-200mg200mg7575 18:1 EPC (Cl Salt) 474945-24-9

890705C-10mg10mg1125 16:0-18:1 EPC (Cl Salt) 328250-19-7

890705C-25mg25mg1380 16:0-18:1 EPC (Cl Salt) 328250-19-7

890705C-100mg100mg4275 16:0-18:1 EPC (Cl Salt) 328250-19-7

890705C-200mg200mg7425 16:0-18:1 EPC (Cl Salt) 328250-19-7

890705P-10mg10mg1275 16:0-18:1 EPC (Cl Salt) 328250-19-7

890705P-25mg25mg1530 16:0-18:1 EPC (Cl Salt) 328250-19-7

890705P-100mg100mg4425 16:0-18:1 EPC (Cl Salt) 328250-19-7

890705P-200mg200mg7575 16:0-18:1 EPC (Cl Salt) 328250-19-7

890717C-10mg10mg1125 14:1 EPC (Tf Salt) 1246304-44-8

890717C-25mg25mg1380 14:1 EPC (Tf Salt) 1246304-44-8

890717C-100mg100mg4275 14:1 EPC (Tf Salt) 1246304-44-8

890717C-200mg200mg7425 14:1 EPC (Tf Salt) 1246304-44-8

890717O-10mg10mg1275 14:1 EPC (Tf Salt) 1246304-44-8

890717O-25mg25mg1530 14:1 EPC (Tf Salt) 1246304-44-8

890717O-100mg100mg4425 14:1 EPC (Tf Salt) 1246304-44-8

890717O-200mg200mg7575 14:1 EPC (Tf Salt) 1246304-44-8

890808P-5mg5mg2925 22:0 Trehalose 66758-35-8

890808P-10mg10mg5175 22:0 Trehalose 66758-35-8

890808P-25mg25mg11100 22:0 Trehalose 66758-35-8

890810C-25mg25mg1335 18:0 DDAB 3700-67-2

890810C-200mg200mg2325 18:0 DDAB 3700-67-2

890810C-500mg500mg3600 18:0 DDAB 3700-67-2

890810C-1g1g5850 18:0 DDAB 3700-67-2

890810P-25mg25mg1185 18:0 DDAB 3700-67-2

890810P-200mg200mg2175 18:0 DDAB 3700-67-2

890810P-500mg500mg3450 18:0 DDAB 3700-67-2

890810P-1g1g5700 18:0 DDAB 3700-67-2

890820C-25mg25mg1500 18:0 DAP 121315-93-3

890820C-200mg200mg3300 18:0 DAP 121315-93-3

890820C-500mg500mg7200 18:0 DAP 121315-93-3

890820C-1g1g13050 18:0 DAP 121315-93-3

890820P-25mg25mg1650 18:0 DAP 121315-93-3

890820P-200mg200mg3450 18:0 DAP 121315-93-3

890820P-500mg500mg7350 18:0 DAP 121315-93-3

890820P-1g1g13200 18:0 DAP 121315-93-3

890830C-25mg25mg1500 16:0 DAP 96326-74-8

890830C-200mg200mg3300 16:0 DAP 96326-74-8

890830C-500mg500mg7200 16:0 DAP 96326-74-8

890830C-1g1g13050 16:0 DAP 96326-74-8

890830P-25mg25mg1650 16:0 DAP 96326-74-8

890830P-200mg200mg3450 16:0 DAP 96326-74-8

890830P-500mg500mg7350 16:0 DAP 96326-74-8

890830P-1g1g13200 16:0 DAP 96326-74-8

890840C-25mg25mg1500 14:0 DAP 72719-84-7

890840C-200mg200mg3300 14:0 DAP 72719-84-7

890840C-500mg500mg7200 14:0 DAP 72719-84-7

890840C-1g1g13050 14:0 DAP 72719-84-7

890840P-25mg25mg1650 14:0 DAP 72719-84-7

890840P-200mg200mg3450 14:0 DAP 72719-84-7

890840P-500mg500mg7350 14:0 DAP 72719-84-7

890840P-1g1g13200 14:0 DAP 72719-84-7

890850C-25mg25mg1500 18:1 DAP 127512-29-2

890850C-200mg200mg3300 18:1 DAP 127512-29-2

890850C-500mg500mg7200 18:1 DAP 127512-29-2

890850C-1g1g13050 18:1 DAP 127512-29-2

890850O-25mg25mg1650 18:1 DAP 127512-29-2

890850O-200mg200mg3450 18:1 DAP 127512-29-2

890850O-500mg500mg7350 18:1 DAP 127512-29-2

890850O-1g1g13200 18:1 DAP 127512-29-2

890860C-25mg25mg1650 14:0 TAP 197974-74-6

890860C-200mg200mg3450 14:0 TAP 197974-74-6

890860C-500mg500mg7350 14:0 TAP 197974-74-6

890860C-1g1g13200 14:0 TAP 197974-74-6

890860P-25mg25mg1500 14:0 TAP 197974-74-6

890860P-200mg200mg3300 14:0 TAP 197974-74-6

890860P-500mg500mg7200 14:0 TAP 197974-74-6

890860P-1g1g13050 14:0 TAP 197974-74-6

890870C-25mg25mg1650 16:0 TAP 139984-36-4

890870C-200mg200mg3450 16:0 TAP 139984-36-4

890870C-500mg500mg7350 16:0 TAP 139984-36-4

890870C-1g1g13200 16:0 TAP 139984-36-4

890870P-25mg25mg1500 16:0 TAP 139984-36-4

890870P-200mg200mg3300 16:0 TAP 139984-36-4

890870P-500mg500mg7200 16:0 TAP 139984-36-4

890870P-1g1g13050 16:0 TAP 139984-36-4

890880C-25mg25mg1650 18:0 TAP 220609-41-6

890880C-200mg200mg3450 18:0 TAP 220609-41-6

890880C-500mg500mg7350 18:0 TAP 220609-41-6

890880C-1g1g13200 18:0 TAP 220609-41-6

890880P-25mg25mg1500 18:0 TAP 220609-41-6

890880P-200mg200mg3300 18:0 TAP 220609-41-6

890880P-500mg500mg7200 18:0 TAP 220609-41-6

890880P-1g1g13050 18:0 TAP 220609-41-6

890890C-25mg25mg1500 18:1 TAP (DOTAP) 132172-61-3

890890C-200mg200mg3300 18:1 TAP (DOTAP) 132172-61-3

890890C-500mg500mg7200 18:1 TAP (DOTAP) 132172-61-3

890890C-1g1g13050 18:1 TAP (DOTAP) 132172-61-3

890890E-25mg25mg1800 18:1 TAP (DOTAP) 132172-61-3

890890E-200mg200mg3600 18:1 TAP (DOTAP) 132172-61-3

890890E-500mg500mg7500 18:1 TAP (DOTAP) 132172-61-3

890890E-1g1g13350 18:1 TAP (DOTAP) 132172-61-3

890890P-25mg25mg1650 18:1 TAP (DOTAP) 132172-61-3

890890P-200mg200mg3450 18:1 TAP (DOTAP) 132172-61-3

890890P-500mg500mg7350 18:1 TAP (DOTAP) 132172-61-3

890890P-1g1g13200 18:1 TAP (DOTAP) 132172-61-3

890895C-25mg25mg1500 18:1 TAP (DOTAP, MS Salt) 144189-73-1

890895C-200mg200mg3300 18:1 TAP (DOTAP, MS Salt) 144189-73-1

890895C-500mg500mg7200 18:1 TAP (DOTAP, MS Salt) 144189-73-1

890895C-1g1g13050 18:1 TAP (DOTAP, MS Salt) 144189-73-1

890895P-25mg25mg1650 18:1 TAP (DOTAP, MS Salt) 144189-73-1

890895P-200mg200mg3450 18:1 TAP (DOTAP, MS Salt) 144189-73-1

890895P-500mg500mg7350 18:1 TAP (DOTAP, MS Salt) 144189-73-1

890895P-1g1g13200 18:1 TAP (DOTAP, MS Salt) 144189-73-1

890898C-25mg25mg2850 DOTMA 104872-42-6

890898C-200mg200mg6000 DOTMA 104872-42-6

890898C-500mg500mg13500 DOTMA 104872-42-6

890898C-1g1g24150 DOTMA 104872-42-6

890898P-25mg25mg3000 DOTMA 104872-42-6

890898P-200mg200mg6150 DOTMA 104872-42-6

890898P-500mg500mg13650 DOTMA 104872-42-6

890898P-1g1g24300 DOTMA 104872-42-6

900100P-1mg1mg510 PGE1 745-65-3

900100P-5mg5mg1725 PGE1 745-65-3

900100P-10mg10mg3075 PGE1 745-65-3

900100P-50mg50mg13350 PGE1 745-65-3

900105P-1mg1mg780 PGF1α 745-62-0

900105P-5mg5mg3150 PGF1α 745-62-0

900105P-10mg10mg4875 PGF1α 745-62-0

900105P-50mg50mg22200 PGF1α 745-62-0

900110P-1mg1mg1005 PGF1ß 10164-73-5

900110P-5mg5mg3825 PGF1ß 10164-73-5

900110P-10mg10mg6975 PGF1ß 10164-73-5

900110P-50mg50mg30450 PGF1ß 10164-73-5

900115P-1mg1mg1005 PGA1 14152-28-4

900115P-5mg5mg3825 PGA1 14152-28-4

900115P-10mg10mg6975 PGA1 14152-28-4

900115P-50mg50mg30450 PGA1 14152-28-4

900120O-1mg1mg1005 PGB1 13345-51-2

900120O-5mg5mg3825 PGB1 13345-51-2

900120O-10mg10mg6975 PGB1 13345-51-2

900120O-50mg50mg30450 PGB1 13345-51-2

900150O-1mg1mg1725 CoQ6 1065-31-2

900150O-5mg5mg6375 CoQ6 1065-31-2

900151P-1mg1mg1725 CoQ8 2394-68-5

900151P-5mg5mg6375 CoQ8 2394-68-5

900200O-1mg1mg1185 Dolichol (13~21) 153857-77-3

900200O-2mg2mg2025 Dolichol (13~21) 153857-77-3

900200O-5mg5mg4350 Dolichol (13~21) 153857-77-3

900210O-1mg1mg1185 Polyprenol (13~21) 153857-77-3

900210O-2mg2mg2025 Polyprenol (13~21) 153857-77-3

900210O-5mg5mg4350 Polyprenol (13~21) 153857-77-3

900220O-1mg1mg1185 Polyprenal (13~21) 1246745-16-3

900220O-2mg2mg2025 Polyprenal (13~21) 1246745-16-3

900220O-5mg5mg4350 Polyprenal (13~21) 1246745-16-3

900300M-1mg1mg1950 C32:6 fatty acid

900300M-5mg5mg7950 C32:6 fatty acid

900300M-10mg10mg14250 C32:6 fatty acid

999800P-25mg25mg5175 14:0 Diether PG 384835-62-5

999800P-200mg200mg18000 14:0 Diether PG 384835-62-5

999800P-500mg500mg36000 14:0 Diether PG 384835-62-5

999971P-50mg50mg780 1-C16 Ether MG 506-03-6

999971P-100mg100mg1365 1-C16 Ether MG 506-03-6

999971P-250mg250mg2850 1-C16 Ether MG 506-03-6

999971P-500mg500mg5100 1-C16 Ether MG 506-03-6

999972P-50mg50mg780 1-C16-2-C1 DG 96960-92-8

999972P-100mg100mg1365 1-C16-2-C1 DG 96960-92-8

999972P-250mg250mg2850 1-C16-2-C1 DG 96960-92-8

999972P-500mg500mg5100 1-C16-2-C1 DG 96960-92-8

999984C-5mg5mg1500 4ME 16:0 Diether PC 200715-69-1

999984C-10mg10mg1950 4ME 16:0 Diether PC 200715-69-1

999984C-25mg25mg4350 4ME 16:0 Diether PC 200715-69-1

999984C-50mg50mg6825 4ME 16:0 Diether PC 200715-69-1

999984C-200mg200mg18000 4ME 16:0 Diether PC 200715-69-1

999984P-5mg5mg1650 4ME 16:0 Diether PC 200715-69-1

999984P-10mg10mg2100 4ME 16:0 Diether PC 200715-69-1

999984P-25mg25mg4500 4ME 16:0 Diether PC 200715-69-1

999984P-50mg50mg6975 4ME 16:0 Diether PC 200715-69-1

999984P-200mg200mg18150 4ME 16:0 Diether PC 200715-69-1

999985C-5mg5mg1500 4ME 16:0 Diether PE 150135-14-1

999985C-10mg10mg1950 4ME 16:0 Diether PE 150135-14-1

999985C-25mg25mg4350 4ME 16:0 Diether PE 150135-14-1

 

PC-12未分化(大鼠肾上腺嗜铬细胞瘤)

产品型号

品       牌

产品简介

金畔生物专业代理销售各种源正常组织,肿瘤细胞株,咨询

详情介绍

 

QGY(人肝癌细胞)
PC-12(大鼠肾上腺嗜铬细胞瘤)
NIH3T3(小鼠胚胎成纤维细胞)
L-02(人肝细胞)
K562(人慢性髓原白血病)
NB-4(人急性早幼粒白血病细胞)
6T-CEM(T细胞白血病)
Jurkat(T细胞白血病)
HEPG2(人肝囊胚细胞)
Hep3B(人肝癌细胞)
COS-7(SV40转化的非洲绿猴肾细胞)
CHO(中国仓鼠卵巢细胞)
ANA-19(T细胞)
293(Ad5DNA转化的胚肾细胞)
B16(小鼠黑色素瘤细胞)
MCF-7(人乳腺癌细胞)
A549(人肺腺癌细胞)
5637(人膀胱癌细胞)
F9(畸胎瘤细胞)
NCL-H460(非小细胞肺癌)
CBRH-7919(大鼠肝癌细胞)
SHZ-88(大鼠乳腺癌细胞)
C6(脑胶质瘤细胞)
293(转染腺病毒E1A基因的人肾上皮细胞)
HEL(红白血病细胞)
PT-67(病毒转染小鼠细胞)
U937(组织细胞淋巴瘤)
V79(中国仓鼠肺细胞)
LoVo(人结肠癌细胞)
SHG44(胶质瘤细胞)
Meg-01(人巨核细胞白血病)
J82(膀胱癌细胞)
RT4(膀胱癌细胞)
TCHu13CNE(人鼻咽癌细胞)
RD(恶性胚胎横纹肌瘤)
K562(慢性髓原白血病
CHRF(人巨核细胞白血病)
A375(人类恶性黑色素瘤)
T-24(膀胱变移细胞癌)
THP-1(人单核细胞)
WI-38(人二倍体胚肺细胞)
PC-12未分化(大鼠肾上腺嗜铬细胞瘤)
JAR(胚绒毛癌细胞)
Jecket(淋巴瘤细胞)

dds-drug磷脂和脂质产品目录

 

dds-drug磷脂和脂质产品目录

NOF从试剂到制药的批量供应高纯度磷脂,磷脂衍生物和脂质体。使用合成和纯化技术,我们开发了各种种类和等级的产品。批量磷脂是在GMP操作下在工厂中生产的,多年来一直在范围内提供很高的声誉。

NOF为天然磷脂提供纯化的鸡蛋PC,鸡蛋PG,大豆PC,氢化大豆PC和鞘磷脂。

关于合成磷脂,PC系列有DDPC,DLPC,DMPC,DPPC,DSPC,DOPC,POPC和DEPC。PG系列提供DMPG,DPPG,DSPG和POPG。DMPA,DPPA和DSPA在PA系列中可用。PE系列提供DMPE,DPPE,DSPE和DOPE。PS系列中有DOPS现货供应。PEG或聚甘油连接的磷脂(PG磷脂)可用于长循环脂质体制剂。

PEG末端或非PEG末端的活化的官能团连接的磷脂也可用于免疫脂质体或靶向用途脂质体。

对于非注射使用,建议将DPPC,POPC和POPG用于肺部递送,而建议将DOPC,POPC和DDPC用于鼻腔。

我们还提供定制的磷脂合成方法,并为药物输送系统(DDS)提供*的脂质体研究试剂盒(空脂质体)。

 

能力

cGMP生产设施
NOF磷脂是在cGMP操作下在工厂生产的,多年来在范围内以良好的声誉提供。

 

美国药品
监管总局(NOF)已向美国FDA提交了涉及多种磷脂的19种DMF,以便客户依赖我们的质量。我们根据客户的要求和发展提交DMF。

  • 1.天然来源的纯化磷脂
  • 2.高度纯化的合成磷脂
  • 3. PEG磷脂
  • 4. PEG二酰基甘油
  • 5.高纯度阳离子脂质
  • 6. SS可裂解且对pH敏感的类脂质物质(COATSOME®SS系列) 
 
COATSOME®CL-8181DA(DODAP)
 

DODAP 
1,2-二油酰氧基-3-二甲基氨基丙烷


 
COATSOME®CL-8181TA(DOTAP)
 

DOTAP 
1,2-二油酰氧基-3-*基氯化铵丙烷


 
COATSOME®CL-E8181DA(DODMA)
 

DODMA 
1,2-二油基氧基-3-二甲基氨基丙烷


 
COATSOME®CL-E8181TA(DOTMA)
 

DOTMA
1,2-二油基氧基-3-*基氯化铵丙烷


 
COATSOME®FE-4040GL(DMPE-Glu)
 

DMPE-Glu 
N-谷氨酰-L-α-磷脂酰乙醇胺,二肉豆蔻酰基


 
COATSOME®FE-4040MA3(DMPE-MAL)
 

DMPE-MAL 
N-(3-马来酰亚胺-1-氧丙基)-L-α-磷脂酰乙醇胺


 
COATSOME®FE-4040SU5(DMPE-NHS)
 

DMPE-NHS 
N-(琥珀酰亚胺氧基-戊二酰)-L-α-磷脂酰乙醇胺,二肉豆蔻酰基


 
COATSOME®FE-6060DT
 

DMPE-Glu 
N-谷氨酰-L-α-磷脂酰乙醇胺,二肉豆蔻酰基


 
COATSOME®FE-6060DT(DPPE-PDP)
 

DPPE-PDP 
N- [3-(2-吡啶基二硫代)-1-氧丙基]-L-α-磷脂酰乙醇胺,双棕榈酰


 
COATSOME®FE-6060GL(DPPE-Glu)
 

DPPE-Glu 
N-谷氨酰-L-α-磷脂酰乙醇胺,双棕榈酰


 
COATSOME®FE-6060MA3(DPPE-MAL)
 

DPPE-MAL 
N-(3-马来酰亚胺-1-氧丙基)-L-α-磷脂酰乙醇胺,双棕榈酰


 
COATSOME®FE-6060SU5(DPPE-NHS)
 

DPPE-NHS 
N-(琥珀酰亚胺氧基-戊二酰基)-L-α-磷脂酰乙醇胺,双棕榈酰

labartsci PC-0200-9B说明书

labartsci PC-0200-9B说明书

 

200UL 96-WELL PCR PLATE, SEMI-SKIRTED 

200UL 96孔PCR板,半裙边

200ul 96-well PCR plate, semi-skirted

 

 

应用:经典热循环,实时循环
兼容于:ABI,MJ / Biorad,Eppendorf,Biometra,Gorbett Research / Qiagen,Ericom,Esco,G-Storm,MWG,Stratagene,TaKara Techne,Thermo / Hybaid
 

Pkgs 10 /盒,50 /箱

货号#PC-0200-9B

 

产品特性
●USP VI级和FDA批准的医用级聚丙烯
●创新的设计和制造确保机械稳定性
●紧密密封,易于处理,低蒸发
●小的样品吸附确保系统精度 
●壁厚均匀且薄,可实现的热传递和光传输
●经认证不含DNase,RNase,蛋白酶和内毒素
●可选条形码